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Abstract 
 
   Alzheimer’s disease (AD) is anticipated to be a serious social problem since the 
average human life span is increasing. Although the pathology of AD is still unclear, it 
has been reported that the deficit of NGF in the brain may be closely related to the cause 
of AD. A number of in vivo animal tests have suggested that NGF has promising 
potential for the treatment of AD. However, the difficulty of delivering NGF to the brain 
has become an obstacle in its therapeutic application. Thus, administering of 
NGF-potentiating substances has been suggested to be an alternative strategy to treat 
AD.  
   In this Ph.D. study, two NGF-mediated neurite outgrowth promoting substances, 
designated as MC14 and MC22, were isolated from a brown alga Sargassum 
macrocarpum. Various aspects of their NGF-potentiating activities, and their 
mechanisms of action were investigated. Regarding the biological activities, MC14 
(sargaquinoic acid) caused a marked enhancement of the NGF-mediated neurite 
outgrowth from PC12D cells in a dose-dependent manner. MC14-enhanced neurite 
outgrowth was completely blocked by a mitogen-activated protein kinase (MAP) kinase 
inhibitor, PD98059, while the promoting effect of MC14 was substantially blocked by 
protein kinase A inhibitor. However, a protein kinase C inhibitor, chelerythrine chloride 
did not significantly inhibit the neurite outgrowth promoting effect of MC14. These 
results demonstrate that MC14 promotes neurite outgrowth via the activation of PKA 
and MAP kinases-mediated signaling pathway in PC12D cells. Study of its 
structure-activity relationship indicated that the benzoquinone of MC14 molecule is the 
structurally essential moiety for the function of MC14. Besides, the substitution of the 
 xvi 
benzoquinone at 1’-position with a hydroxy group may significantly enhance its 
NGF-potentiating activity. Regarding the enzymatic activity, bioassay of the 
acetylcholin-esterase activity in PC12D cells revealed that treatment of PC12D cells 
with 3 µg/ml MC14 and 50 ng/ml NGF significantly increased the specific AchE 
activity by 1.5-fold compared with those treated with 50 ng/ml NGF alone. These 
results suggest that MC14 promotes morphological as well as biochemical 
differentiation of PC12D cells. Concerning the neuroprotective effect, MTT 
measurement indicated that the viability of neuronal PC12D cells decreased 
substantially in NGF-deprived serum-free medium. However, treatment of cells with 
MC14 significantly promoted the NGF-induced survival of neuronal PC12D cells in 
serum-free medium. Approximately 25-40% enhancement of viable cells were detected 
by the treatment of cells with 1.5 µg/ml MC14 in the presence of 0.02-50 ng/ml NGF, 
compared with the NGF-only control. Unexpectedly, MC14 alone also exhibited 
significant neuronal survival supporting effect on neuronal PC12D cells incubated in 
NGF-deprived serum-free medium. These results imply that MC14 may effectively 
rescue the neuronal cells in NGF-deficient or even NGF-deprived condition. In addition, 
MC14 showed protective effect on PC12D cells against hydrogen peroxide-induced 
oxidative stress, implying that MC14 may protect cells from free radical-mediated 
cellular damage. Apart from the neuroprotective activity, neurite-regenerating effect of 
MC14 was analysed by the use of neurite-sheared neuronal PC12D cell model. 
Microscopic observation showed that the number of neurite-regenerated cells increased 
from 1.9-fold to 3.6-fold after the neurite-sheared cells were treated with 3 µg/ml MC14 
in the presence of NGF at 0.4-50 ng/ml, compared with the MC14-untreated control.  
   Collectively, the neurite outgrowth enhancing activity, neuronal survival supporting 
 xvii
activity and neurite regeneration promoting activity of MC14 clearly demonstrate that 
MC14 may be a promising candidate as a therapeutic agent to treat neurodegenerative 
diseases such as Alzheimer’s disease. On the other hand, MC22 also exhibited neurite 
outgrowth promoting and survival supporting activities on PC12D cells, although they 
were less effective than those of MC14.    
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Chapter I 
General Introduction 
 
 
1. Aging society 
 
   The average life expectancy has increased, especially since the turn of 20th century, 
although the maximum number of years that human beings can live has not increased 
significantly in the recorded history, In some countries such as Scandinavia and the 
European Union, the population over age of 60 is projected to rise 30% by the year 
2030 (Whitehouse, 1997). In Japan, the birth rate is below replacement levels, so that 
the ratio of active workers to retirees in the future will cause significantly social, 
economic and political strains. This increasing tendency of life span has unmasked a 
new epidemic – dementia, which is defined as the deterioration of mental function.  
 
2. Aging in brain 
 
   Several hypotheses have been proposed for the mechanisms of aging, including the 
DNA mutations, chromosome anomalies, and errors in duplication of DNA (Medvedev, 
1972). Another theory, based on the work of Hayflick (1965), has proposed that cells 
possess a biological clock that dictates their life span. These studies indicate that at least 
some aspects of aging are intrinsic. No matter what mechanisms exactly cause aging in 
brain, some general changes occur in the brain with age, such as decrease in brain 
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weight, decrease in the level of proteins, shrinkage and loss of neurons, changes in 
cholinergic function, and reduction in enzymes that synthesize dopamine and 
norepinephrine. These age-related alterations in the brain appear to be normal. However, 
the age-related neurodegeneration accelerates and intensifies these changes, leading to 
dementia.  
 
3. Age-related neurodegenerative disorders 
 
(1) Dementia 
   Dementia is defined as a progressive decline in mental function, memory and 
acquired intellectual skills. Although dementia is not an inevitable consequence of aging, 
it is age-related. It is dehumanizing if a patient’s intellectual capacity deteriorates to an 
extent that the performance of routine daily activities is impaired. Several forms of 
dementia have been distinguished, the most common cause of dementia is Alzheimer’s 
disease.  
 
(2) Alzheimer’s disease  
Alzheimer’s disease (AD) accounts for about 70% of all cases of dementia, and is the 
leading cause of loss of independent living (Brinton & Yamazaki, 1998). Alzheimer’s 
Disease International estimates that there are currently 12 million AD patients 
worldwide (http://www.alz.co.uk/alz/index.html). The health care costs for AD in the USA 
alone have been estimated to be greater than $1000 billion dollars (Whitehouse, 1997). 
AD is characterized by a progressive loss of cognitive function over a period of 5-15 
years before death ultimately occurs (Henderson, 1997). The first symptoms of AD are 
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deficits in memory function, which increases in severity with increasing duration of the 
disease. At the later stage, most AD patients will exhibit deficits in higher cognitive 
functions such as abstract reasoning, judgement and language. Affective disturbances 
such as apathy, depression, agitation, anxiety or delusion are also apparent (Brinton & 
Yamazaki, 1998). With the increase in human life span, the number of AD patients is 
expected to drastically increase because age is the greatest risk factor for this 
devastating disease.    
 
(3) Pathology of Alzheimer’s disease 
   It is clear that AD is a multifactorial degenerative process (Roses, 1996). About 10% 
of AD is caused by familiar type. Among them, the mutations in chromosomes 1, 14, 19, 
and 21 have been identified as an inheritance factor for the disease. The remaining 90% 
of AD cases is classified as spontaneous AD (Spilantini et al., 1998). One of the 
pathological hallmarks of AD is the formation of beta amyloid plaques, which are 
accumulations of an insoluble form of beta amyloid protein with 42 amino acids, in the 
extracellular space in the brain (Crystal, et al., 1988). The intracellular characteristic of 
AD is the neurofibrillary tangles, which are mainly generated by paired helical 
filaments linked together by hyperphosphorylated tau proteins (Solodkin & Hoesen, 
1997). No matter what pathology cause AD, the brain will suffer from loss of synapses 
and ultimately neuronal death. Thus, the shrinkage of brain and drastic reduction of 
brain weight are the typical characteristics of AD patients.  
 
(4) Neuronal cell death in AD 
   Two forms of neuronal cell death have been identified within the central nervous 
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system (CNS) – necrosis and apoptosis (Altman, 1992). Apoptosis is defined as a 
process of active cell death, characterized by cell and nuclear shrinkage, chromatin 
condensation, and membrane blebbing. In contrast, necrosis has been characterized by 
cellular swelling and lysis resulting in a cytokine-mediated inflammatory response. 
Besides, necrosis results in the appearance of random DNA fragmentation whereas 
apoptosis is associated with the cleavage of DNA into fragments with 
oligonucleosomal-sizes (Altman, 1992; Dragunow & Preston, 1995). Neuronal cell 
death in AD has been postulated to occur via apoptosis. Recent research has indicated 
that DNA fragmentation occurs in cells within the temporal cortex and hippocampus of 
patients with AD (Su et al., 1994; Dragunow et al., 1995; Anderson et al., 1996), further 
suggesting that apoptosis may be the process of neuronal death observed in AD brain.        
 
4. Pharmaceutical strategies to treat AD 
 
   In this decade, various approaches have been immerged, showing promises to treat 
AD. They include hormone replacement approaches such as estrogen replacement 
therapy (Birge, 1997); anti-inflammatory approaches such as the use of steroidal and 
nonsteroidal anti-inflammatory drugs (McGeer & Rogers, 1992); cholinergic 
pharmaceutic approaches such as the treatment with cholinergic agonists (Bowen, 
1981); gene therapies which address the mutations in three genes (amyloid precursor 
protein, presenilin 1 and 2) (Clark & Goate, 1997); and neurotrophic factor approach 
(Olson, 1993). In this study, the approach of using neurotrophic factor is concentrated 
and so it will be described in detail in the following sections.  
5. Nerve growth factor and the treatment of Alzheimer’s disease 
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   Considerable evidence from both animal and human studies suggests that 
cholinergic systems are important for learning, momory and cognition (Nicholls et al., 
1992). Interest in the role of basal forebrain cholinergic neurons in learning and memory 
has increased after finding that declines in cognitive capacity with aging are paralleled 
with the loss of cholinergic neurons in the basal forebrain (Dunnett, 1991). This is 
particularly pronounced in patients with AD. On the other hand, it has been known that  
NGF can bind to cholinergic neurons of the basal forebrain and prevent their 
degenerations under certain experimental conditions (Nicholls et al.,1992). These led to 
the suggestion that neuronal degeneration in AD may be prevented or slowed down by 
the treatment of NGF. The location of hippocampus in the brain and cholinergic 
innervations of the cortex and hippocampus by neurons in the septal nuclei and nucleus 
basalis are shown in Fig. 1-1.          
 
6. Physiological functions of NGF 
 
(1) Survival support  
   For an adult brain, the main role of NGF is to support the survival and maintain the 
functions of neurons. NGF is produced by the tissues that are innervated by 
NGF-dependent neurons such as cholinergic, sympathetic and sensory neurons in the 
CNS. Experimental manipulations have confirmed that the larger the quantity of target 
tissue, the larger the number of survival neurons (Nicholls et al., 1992). In vitro studies 
have shown the NGF-sensitive neurons die if their axons are cut in the adult brain. 
However,  
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Fig. 1-1. (A) Location of hippocampus in the brain. (B) Cholinergic innervation 
of the cortex and hippocampus by neurons in the septal nuclei and nucleus 
basalis (Nicholls et al., 1992).  
A 
B 
Hippocampal 
formation 
Subiculum Dentate gyrus 
Hippocampus 
Hippocampus Nucleus basalis 
Cingulate bundle 
External capsule 
Septal nuclei 
 
 
Chapter I  General Introduction 
 7 
these neurons survive axotomy if NGF is infused into the CNS (Fischer et al., 1989). 
These results clearly suggest that the survival of these neurons can be directly 
manipulated by the application of NGF.  
   One of the most important findings demonstrating the capability of NGF to treat AD 
is that the basal forebrain cholinergic neurons (BFCNs) respond to and depend on NGF 
for phenotypic maintenance and neuronal survival (Hefti & Weiner, 1986; Thoenen et 
al., 1987; Whittemore & Seiger, 1987; Chen et al., 1989; Cuello, 1993; Lapchack, 
1993). These findings strongly support the potential use of NGF to prevent the 
cholinergic neuronal loss observed in AD pathology since BFCNs are selectively 
vulnerable in AD and the impairment of their functions may be responsible for the 
cognitive deficits observed in AD (Hefti, 1986; Lapchack, 1993). Besides, chronic  
treatment with NGF has been observed to increase the capacity of surviving 
hippocampal cholinergic neurons to synthesis, store and release acetylcholine, which is 
the neurotransmitter that promote nerve functions (Lapchack & Hefti, 1991). On the 
other hand, one of the well-known neurotrophic action of NGF is that it can protect 
neurons against axotomy-induced neurodegeneration and aged-related atrophy (Hefti et 
al., 1984). NGF can also protect cultured hippocampal and cortical neurons from 
excitotoxic injury (Shimohama et al., 1993; Mattson et al., 1995).   
   Concerning the molecular mechanisms of NGF, it has been proposed that NGF plays 
a role in its survival supporting action by suppressing the expression of certain ‘suicide 
genes’, which will induce apoptotic cell death when activated (Estus et al., 1994; Ham 
et al., 1995). The loss of transcriptional suppression of the ‘suicide programme’ due to 
the deficit of NGF level may result in the neuronal atrophy observed in normal aging 
and the neuronal loss in AD patients. Recent findings have shown that a transcription 
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factor, nuclear factor κB (NF-κB) may be activated by NGF-mediated intracellular 
signal to support survival of sympathetic neurons and neuronally differentiated PC12 
cells (Taglialatela et al., 1997; Maggirwar et al., 1998) although the mechanisms by 
which NF- κB protects neurons from apoptosis remain poorly understood. Previous 
studies showed a significant induction in the level of the immediate-early-genes, c-Jun 
and c-Fos in cultured sympathetic neurons that were destined to die (Estus et al., 1994; 
Ham et al., 1995). Therefore, the activation of NF- κB by NGF might suppress the 
expression of c-Jun, leading to the rescue of neurons. 
 
(2) Neuroprotection against oxidative stress 
   It is known that generation of free radicals causes neuronal cell death. Extensive 
work has been demonstrated that NGF provides protection from 6-hydroxydopamine, a 
neurotoxin generates hydrogen peroxide (Castiglioni & Perez, 1981; Perez & Werbach, 
1987). The NGF-mediated protection from free radicals generated by direct application 
of hydrogen peroxide has also been demonstrated. NGF may protect neuronal cells from 
this peroxidative events and consequent cell death by the induction of free radical 
detoxifying mechanism such as catalase activity (Jackson et al., 1990).  
 
(3) Neural differentiation  
   The most obvious neurotrophic action of NGF for neural differentiation is its neurite 
outgrowth inducing effect. If a small piece of a dorsal root ganglion or sympathetic 
ganglion is placed in a culture dish in a nutrient medium, the neurons only extend short 
neurites. However, if NGF is added to the medium, the neurite outgrowth of the neurons 
is strongly stimulated (Mattews, 1998). Apart from inducing neurite outgrowth, NGF 
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acts as a chemotropic signal for directing the growth of neurite. A classical experiments 
conduced by Levi-Montalcini (1978) indicated that neurites tend to grow toward regions 
containing high concentration of NGF. 
   Induction of neural differentiation by NGF is regulated by the expression of great 
diversity of gene expressions, leading to the activation of enzymes for the synthesis of 
neurotransmitter, cellular adhesion molecules and ion channels, and cell cycle arrest 
(Yan & Ziff, 1997; Li & Wurtman, 1998; Noma et al., 1999; Bang et al., 2000; Chou et 
al., 2000; Keller & Grover, 2000). 
 
(4) Axonal regeneration   
   If a neuron is disconnected from its target by severing its axon, a characteristic 
sequence of changes occurs. As shown in Fig. 1-2, when the axon is severed, the distal 
portion and a short length of proximal portion of the axon degenerate from the site of 
lesion. Subsequently, the glial cells will dedifferentiate and phagocytize the axonal 
remnants. Within a few hours, new axonal sprouts will emerge from near the tip of the 
proximal stump and begin regenerating. If the neuron successfully reestablishes 
synaptic contact with a target, the cell body usually regains its original appearance. If 
the neuron fails to reestablish synaptic contact with its target, the neuron usually shrinks 
and finally dies. For NGF-sensitive neurons such as sympathetic neurons and sensory 
neurons, the nearby Schwann cells proliferate and synthesize NGF, which sustain the 
neurons, stimulate their axonal regeneration, and provide guidance for the navigation of 
the axonal growth cone to reconnect to their targets (Nicholls et al., 1992).  
   Previous report has described that NGF stimulates the synthesis of structural neural 
proteins such as growth-associated protein and Tα1 α-tubulin in neuronal cell body  
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Fig. 1-2. Degenerative changes after axotomy. (A) A typical motor neuron in an 
adult vertebrate. (B) After axotomy the nerve terminal, the distal segment of the 
axon, and a short length of the proximal segment of the axon degenerate. 
Schwann cells dedifferentiation, proliferate, and, together with invading 
microglia and macrophages, phagocytize the axonal and myelin remnants. The 
axotomized neuron undersoes chomatolysis, presynaptic terminals retract, and 
degenerative changes may occur in pre- and postsynaptic cells. (C) The axon 
regenerations along the column of Schwann cells within the endoneurial tube and 
sheath of basal lamina that had surrounded the original axon.  
. 
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(Mohiuddin et al., 1995). These cellular alterations induced by NGF are suggested to 
contribute to the microtubules assembling for the regeneration of neurites (Horner & 
Gage, 2000). Several animal models with nerve terminals degeneration have shown that 
administration of human recombinant NGF can facilitate the regeneration of injured 
sensory neuron (Schicho et al., 1999; Horner & Gage, 2000).  
 
7. Experimental evidence for the potential of NGF to treat AD 
 
   Given that the vital relationship between NGF and neurons vulnerable in AD, it has 
been suggested that AD pathology may be due to a deficit of NGF level in the CNS 
(Hefti, 1986, Hefti & Weiner, 1986; Olson 1993; Semkova & Krieglstein, 1999; Wyman 
et al., 1999). A great deal of efforts have been put forth to create a strong foundation for 
the use of NGF to protect cholinergic neurons from death and to restore cholinergic 
innervation to the hippocampus (Connor & Dragunow, 1998). Substantial studies using 
cultured neuronal cells and genetic models of neurodegeneration have demonstrated that 
NGF can effectively prevent neuronal death associated with AD (Connor & Dragunow, 
1998). In addition, the animal studies have been very successful. For example, NGF has 
been shown to significantly ameliorate the neuronal degeneration in rat cerebral cortex 
and hippocampus after ischemic insults (Shigeno et al., 1991; Buchan et al.,1997). 
Effect of NGF in non-human primate brain after fimbrial transection also showed that 
intraventricular infusion of NGF substantially reduced lesion-induced cholinergic 
neuronal degeneration, suggesting that NGF may ameliorate memory impairment  
caused by AD (Tuszynski et al., 1991; Koliatsos et al., 1991; Burgos et al., 1995). On 
the other hand, Smith et al. (1999) reported that NGF gene therapy reverses 
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age-associated neuronal atrophy occurs in the primate brain. In addition, a genetic mice 
model of Downs syndrome, which was used for the study of neurodegeneration in AD, 
has been demonstrated that the atrophy of basal forebrain cholinergic neurons is 
reversed by NGF administration (Holtzman et al., 1993; Holtzman & Mobley, 1994). 
Taken together, the administration of NGF has been suggested to have great potential to 
improve cholinergic function and survival, ameliorate age-related impairment in 
memory and improve cognitive behavior, prevent leison-induced loss of cholinergic 
neurons, and prevent neuronal loss in hippocampus. More importantly, clinical trails 
with AD patients have shown promising results. NGF administration early in the disease 
could potentially much prevent the cholinergic neuronal atrophy observed in the basal 
forebrain of AD patients (Saffran, 1992; Seiger et al., 1993).   
 
8. Limitation of the therapeutic application of NGF  
 
   A major obstacle of NGF therapy in humans is its delivery problem. NGF is a large 
protein molecule (Fig. 1-3) that does not cross the blood-brain barrier (Brinton & 
Yamazaki, 1998). While intraventricular administration in animals is easily achieved 
and regulated, it is not the case for AD patients. So far, the administrations of NGF to 
the human trials are conducted by intracranial or intracerebroventricular infusion of 
NGF into the patient’s brain. As one can expected, it causes great painful to the patient 
during the process of NGF administration. Therefore, the alternative approaches have 
been proposed such as the use of NGF-potentiating substance.    
 
9. Alternative strategy: NGF-potentiating substances 
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α α
γ γ
Zn Zn 
β  β  
Fig. 1-3. Schematic representation of the molecular structure of NGF. NGF is a 
high molecular weight complex composed of two α-subunits, β dimer and two 
γ-subunits. Both α- and γ-subunits have molecular weight of about 26,000 
daltons. The β dimer , which possesses all of the NGF activities, is composed of 
118 residues with a molecular weight of about 26,512 daltons (adapted from 
Varon et al., 1982). 
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   As an alternative strategy of addressing the drug delivery problem, it has been 
suggested that the administration of low molecular weight drugs that can enhance the 
action of NGF may be a promising approach (Aisen & Davis, 1997; Brinton & 
Yamazaki, 1998). As mentioned before, AD pathology may be due to the deficit of NGF 
in the CNS, the administration of such NGF-potentiating drugs may enhance the 
survival supporting action of NGF to protect the neuronal cells from neurodegeneration. 
In the literature, the NGF-potentiating substances have shown promising enhancing 
effect on NGF. Several synthetic compounds such as AIT-082, SR57749A and Aroclor 
1254 have been reported to show NGF-potential effect in vitro (Angus et al., 1995; 
Middlemiss et al., 1995; Pradines et al., 1995). Apart from synthetic compounds, a 
number of naturally occurring substances are also found to be the NGF-enhancers. They 
will be described in the section 10. 
 
10. Sources of NGF-potentiating substances 
 
   A number of natural compounds that exhibit NGF-enhancing effects have been 
successfully isolated from Fungus, medical plants, chinese mushroom, coffee bean, 
marine sponge and the rat basophilic leukemia cells (Suzuki et al., 1998; Ito et al., 
1999; Li et al., 1999; Tohda et al., 1999; Cheung et al., 2000; Li et al., 2000). These 
findings demonstrate that NGF-potential substances can exist in diverse sources. In our 
laboratory, we have been focusing on searching for the NGF-potentiating substances 
from the marine algae because they have been demonstrated to be the potential source 
of unique and pharmacologically useful compounds (Table 1-1). A screening program  
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Table 1-1. Pharmacologically useful compounds from algae. 
Compound Source Use 
Fucosterol Phaeophyta Base for sexual hormone 
Sterols Fucus gardneri 
Sargarrum muticum 
Reduction in blood cholesterol 
levels 
Caulerpin Caulerpa spp. Mild anaesthetics 
Caulerpicin Caulerpa spp. Mild anaesthetics 
Pachydictyol Pachydictyon coriaceum Fungicidal/bacteriocidal activity 
Isozonarol/Zonarol Dictyopteris zonaroides  
Squalene Fucus vesiculosus  
Stypoldione Stypopodium zonale Antitumour properties 
(Adapted from Chapman, 1979) 
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of the marine algae had been conducted in our laboratory from 1994-95 (Sagara et al., 
1997). The bioassay of neurite-outgrowth promoting activity on PC12D cells, a subline 
of PC12 cells, was used for the screening of algae. The screening result will be 
described in section 13. As the PC12 cell line is also a useful model for studying other 
biological effects of NGF on neuronal cells, it will be described in more detail in the 
following section.   
 
11. PC12 cell line: A versatile cell model for studying the actions of NGF on 
neuronal cells 
 
(1) Origin of PC12 cell line 
   Over the past decades, the clonal PC12 cell line has been widely used for various 
model studies on neurons (Greene & Tischler, 1976). PC12 cell line was originally 
cloned in 1975 from the transplantable rat adrenal medullary pheochromocytoma (a 
tumors of the chromaffin cells). PC12 cells share many common properties as 
sympathetic neurons such as responsiveness to NGF, storing and secreting 
catecholamines (Greene & Tischler, 1976). It has been suggested that PC12 cells and 
sympathetic neurons develop from the same embryological origin, therefore, PC12 cells 
possess the pluripotency of a primitive progenitor which can differentiate along the lines 
of either chromaffin cells or sympathetic neurons, with NGF promoting their 
differentiation in a neuronal direction (Greene and Tischler, 1976).  
 
(2) Morphological differentiation in response to NGF  
   A major characteristic of PC12 cells is that they respond to NGF by slowly shifting 
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from a proliferative pheochromocytoma cell-like phenotype (naïve PC12 cells) to that 
of nonproliferating, neurite-bearing sympathetic-like neuron (neuronal PC12 cells). This 
specific feature of PC12 cells has made them an excellent cell model for the study of the 
mechanisms of action of NGF and the role of NGF in developmental neuroscience. In 
addition, the neurite outgrowth response of PC12 cells to NGF provides a useful 
morphological parameter for bioassay of the effect of NGF and other substances that 
can promote the action of NGF (Greene et al., 1987).  
 
(3) Biochemical differentiation  
   PC12 cells are also useful in neurochemical study because they synthesize and store 
the catecholamine neurotransmitters (dopamine and norepinephrine). The levels of 
catecholamine and their synthetic enzymes are comparable to those found in rat 
adrenals (Greene and Tischler, 1976). Besides, it has been found that the 
acetylcholinesterase and choline acetyltransferase activities in PC12 cells can be 
regulated by NGF. The former enzyme has a specific activity that does not vary as a 
function of cell density (Rieger et al., 1980). Thus, the measurement of 
acetylcholinesterase in PC12D cells has become a biochemical marker for the action of 
NGF (Greene & Rukenstein, 1981). 
 
(4) Apoptotic cell death 
   The rapid advancement about the understanding of molecular mechanisms involved 
in neuronal cell death and other neurodegeneration processes including AD may be 
mostly contributed by the research using PC12 cells as neuronal cell death model. 
Neuronal PC12 cells differ from sympathetic neurons in that they can survive without 
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NGF if cultured in the presence of serum (Green & Tischler, 1976). However, neuronal 
PC12 cells rapidly die in serum-free nutrient unless NGF is present (Green, 1978). In 
other words, the neuronally differentiated PC12 cells depend on NGF for their survival 
in serum free medium. The utilization of neuronal PC12 cells in this serum-free 
paradigm has been extensively used to elucidate the mechanisms by which neuronal 
survival and cell death are regulated by NGF. Recent researches have proved that this 
model is also suitable for investigation of the apoptosis mechanisms. Substantial 
evidence has shown that the death of NGF-deprived neuronally differentiated PC12 
cells resembles apoptosis in neurons, including the requirement of new gene expression, 
possibility of cell death blockage by transcription inhibitors, and the DNA 
fragmentation (Batistatou & Greene, 1991; Mesner et al., 1992; Mesner, 1995). These 
features of neuronal PC12 cells establish them as one of the most important model for 
studying neuronal apoptosis.  
 
(5) PC12D cells 
   PC12D cells were first isolated from the PC12 cell cultures by Dr. Sano et al 
(Institute for Developmental Research, Aichi Prefecture Colony, Japan). They found 
that PC12D cells extend neurites in response to NGF more rapidly than the PC12 cells. 
Neurite outgrowth is observed on PC12D cells within 24 h in response to NGF 
(Katoh-Semba et al., 1987) while that on PC12 cells takes about 6-7 days (Greene & 
Tischler, 1976). Therefore, PC12D cells are ideal for screening of large amount of 
samples. Regarding the enzymatic activity, the tyrosine hydroxylase, 
acetylcholinesterase, and ornithine decarboxylase activities in PC12D cells can be 
enhanced by NGF (Katoh-Semba et al., 1987), suggesting that the biochemical events 
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of PC12D cells are similar to those of PC12 cells. 
 
12. Signaling pathways regulating the cellular responses   
 
(1) Protein kinases and signal transduction 
   Phosphorylation and dephosphorylation of cellular proteins provide a molecular 
switch for activating or deactivating the intracellular proteins. Reversible protein 
phosphorylation is mainly manipulated by various protein kinases. Phosphorylation by a  
kinase results in the activation (or sometimes deactivation) of its substrate, which can be 
another kinase or other downstream effector protein. In this way, the intracellular signal 
can be transmitted from the cell surface into nucleus, where the gene transcriptions are 
initiated for various cellular responses such as differentiation, cell division or apoptosis 
(Bruce et al., 1994).  
 
(2) Classification of kinases 
   Protein kinases can be classified based on their regulatory mechanisms. For example, 
protein kinase A (PKA) is activated by the changes in the concentration of intracellular 
second messengers (e.g. cyclic AMP, cyclic GMP, and inositol triphosphate). The 
common feature of this class of  protein kinases is that they are inactive in the absence 
of second messengers. On the other hand, tyrosine receptor kinase A (TrkA) represents 
another group of kinases, which contain receptor domain that can be activated by 
ligand-binding via autophosphorylation (Bruce et al., 1994). Other class of kinases can 
be activated by other kinase, such as the mitogen-activated protein (MAP) kinase (Hardi 
& Hanks, 1995). 
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(3) Role of kinases in signaling transduction network 
   Intracellular signaling pathways form a complex networks that allow the 
interconnect systems of proteins to regulate specific cellular responses. If gene 
expression is involved, signal has to transmit from cytoplasm to nucleus. This job is 
usually carried out by a member of the MAP kinases. There are large number of distinct 
upstream MAP kinase and MAP kinase kinase to provide a cascade that can be 
amplified from the surface signals in order to increase the sensitivity of the responses. 
Recent findings have indicated that several MAPK cascades exist that are activated by 
different external signals (Iwasaki et al., 1999; Klockow et al., 2000; Pouyssegur, 2000). 
It should be noted that cross talk between kinases in the MAP kinase-dependent 
pathways is possible in order to modulate the cellular responses. Other kinases, such as 
protein kinase C (PKC) are believed to coordinate the signaling networks because PKC 
can phosphorylate certain upstream members of the MAP kinase family (Bruce et al., 
1994). In addition, several mediators in the MAP kinase cascades have been identified, 
such as PKC, Raf-1, MEK, ERK, RSK, and GSK3. ERK1 and ERK2 are the first 
MAPK isoforms to be identified in the MAPK family. Following their activation, the 
ERKs phosphorylate a large number of regulatory proteins and thus controlling several 
cellular processes including transcription, translation, and cytoskeletal rearrangement as 
the nuclear targets of activated kinases are believed to be transcriptional activation 
factors. Actually, the signaling pathways have been implicated in the regulation of a 
wide variety of cellular processes such as proliferation, differentiation, development, 
cell cycle, and programme cell death (Bruce et al., 1994).     
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(4) Signaling pathway involved in NGF-induced neurite outgrowth on PC12 cells 
 
   Although the mechanisms underlying neuronal cell differentiation in detail have not 
been fully understood yet, the signaling pathways induced by NGF leading to neurite 
outgrowth on PC12 cells have been characterized. In response to the stimulation of cells 
with NGF, the tyrosine receptor kinase A is activated by autophosphorylation on 
tyrosine resides. The autophosphorylation of TrkA results in the activation of a serious 
of adapter molecules including SHC, GRB, and SOS by protein-protein interactions. 
They activate multiple downstream effector proteins such as a small GTP binding 
protein, Ras, which in trun activates Ras-MAP kinase signaling cascade via MEK. The 
activated MAP kinase translocates into nucleus and activates Elk-1-dependent gene 
transcription, which initiates neurite outgrowth response in PC12 cells (Yoon et al., 
1997; Encinas et al., 1999). It has been reported that other pathways can also be 
involved in neurite outgrowth and they seem to be NGF-independent. These signaling 
pathways include cyclic AMP-mediated pathway or PKC-dependent pathways. Some 
cross-talk between the signal cascades may exist although most of these signals are 
transmitted via sequential activation of cytoplasmic protein kinases (Matthews, 1998). 
As described above, the intracellular signaling systems activated by NGF are 
complicated, and other cellular responses induced by NGF have not been fully 
elucidated. This complexity is expected for activating a wide variety of genes in the 
proper sequence to produce a functional neuron (Matthews, 1998). 
 
(5) Signaling molecule inhibitors  
   Various signaling molecular inhibitors for each class of kinase have been widely 
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used to investigate the functions of certain kinases, and to identify their corresponding 
signaling pathways in regulating neuronal cell processes in response to external stimuli 
or neurotrophic factors (Felipo et al., 1990; Pawlowska et al., 1993; Pang et al., 1995). 
Specific inhibitors can act on both catalytic and regulatory domains of target kinases to 
prevent substrate interaction, or to block the ATPase activity. For example , a PKC 
inhibitor, chelerythrine chloride can bind to the active site of the kinase while another 
PKC inhibitor, calphostin C inhibits the cofactor binding (Felipo et al., 1990). Some 
inhibitors are non-specific as they can inhibit a number of different protein kinases or 
similar isozymes. For example, K252a can inhibit general intracellular protein kinases 
and it can also specifically inhibit TrkA receptor at a much lower effective concentration 
for general kinase inhibiton (Pawlowska et al., 1993).  
 
13. Research objectives 
 
   The screening of a total number of 299 algal species from 598 collected samples has 
led to the identification of a neural active compound, which was designated as MC14, 
from a marine brown alga, Sargassum macrocarpum collected from Kashiwa island, 
Saga, Japan (Fig. 1-4). Bioassay result indicated that MC14 significantly enhances the 
NGF-induced neurite outgrowth from PC12D cells (Sagara & Kamei, 1998).  
   In this doctoral thesis research, the primary objective is to elucidate the chemical 
structure of MC14. The modified procedure for the purification, and the results of 
chemical structure analysis of MC14 will be described in chapter II.  
   In chapter III, the distribution of MC14 in the algal body of S. macrocarpum was 
studied for exploring the possibility of simplifying the original purification procedure of 
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MC14. 
  
Fig. 1-4. Sampling location (  ) of the brown alga, Sargassum macrocarpum.
Kyushu 
Kashiwa island 
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  Since the NGF-induced neurite outgrowth on PC12D cells is the most obvious 
indication of NGF’s action, the NGF-potentiating activity of MC14 was first evaluated 
by examining its NGF-mediated neurite outgrowth promoting activity on PC12D cells. 
Apart from serving as the first evidence of its NGF-potentiating activity, the neurite 
outgrowth promoting effect of MC14 is also an importing implication for its capability 
of promoting neural differentiation during embryonic developmental stage. Therefore, 
this activity was studied in detail, including the mechanisms of action of MC14 in the 
intracellular signaling pathways. The elucidation of signaling pathway mediating the 
MC14-enhanced neurite outgrowth would be important for exogenous manipulation of 
neuronal differentiation. In addition, these results would be useful for understanding the 
regulatory mechanisms leading to this important cellular response during neurogenesis. 
For confirming the use of PC12D cells as important cell model for studying 
neuroscience, the mechanisms of NGF-induce neurite outgrowth in PC12D cells were 
also investigated and these results will be described in chapter IV. On the other hand, a 
biochemical marker, acetylcholinesterase activity was measured in PC12D cells to 
investigate the functional differentiation promoting activity of MC14. 
   As described in chapter I, NGF has diverse neuronal actions, including the induction 
of neural differentiation, neuronal survival support, neuroprotection and 
neuroregeneration. Besides, substantial evidence has indicated that these effects may be 
mediated by different mechanisms via distinct signaling pathways. Therefore, it is 
important to further clarify whether MC14 can promote these neuroprotective effects of 
NGF.  
   Given that the ultimate objective of this study is to evaluate the potential of MC14 
as a therapeutic agent to treat neurodegenerative diseases, it is essential to investigate 
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the neuronal survival supporting activity of MC14. In chapter VI, the survival 
supporting effect of MC14, as well as the NGF-induced survival promoting effect of 
MC14 will be described. To get a further insight into its neuroprotective effect, the 
cellular mechanisms regulating this effect of MC14 on neuronal PC12D cells were 
investigated. Furthermore, as a number of neurodegeneration is resulted from the 
oxidative stress such as the beta-amyloid accumulation in the brain of AD patients, the 
neuroprotective effect of MC14 against oxidative stress was studied. These result will 
be discussed in chapter VI. 
   On the other hand, synaptic connection has important role in normal function of 
nervous system, it has been demonstrated that synapses are usually the first site to be 
affected in neurodegenerative diseases. For investigating whether MC14 can help 
restoring the functional regeneration of  synapses, the neurite regenerating effect of 
MC14 was studied in various aspects, including the neurite degeneration alleviating 
activity, neurite regeneration effect under NGF-deficient condition. Moreover, 
neurite-severed neuronal PC12D cells were used to examine the neurite regrowth 
activity of MC14. These results will be discussed in chapter VII. 
   To analyze the structure-activity relationship of MC14, various structural analogs of 
MC14 were examined for their NGF-induced neurite outgrowth activity. The result will 
be described in chapter VIII. During the comparative study of MC14 analog, vitamin K 
compounds were found to share structural similarity to MC14. To explore the activity of 
vitamin K in the nervous system, the NGF-potentiating activity of vitamin K 
compounds and their mechanisms were studies, and will be described in chapter IX.  
   During a modified procedure for the extraction of MC14, another NGF-potentiating 
substance were identified from the same alga, S. macrocarpum. This substance has been 
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successfully purified and its chemical structure was elucidated. The purification 
procedure, together with the results of NGF-potentiating bioassays will be described in 
chapter X.  
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Chapter II  
Isolation and Purification of MC14 from Sargassum 
macrocarpum  
 
 
   In general, the isolation of natural products is usually achieved by solvent extraction, 
open column chromatography, thin layer chromatography (TLC), and finally purified by 
high performance liquid chromatography (HPLC). Every natural product isolation is 
different and a targeted substance can be isolated and purified by various methods. As 
mentioned in chapter one, the previous algal extraction procedure consumed a relatively 
large amount of chloroform at the initial solvent extraction step. Considering the higher 
cost and high toxicity of chloroform, the isolation procedure has been modified in order 
to extract MC14 from the crude algal extract in a more effective and safer way. In this 
chapter, the detailed modified procedure for the isolation and purification of MC14, its 
physical characteristics and the structural determination of MC14 will be described.    
 
2-1. Materials and Methods 
 
2-1-1. Preparation of crude extracts  
   The algal sample (500 g wet weight) of the brown alga Sargassum macrocarpum 
was washed 3 times with artificial sea water (ASW, Jamarine Laboratory) to remove the 
sands and other debris attached on the algal surface, and once with phosphate buffered 
saline (PBS). The sample was then cut into small pieces and homogenized in 2L PBS 
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with a domestic mixer. The residue after centrifugation at 5000 x g was extracted with 
2L methanol (MeOH) for 1h by a mechanical homogenizer (Polytron, Kinematica) and 
the MeOH-extract was obtained after suction filtration through a #1 filter paper 
(Advantec). The resultant residue was further extracted with 1L chloroform (CHCl3). 
The filtrates of MeOH- and CHCl3-extracts were pooled together and concentrated by 
vacuum-evaporation to minimal volume, and then partitioned with 1L 
hexane-water-methanol (3:2:1) mixture. The fraction of aqueous methanol layer was 
further partitioned with chloroform-methanol-water (3:1:2). The chloroform fraction 
was subjected to the silica gel column chromatography.  
 
2-1-2. Silica gel column chromatography 
   The chloroform-layer collected from solvent extraction described above was 
concentrated to suitable volume and chromatographed on silica gel (silica gel 60, 
Merck) (column size, ∅ 3.2 x 50 cm) eluting with chloroform-methanol (15:1). The 
flow rate was adjusted to 5ml/min and a volume of approximately 5 ml per fraction  
was collected in glass tubes. The active fraction in the following purification step was 
determined in the same way.  
 
2-1-3. Size exclusion chromatography  
   The pooled active fractions obtained from the silica gel open column described 
above were subjected to the size exclusion chromatography (Toyopearl HW-40F, 
TOSOH) (column size, ∅ 3.2 x 50 cm1.7 x 50 cm) with 100% MeOH as eluting solvent. 
Active fractions were pooled, evaporated to suitable volume and then redissolved in 
chloroform-methanol (98:2). 
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2-1-4. High performance liquid chromatography (HPLC) 
   The active factions collected after size exclusion chromatography were purified by 
HPLC using Inertsil SIL column (∅ 20 x 250 mm, GL Science), eluting with 
chloroform-methanol (98:2) at a flow rate of 5 ml/min and detecting at 250 nm by a UV 
detector (UV-970, Jasco). The purified active substance MC14 was confirmed its purity 
by Inertsil SIL HPLC column (∅ 7.6 x 250 mm, GL Science) eluting with 
chloroform-methanol (98:2) at a flow rate of 0.5 ml/min and detecting at 250 nm by a 
UV detector as described above.  
 
2-1-5. UV/VIS absorption spectrometry 
   The UV/VIS spectrum of the purified MC14 was determined in MeOH by a 
spectrophotometer (V-550, Jasco). 
 
2-1-6. Mass spectrometry 
   The molecular weight of MC14 was further confirmed by high resolution electron 
impact mass spectrometry (EI-MS, JMS-DX303, JEOL). 
 
2-1-7. 1H- and 13C-nuclear magnetic resonance (NMR) spectrometries 
   The purified MC14 was measured to obtain 1H - and 13C-nuclear magnetic 
resonance spectra by Toray Research Center. The 1H - and 13C-NMR spectra of MC14 
were recorded in CD3OD by a GSX400 NMR spectrometer and a UNITY INOVA600 
NMR spectrometer (Varian), respectively.  
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2-1-8. Bioassay of neurite outgrowth promoting activity 
   PC12D cells were harvested and seeded at a cell density of 5 X 103 cells per well on 
96-well tissue culture plate. After 24 h incubation in humidified air (5% CO2) at 37˚ C 
in DMEM supplemented with 10% horse serum and 5 % fetal bovine serum, MC14 and 
10 ng/ml NGF were added to the cells. Cells treated with 10 ng/ml and 50 ng/ml NGF 
alone were assigned as negative and positive controls, respectively. After 48 h 
incubation, the neurite outgrowth promoting activity was determined as follow: 
 
 
Neurite-bearing cells were defined as cells with processes twice longer than the 
diameter of their cell bodies. The activity of the sample was compared with 10 ng/ml 
NGF (negative control) and 50 ng/ml NGF (positive control)-treated cultures. For each 
datum point, the mean value was calculated from four random field observations of two 
replicate experiments, and a minimum of 100 cells per field were counted.  
 
2-2. Results  
 
2-2-1. Isolation and purification of MC14  
   The active fractions collected from solvent extraction and open column 
chromatography were confirmed by thin layer chromatography with a Rf value of 
0.7-0.75. In the final purification by the Inertsil SIL HPLC column, a single peak of 
Neurite outgrowth    Number of neurite-bearing cells 
Promoting activity Total number of cells in the same field of observation 
=
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MC14 was observed and assayed the neurite outgrowth promoting activity as described 
in section 1-1-6. The HPLC profile of MC14 is shown in Fig. 2-1. The retention time of 
MC14 eluted with chloroform-methanol (98:2) with the flow rate of 0.5 ml/min was 
about 24 min. MC14 was then stored in methanol at 4°C for further bioassay and 
physicochemical characterization. 
 
2-2-2. Appearance and solubility 
  MC14 showed pale yellow oil after freeze-dried. The purified MC14 was dissolved in 
methanol as a stock solution for several analyses. MC14 was soluble in toluene, diethyl 
ether, chloroform, acetone and methanol.      
 
2-2-3. UV/VIS absorption spectrum of MC14 
   The absorption spectrum of MC14 showed that the maximum absorption peak was 
seen at 251 nm (Fig. 2-2).  
 
2-2-4. Structure elucidation of MC14 
   The molecular structure of MC14 was elucidated by 1H- and 13C-NMR. The 
13C-NMR spectrum of MC14 showed 27 resolved peaks, which appeared to be 5 -CH3, 
7 -CH2-, 6 =CH-, 6 =C<, 2 >C=O (ketone) and 1 -COOH- by analysis of the DEPT 
spectra. From the 13C-NMR spectrum, the chemical shifts at 188.9 and 189.5 ppm 
suggested a keto-carbonyl moiety, which represents a typical benzoquinone structure. 
Since the 1H-NMR spectrum displayed peaks at 6.566 and 6.433 ppm with low spin 
coupling constant, they represented the split protons. Based on COSY spectrum (data 
not shown),  
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Fig. 2-1. HPLC profile of MC14 on Inertsil SIL column using CHCl3-MeOH 
(98:2) as the eluting solvents at a flow rate of 0.5 ml/min and detected by the 
absorbance at 250 nm. 
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Fig. 2-2. UV/VIS absorption spectrum of MC14 
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the signal peaks at 6.566 ppm and 6.433 ppm were resulted from the long-range 
couplings from CH3 (δ 2.027) and CH2 (δ 3.123), respectively. These data suggested the 
partial structure as shown in Fig. 2-3. In addition, the HSQC spectra (data not shown) 
suggested the following partial structures in MC14:  
  =CH (5.808ppm)-CH2 (2.502 ppm) -CH2 (2.08 ppm)- 
  =CH (5.130 ppm)-CH2 (2.14 ppm)- 
  =CH (5.087 ppm) – CH2 (2.09 ppm) – 
Besides, the main structure of MC14 was elucidated based on the analysis of HMBC 
spectra (data not shown). For the ease of identification, the C atoms in the chemical 
structure of MC14 is assigned with number (Fig. 2-4). The long range coupling from 
CH3-proton (indicated by thick lines) is shown in Fig. 2-5A. In consistent with the 14’ 
(CH) and 15’ (C)-13C, the chemical shifts of CH3 at 1.575 and 1.661 ppm were assigned 
to the position at 16’ and 20’ based on the HMBC spectra (the difference between 16’ 
and 20’ was determined by NOE spectra, data not shown). The long-range couplings 
from proton at 1’ are shown in Fig. 2-5B (think lines), Together with the interpretation 
of Fig. 2-5A, the partial structure from 1’ to 4’ ,and 17’, as well as a quinone structure 
were determined. On the other hands, the chemical shift of COOH (δ 172.0) and the 
protons between CH2 (δ 2.21) to CH (δ 5.808) were observed in HMBC spectra. The 
couplings from protons in –CH= (δ 5.808) are shown in Fig. 2-5C (think lines) 
suggested that a COOH group is linked to position 6’-12’. The carbon chain of MC14 
was confirmed by the peaks appeared between the 5’-4’ and 6’-5’ in HMBC, H-12’(δ 
2.21) and the 13’,14’-13C peaks in the HMBC spectra. Besides, the structure in the 
Fig.2-5D (thick lines) was elucidated by TOCSY spectra (data not shown). According to 
NOESY spectra, the NOE between =CH- and CH3 was only observed at the H-14’ (δ  
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Fig. 2-3. Partial structure of MC14 determined by NMR 
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Fig. 2-4. Chemical structure of MC14 determined by NMR analysis. 
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Fig. 2-5. The main chemical structure determined by HMBC spectra (A-C) 
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5.087) and the signal peak at 1.661 ppm, indicating that the chemical shift at 1.661 ppm 
represented H-16’. NOE of (2’,4’) and (10’,12’) indicates the presence of trans-double 
bonds at 2’ and 10’. Although the NOE of the H-6’was overlapped with the protons at 4’, 
8’ and 13’ and caused it difficult to be observed, its broad cross peak suggested that it 
should be appeared at 4’ and 8’ position. Since NOE was not observed at 6’ and 18’, the 
double bond at 6’ was also a trans conjugated substitution. The assignments of NMR are 
summarized in Table 2-1.   
   Together with the data from high resolution EI-MS, which showed an ion peak at 
m/z = 424, the molecular formula of MC14 was elucidated to be C27H36O4 with 
molecular mass of 424 and its chemical structure is shown in Fig. 2-6.  
 
2-2-5. Neurite outgrowth promoting activity of MC14 
   MC14 significantly enhanced the proportion of cells with neurite in the presence of 
10 ng/ml NGF in dose dependent manner (Fig. 2-6). At 6.25 µg/ml MC14, 
approximately 5-fold and 1.5-fold increases in the proportion of neurite-bearing cells 
were noted compared with that of negative control and positive control, respectively. 
Optimal effective concentration of MC14 was observed at 6.25µg/ml. Cytotoxic effect 
on PC12D cells was observed at 12.5 µg/ml MC14.    
 
2-3. Discussion 
 
   The neurite outgrowth promoting substance, MC14 was extracted from the brown 
alga Sargassum macrocarpum with methanol and chloroform, and successfully purified 
by silica gel column chromatography, size exclusion chromatography and finally two  
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Table 2-1. 1H and 13C-NMR chemical shifts of MC14. 
1  189.5  --- 
2   147.6  --- 
3  134.0  6.566 
4  188.9  --- 
5  133.1  6.433   J 5,1’=1.6 
6  150.0  --- 
2-CH3  *  2.027   JCH3,3’=1.5 
1’  28.6  3.123    J 1’,2’=7.3 
2’  120.1  5.179   
3’   140.5  --- 
4’  40.7  2.09 
5’  27.3  2.14 
6’  125.7  5.130   J 5’,6’=7.0 
7’  135.9  --- 
8’  40.3  2.08 
9’  29.1  2.502   J 9’,8’=7.3 
10’  141.9  5.808   J 9’,10’=7.3 
11’  133.9  --- 
12’  36.1  2.21 
13’  29.0  2.09 
14’  124.8  5.087   J13’,14’=7.0 
15’  132.9  --- 
16’  25.9  1.661 
17’  *  1.649 
18’  16.0  1.600 
19’  172.0  --- 
20’  17.8  1.575 
  *16.1, 16.2  
Carbon    13C chemical  1H chemical  J value 
number  shifts (ppm) shift (ppm)  (Hz) 
Chemical shifts are shown with reference to CD3OD. 
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Fig. 2-6. Neurite outgrowth promoting activity of MC14. PC12D cells treated with 
the indicated concentration of MC14 in the presence of 10 ng/ml NGF for 48 h. Cells 
treated with 50 ng/ml NGF (      ) and 10 ng/ml (      ) were used as positive and 
negative controls, respectively. Arrows indicate cytotoxicity. Significant difference 
from the negative control: *p < 0.05; ** p < 0.01 (Student’s t-test). 
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steps of HPLC. Approximately 3.4 mg of the MC14 was purified from 500 g wet weight 
of the algal sample. Compared with the previous extraction procedure, much lesser 
amount of chloroform was used and therefore the cost for the initial solvent extraction 
can be reduced. Besides, the handling of methanol is safer than chloroform in terms of 
the inhalation of the toxic and volatile chloroform vapor.   
   Based on the NMR analyses, the structure of MC14 was elucidated to be 
sargaquinoic acid, which is recognized to have a novel neurite outgrowth promoting 
activity. Sargaquinoic acid was first discovered and purified by Kusumi et al (1979) 
from the methanol extract of a brown alga Sargassum serratifolium during a course of 
the investigations on the constituents of algae. It also has been reported that 
sargaquinoic acid is found in a brown alga Sargassum sagamianum (Segawa & 
Shirahama, 1987). These findings suggest that this naturally occurring quinone may be a 
unique metabolites in the family of Sargassaceae. Surprisingly, during a screening 
program conducted in our laboratory, we found that only the extract from Sargassum 
macrocarpum showed potent neurite outgrowth promoting activity out of 30 Sargassum 
species (Table 2-2). This result suggests that S. macrocarpum contains a particularly 
high level of sargaquinoic acid, implying that this species of brown alga will be a rich 
source of this useful compound. On the other hand, the screening of more Sargassum 
species will be important for identifying the other natural sources of MC14.       
   The elucidation of the chemical structure of MC14 will be very crucial for further 
analysis of its structure-activity relationship, which will be discussed in chapter VIII, as 
well as the synthesis of this useful chemical in the chemical industry.          
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Table 2-2. Sargassaceae family tested in the screening program of marine algae 
collected from Japan coastline  
 
Species Japanese name 
Hizikia fusiformis 1 Hijiki 1 
Hizikia fusiformis 2 Hijiki 2 
Sargassum - Ezonnejimoku 
Sargassum - Hahakimoku 
Sargassum alternato-pinnatum Kirebamoku 
Sargassum confusum Hushisujimoku 
Sargassum crassifolium Atsubamoku 
Sargassum crispifolium Kobukuromoku 
Sargassum cristaefolium Tosakamoku 
Sargassum duplicatum Hutamoku 
Sargassum filicinum Shidamoku 
Sargassum fulvellum Hondawara 
Sargassum hemiphyllum Isomoku 
Sargassum horneri Akamoku 
Sargassum ilicifolium - 
Sargassum macrocarpum Nokogirimoku 
Sargassum micracanthum Togemoku 
Sargassum miyabei Miyabemoku 
Sargassum nipponicum Tamanashimoku 
Sargassum oligocystum - 
Sargassum patens Yatsumatamoku 
Sargassum piluliferum Memetawara 
Sargassum polycystum Kobamoku 
Sargassum polyporum - 
Sargassum ringgoldianum Oobamoku 
Sargassum ringgoldianum Yanagimoku 
Sargassum siliquastrum Toremoku 
Sargassum sp. 1 Hondawara sp. 1 
Sargassum sp. 2 Hondawara sp. 2 
Sargassum thunbergii Uminotoranoo 
Sargassum yendoi Endoumoku 
Turbinaria ornata Rappamoku 
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Chapter III    
Distribution of MC14 in Sargassum macrocarpum  
 
 
   In chapter II, the neurite outgrowth promoting substance, MC14 was found in the 
brown alga, Sargassum macrocarpum, and also successfully isolated and determined its 
chemical structure. At the early stages of the extraction from Sargassum macrocarpum, 
one of the most obvious questions to ask is whether the natural product of interest is 
localized in the same particular portion of the organisms. In the case of marine algae, it 
is fairly straightforward to determine the localization of the compounds of interest as the 
morphological structure of most marine algae can be divided into leaves, root, stem or 
air-sac for some species. If so, this may allow for disposal of the certain part of algal 
plant before the actual extraction work begins, thus rendering the crude extract less 
complex and possibly leading to avoidance of problems brought about by the presence 
of other parts of the algae. Besdies, less extraction solvent and higher yield of 
purification can be achieved. Accordingly, the distribution of MC14 in S. macrocarpum 
should be proved for further efficient extraction of MC14. Thus, the distribution of 
MC14 in S. macrocarpum was studied and is described in this chapter.  
 
3-1. Materials and Methods 
 
3-1-1. Preparation of crude extracts 
   After washing with ASW and PBS as described in detailed in chapter II, the plant 
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body of S. macrocarpum was divided into leaf, stem and air-sac based on its 
morphological structure. Each portion (50 g) was homogenized in 200 ml PBS with a 
domestic mixer. After centrifugation at 5000g for 20 min, the supernatant (PBS extract) 
was collected and used for bioassay. The residue was extracted with 200 ml methanol 
by a mechanical homogenizer (Polytron) at 1,3000 rpm and the methanol-extract was 
collected after filtration, evaporated to complete dryness for dry weight determination. 
The tested concentration was prepared by dissolving the extract in suitable amount of 
methanol. The test concentration of PBS-extract was prepared by diluting the original 
solution with PBS.  
 
3-1-2. Bioassay of neurite outgrowth promoting activity 
   The bioassay test was conducted as described in section 2-1-8. 
 
3-2. Results and Discussion 
 
   As shown in Fig. 3-1, the morphology of the brown alga S. macrocarpum is mainly 
composed of stem, leaf and air-vesicle. They are divided from the plant body and 
extracted separately for the bioassay of neurite outgrowth promoting activity. The 
results showed that the chloroform-extract of stem (10 µg/ml) could markedly enhance 
the neurite outgrowth from PC12D cells in the presence of 10 ng/ml NGF compared 
with negative control. By contrast, no significant activity was observed for the 
chloroform-extract of leaf or air-vesicle even at 100 µg/ml (Fig. 3-2A). Regarding the 
PBS-extract, none of the algal portion showed significant neurite outgrowth promoting 
activity (Fig. 3-2B).  
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Fig. 3-1. (A) Morphology of S. macrocarpum. (B) An enlarged photo showing a leaf of 
the alga. (C) The air-vesicle is a spherical hollow structure branched out from the stem 
region of the alga.   
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Fig. 3-2. Neurite outgrowth promoting activity of chloroform- and PBS-extract from 
stem, leave and air-vesicle of S. macrocarpum. PC12D cells were treated with the 
indicated concentrations of (A) chloroform-extract and (B) PBS-extract in the 
presence of 10 ng/ml NGF for 48h. Cells treated with 50 ng/ml (          ) and 10 
ng/ml NGF (          ) were used as positive and negative controls, respectively. 
Arrows indicate cytotoxicity. 
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   These findings clearly show that the stem region of S. macrocarpum contains high 
level of the neurite outgrowth promoting substance while the air-vesicle or leaf may not 
contain any neurite outgrowth promoting substance or its level is too low to be detected. 
Hornsey and Hide (1976a; 1976b) have examined 151 species of British algae and 
determined species activity, seasonal variation, and selective concentration within the 
algal thallus. Although the reason underlying the uneven distribution of this active 
compounds in S. macrocarpum is not known, the important finding of this study is that 
during the purification of MC14 from this alga, it is possible to dispose almost half of 
the plant  by weight before the initial solvent extraction and concentrate on the 
extraction of the stem portion. Therefore, direct extraction from this algal stem is likely 
to make easier the extraction and purification of MC14. More importantly, smaller 
volume of organic solvent can be used and the yield would also be elevated compared 
with the extraction from the whole bulk of biomass. 
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Chapter IV  
 
Neurite Outgrowth Promoting Activity of MC14 
 
 
 
   Nerve growth factor (NGF) are essential for the normal development and functional 
maintenance of nerve cells in both central nervous system and peripheral nervous 
system. The most classical and representative effect of NGF is its ability to induce the 
outgrowth of neurite from sensory, sympathetic and certain central cholinergic neurons 
to their targets during developmental stage of the nervous system (Matthews, 1998). 
NGF has been demonstrated to play a crucial role in regulating the distribution of axon 
processes within the target tissues to establish functional synaptic connections with 
them (Campenot, 1977).  
   The rat pheochromocytoma PC12 cell line is widely used as a neuronal cell model 
system for the investigation of neurotrophic action of NGF because they respond to 
NGF by extending neurite and differentiating into sympathetic neuron-like phenotype 
(Greene & Tischler, 1976). Recently, a subline of PC12 cells (PC12D cells) has been 
established. PC12D cells were found to be capable of responding to NGF in a faster rate 
by extending neurites within 48 h (Katoh-Semba et al., 1987). This property of PC12D 
cells made them an ideal cell model system for screening the neuroactive substances as 
well as studying the biological effect of NGF and NGF-potentiating substances. As a 
first step to explore the NGF-potentiating activity of the purified active substance MC14, 
the NGF-induced neurite outgrowth promoting activity of MC14 to PC12D cells, as 
well as the neurotrophic effect of MC14 in the absence of NGF on PC12D cells were 
evaluated. The concentration-dependent effect of MC14 and its promoting activity in 
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the presence of different concentrations of NGF were also analysed. In addition to the 
study of neurite outgrowth promoting effect of MC14 during the initial differentiating 
stage of PC12D cells, the chronic neurite outgrowth maintaining effect of MC14 was 
also investigated in order to pursue a more comprehensive study on the neuritogenic 
action of MC14.  
   In the second part of this chapter, the signaling cascades mediating the NGF-induced 
and MC14-enhanced neurite outgrowth in PC12D cells will be described in an attempt 
to elucidate the mechanisms of action of MC14 in PC12D cells. Cumulative efforts 
from many laboratories over the past decade have led to the discovery and synthesis of 
various specific inhibitors specific to the signaling molecular and effector proteins 
involved in intracellular signal transduction pathways. The utilization of these signaling 
molecule inhibitors has provided a powerful tool and pharmacological evidence for the 
elucidation of how the complicated intracellular signaling cascades mediate the signals 
initiated by the nerve growth factor leading to its great diversity of cellular processes 
such as proliferation, differentiation, development and apoptosis of the neuronal cells. 
In the present study, the signaling pathways that mediate the NGF-induced neurite 
outgrowth from PC12D cells, and the mechanisms of action of MC14 on promoting 
NGF-induced neurite outgrowth were elucidated using several representative signaling 
molecule inhibitors which have already been known to specifically inhibit certain 
signaling molecules or effector proteins in the signaling cascades.  
   Since most of the NGF-induced cellular responses are initiated by the binding of 
NGF to its specific tyrosine receptor kinase type A (TrkA), and subsequently activating 
the downstream protein kinases and effector proteins (Kaplan et al., 1991a; Kaplan et 
al., 1991b), the effect of MC14 on binding of NGF to the surface receptor TrkA was 
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investigated as a first step to investigate its mechanisms. To achieve this objective, a 
general protein kinase inhibitor K252a was used because it can act as potent inhibitor of 
TrkA receptor at 3 nM while it can inhibit many other protein kinase including PKA and 
PKC at a concentration higher than 25 nM (Hashimoto, 1988; Koizuma et al., 1988; 
Tapley et al., 1992; Pawlowaka et al., 1993). In addition, a high dose of K252a was 
tested to confirm the role of potential protein kinases on the action of MC14 in PC12D 
cells. Concerning the involvement of MAPK-mediated signaling pathway in the 
MC14-stimulated neurite outgrowth enhancement on PC12D cells, a specific 
mitogen-activated protein kinase (MAPK) kinase inhibitor PD98059 was used in the 
study. Mitogen-activated protein kinases are a group of protein serine/threonine kinases 
that are activated in response to a variety of extracellular stimuli (e.g. NGF) and 
mediate signal transduction from the cell surface to the nucleus. The selective inhibitor 
of MAP kinases PD98059 acts by inhibiting MAP kinases and subsequent 
phosphorylation of MAP kinase substrates. It has been reported that the pretreatment of 
the traditional PC12 cells with PD98059 completely blocked the 4-fold increase in MAP 
kinase activity produced by NGF at 2 µM. However, it has no effect on NGF-dependent 
tyrosine phosphorylation of the TrkA receptor or its substrate Sch and did not block 
NGF-dependent activation of PI 3-kinase (Dudley et al., 1995; Pang et al., 1995; Waters 
et al., 1995). Hence, PD98059 is an ideal inhibitor on studying the role of MAPK 
kinase-mediated signal pathway for MC14 activity to PC12D cells. With respect to the 
involvement of PKA-mediated signaling pathway in response to MC14 on PC12D cells, 
a PKA inhibitor was used as it can effectively block the signal transduction of cyclic 
adenosine monophosphate (cAMP) by inhibiting PKA at Ki of 2-8 nM (Santa cruz 
biotechnology, Inc.). Finally, another potent and specific inhibitor of protein kinase C 
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(PKC, IC50 = 0.66 µM), chelerythrine chloride, was also selected to determine the 
involvement of PKC for MC14-stimulated activity because it can interact with the 
catalytic domain of PKC and may also affect the translocation of PKC from cytosol to 
plasma membrane (Herbert et al., 1990; Eckly-Michel et al., 1997; Chao et al., 1998;). 
These studies contributed to the elucidation of the mechanism of action of MC14 on 
neurite outgrowth promoting activity to PC12D cells.              
 
4-1. Methods and Materials 
 
4-1-1. Medium and reagents 
   The following chemicals were obtained from the indicated sources: Dulbecco’s 
modified Eagle’s medium (DMEM, high glucose) and horse serum (HS) from Gibco 
RBL; fetal bovine serum (FBS), 2.5 S NGF (mouse submaxillary glands), poly-L-lysine 
(MW 30,000-70,000), penicillin, streptomycin, ampicillin and chelerythrine chloride 
from Sigma. K252a and PD98059 from Calbiochem; protein kinase A (PKA) inhibitor 
from Santa Cruz Biotechnology. 
 
4-1-2. Cell culture 
   Rat pheochromacytoma PC12D cells were obtained from Dr. M. Sano (Aichi 
Human Service Center, Japan). Cultures of PC12D cells were maintained in DMEM 
supplemented with 10% HS, 5% FBS, 100 U/ml penicillin, 200 µg/ml streptomycin and 
25 µg/ml ampicillin (complete medium) in a water-saturated atmosphere of 5% CO2 at 
37˚C.     
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4-1-3. Bioassay of neurite outgrowth promoting activity of MC14  
   PC12D cells were harvested and seeded at a cell density of 5 X 103 cells per well on 
96-well tissue culture plate coated with poly-L-lysine (10 µg/ml). After 24 h incubation 
in humidified air (5% CO2) at 37˚ C in complete medium, MC14 (3 µg/ml) and NGF 
(0-100 ng/ml) were added to the cells. In the experiment, MC14 was dissolved in 
MeOH and added to the cells in less than 1% v/v of medium, which was determined to 
have no effect on PC12D cells. After 48 h incubation, the proportion of neurite-bearing 
cells were determined with a microscope with 200X magnification. Process with length 
longer than two diameters of the respective cell body was counted as neurite. For each 
datum point, the mean value was calculated from four to six random field observations 
of two replicate experiments, and a minimum of 100 cells per field were counted.  
 
4-1-4. Dose response assay of MC14  
   PC12D cells were harvested and seeded on the tissue culture plate as described in 
section 4-1-1. After 24 h incubation in complete medium, MC14 was added at a 
concentration range from 0.2 to 6.25 µg/ml (predetermined highest concentration of 
MC14 without causing cytotoxic effect on PC12D cells) in the presence of 10 ng/ml 
NGF (the predetermined optimal concentration of NGF for observing neurite outgrowth 
promoting activity of MC14). Cells were treated with 10 ng/ml and 50 ng/ml NGF alone 
for comparing the effect of MC14. After 48 h incubation, the proportion of 
neurite-bearing cells were determined as described above.   
 
4-1-5. Assay of chronic neurite outgrowth supporting effect of MC14  
   PC12D cells were seeded on the tissue culture plate as described above. After 24 h 
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incubation, the medium was changed to fresh medium containing 6.3 µg/ml MC14 and 
1.25-25 ng/ml NGF. Medium in each well was renewed every 3 days to maintain a 
constant concentration of MC14 and NGF throughout the experimental period. At the 
same time, effect of NGF alone was also tested by adding NGF into the medium only. 
Neurite outgrowth of PC12D cells was monitored regularly for an experimental period 
of 28 days using a phase-contrast microscope.  
 
4-1-6. Inhibitors to MC14-stimulated neurite outgrowth  
   PC12D cells were seeded on the tissue culture plate and incubated for 24 h as 
described above. Medium was changed with fresh complete medium containing the 
tested inhibitor and incubated for 1 h before the additions of MC14 and NGF. After 48 h 
incubation, the proportion of neurite bearing cells were determined as described above. 
The following stock concentrations of the inhibitors dissolved in the indicated solvent 
were used in the experiments: PD98059 (20 mM, DMSO); PKA inhibitor (5 mg/ml, 
DMEM); chelerythrine chloride (0.5 mg/ml, DMEM); K252a (200 µM, MeOH). Each 
inhibitor was further diluted with DMEM to a suitable working concentration in the 
experiment and aliquot of the working concentration of each inhibitor was added to the 
test well in less than 1% v/v of medium, in which no solvent effect was observed on 
PC12D cells. Because the absolute number of neurite-bearing cells in NGF-treated 
cultures varied slightly between experiments, the effects of inhibitor were compared 
with those of NGF treatment on positive control culture (50 ng/ml NGF) from the same 
experiment.     
 
4-1-7. Morphological observation of PC12D cells 
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   The morphological changes of PC12D cells after various treatments were recorded 
using a phase-contrast microscope (Olympus IMT2) with 200-400X magnification. 
Photo-slides were taken using a compatible Olympus SC-35 type camera which 
connected serially to the phase-contrast microscope. Image was scanned from the slide 
and transformed into computer file using Polaroid Polascan 35/LE system. Contrast of 
the image was adjusted if necessary.  
 
4-1-8. Statistical analysis 
   Each datum point is the mean ± S.D. of four-six random field observations from at 
least two replicate experiments. Significant difference from the control was determined 
by the Student’s t-test. P < 0.05 was considered to be a significant difference.  
 
4-2. Results 
 
4-2-1. Morphological changes of PC12D cells treated with NGF and MC14  
   When cultured in complete medium only, PC12D cells were in round shape without 
neurite extension (Fig. 4-1A). In the presence of 10 ng/ml NGF, only a few 
neurite-bearing cells were observed (Fig. 4-1B) while 50 ng/ml NGF caused a robust 
outgrowth of neurite from PC12D cells after 48 h (Fig. 4-1C). Treatment of cells with 
6.3 µg/ml MC14 and 10 ng/ml NGF markedly enhanced the number of neurite-bearing 
cells. The growth cone was observed at the tip of extending neurite, as those induced by 
50 ng/ml NGF (Fig. 4-1D). Besides, the average neurite length of the MC14-treated 
cells was comparable to those induced by 50 ng/ml NGF.  
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Fig. 4-1. Phase-contrast micrographs of PC12D cells after various treatments for 
48 h. (A) Untreated control culture. (B) PC12D cells treated with 10 ng/ml NGF 
only. (C) PC12D cells treated with 50 ng/ml NGF only. (D) PC12D cells treated 
with 6.3 µg/ml MC14 in the presence of 10 ng/ml NGF. Scale bar: 20 µm.  
A B 
D C 
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4-2-2. Effect of NGF on neurite outgrowth promoting activity of MC14   
Addition of 50 ng/ml NGF induced 25-31% of PC12D cells to extend neurite after 48 h 
(Fig. 4-2). The proportion of neurite-bearing cells did not significantly increase at 100 
ng/ml NGF treatment, suggesting that 50 ng/ml NGF was the saturating concentration 
for neurite outgrowth of PC12D. Addition of MC14 (3 µg/ml) together with the 
saturating concentrations of NGF (50 ng/ml and 100 ng/ml) further enhanced the 
proportion of cells with neurite up to a 2-fold enhancement compared with the cultures 
treated with NGF alone. Besides, significant neurite outgrowth enhancing activity of 
MC14 was observed in the presence of relatively low concentration of NGF ranging 
from 1.25-25 ng/ml (P < 0.01, Student’s t-test). A maximum of approximately 50% 
neurite-bearing cells was recorded at cultures treated with 100 ng/ml NGF in the 
presence of MC14. Although MC14 exhibited strong activity in enhancing 
NGF-induced neurite outgrowth, MC14 alone could not show any neurotrophic action 
on PC12D cells. It can be observed that the addition of MC14 to PC12D cells shifted 
the dose-response curve of NGF to the left (Fig. 4-2), implying that in the presence of 
MC14, either a greater number of NGF receptors were activated so that the 
NGF-receptor mediated intracellular signaling pathway was amplified, or that MC14 
and NGF might employ distinct but complementary signal transduction cascades.  
 
4-2-3. Dose-dependent activity of MC14 
   The action of MC14 was dose-dependent (Fig. 4-3). The minimal effective 
concentration of MC14 was about 0.8 µg/ml in the presence of 10 ng/ml NGF. A linear 
neurite outgrowth enhancing effect of MC14 was observed from 0.8-6.3 µg/ml. At 6.3 
µg/ml MC14, a 5-fold enhancement of the number of neurite-bearing cells was recorded  
 
 
Chapter IV  Neurite Outgrowth Promoting Activity 
 57 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0 1.25 2.5 5 10 25 50 100
NGF concentration (ng/ml)
Pr
op
or
tio
n 
of
 c
el
ls
 w
ith
 n
eu
ri
te
 MC14 + NGF 
NGF 
** 
** ** **
** 
**
**
Fig. 4-2. Neurite outgrowth promoting activity of MC14 in the presence of NGF. PC12D 
cells were treated with or without 3 µg/ml MC14 in NGF for 48 h. Each point represents 
the mean ± SD from two replicate experiments. Significant difference from the NGF-only 
control: ** P < 0.01 (Student’s t-test) 
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Fig. 4-3. Dose-response curve of the neurite outgrowth enhancing effect of 
MC14 on PC12D cells in the presence of 10 ng/ml NGF. The horizontal solid 
line represents the mean value for cultures treated with 10 ng/ml NGF alone, 
the dotted lines represent the SD of this value. Neurite outgrowth is expressed 
as a percentage relative to the saturated concentration of NGF (50 ng/ml, 
100%). Each point represents the mean ± SD from two replicate experiments. 
Significant difference from the NGF-only control: * P < 0.05; ** P < 0.01 
(Student’s t-test). 
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compared to the cultures treated with 10 ng/ml and 50 ng/ml NGF alone, respectively.      
 
4-2-4. Chronic neurite outgrowth enhancing effect of MC14 on PC12D cells  
   As MC14 showed an acute effect on NGF-mediated neurite outgrowth enhancement 
on PC12D cells after 48 h, it is important to further investigate whether MC14 also 
exhibits a chronic effect on PC12D cells in terms of promoting and supporting the 
extended neurites from the cells. The chronic effect of MC14 on PC12D cells was 
studied by monitoring the morphology of MC14-treated PC12D cells for a period of 28 
days with constant renewal of NGF and MC14 in the medium. The result showed that 
MC14 firstly promoted neurite outgrowth and subsequently maintained the outgrowth 
processes from PC12D cells. The morphological changes of PC12D after the long-term 
treatment with MC14 in the presence of NGF is shown in Fig. 4-4. Cells treated with 
6.3 µg/ml MC14 in the presence of 50 ng/ml NGF extended short neurites after 24 h 
(Fig. 4-4B) and the neurite length further increased with incubation time (Fig. 4-4C,D). 
At day 7, some neurites had contacted to the neighboring cells and seemed to form a 
connection with those cells (Fig. 4-4E). Both the proportion of neurite-bearing cells and 
the observed average neurite length increased with the culturing time and the most 
striking observation was that a network-like neuritic connection among cells was 
constructed at day 14 (Fig. 4-5F). In contrast, much lower degree of network-like 
formation from the neurite-bearing cells was observed for the cells incubated in the 
same concentration of NGF alone because the cells only extended short neurites that 
failed to make contact with the nearby cells (Photo not shown). These observations 
suggest that MC14 does not only promote neurite outgrowth as an acute effect on 
PC12D cells, but also maintains the outgrowth of neurite and further enhances the  
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Fig. 4-4.   Morphology of PC12D cells treated with 6.3 µg/ml MC14 and 50 
ng/ml NGF for (A) 0, (B) 1 ,(C) 2, (D) 5, (E) 7 and (F) 14 days. The medium was 
renewed every 3 days to maintain the concentration of MC14 and NGF during 
the experiment. Scale bar = 20 µm   
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Fig.4-5. Long-term effect of MC14 on neurite outgrowth promoting activity on 
PC12D cells. Cells were treated with 6.3 µg/ml MC14 in the presence of NGF 
during the incubation period of 28 days. The medium was renewed every 3 days to 
maintain the concentration of MC14 and NGF during the experiment. Each datum 
point represents the mean ± SD (n=6).
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extension of neurites for the ultimate formation of network-like structure among PC12D 
cells. The proportion of neurite-bearing cells for the cultures treated with 6.3 µg/ml 
MC14 in the presence of NGF at 1.25-50 ng/ml NGF is shown in Fig. 4-5. The 
treatment with MC14 in the presence of 50 ng/ml NGF resulted in an elevation of 
neurite-bearing cells from 40% at day 1 to 90% at day 12, and almost 100% of cells 
were bearing neurite at day 28, while only 40% of neurite-bearing cells was observed in 
the culture incubated with 50 ng/ml NGF (Fig.4-6). The similar pattern of neurite 
outgrowth, although in lesser extent, was observed for the MC14-treated cells in the 
presence of 25 ng/ml NGF. The percentage of neurite-bearing cells maintained at 
approximately 60% from day 12 to day 28, at which a 3-fold increase of the 
neurite-bearing cells was observed compared with the culture treated with 25 ng/ml 
NGF alone. It is worth noting that the neurite outgrowth promoting and supporting 
effects of MC14 were also observed at relatively low concentrations of NGF. Significant 
neurite outgrowth enhancement was observed at concentrations of NGF as low as 1.3 
ng/ml compared with the NGF-only control. Surprisingly, MC14 appeared to show 
neurotrophic effect in chronic treatment as 18% of neurite-bearing cells were recorded 
in the culture treated with MC14 alone. These results demonstrated that MC14 could 
significantly enhance the neurite outgrowth from PC12D cells and subsequently 
maintain and support the neurite outgrowth in long-term incubation period. 
 
4-2-5. Mechanisms of action of MC14 
   The mechanisms of neurite outgrowth promoting activity of MC14 to PC12D cells 
were investigated in the intracellular signaling transduction level. Several representative 
intracellular signaling cascades were examined by the utilization of specific inhibitors.   
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Fig. 4-6. Long-term effect of NGF on PC12D cells. Cells were treated with 0-50 
ng/ml NGF for 28 days. The medium was renewed every 3 days to maintain the 
concentration of NGF during the incubation period. The medium was renewed 
every 3 days to maintain the concentration of MC14 and NGF during the 
experiment. Each datum point represents the mean ± SD (n=6).  
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(1) Effect of general protein kinases inhibitor on MC14-enhanced neurite outgrowth  
from PC12D cells 
   A general protein kinase inhibitor K252a was tested on its effect of NGF-induced 
and MC14-enhanced neurite outgrowth from PC12D cells. The neurite outgrowth 
inhibitory effect of K252a was examined at concentrations ranging from 1 to 64 nM on 
PC12D cells induced with 10 ng/ml and 50 ng/ml NGF. The lowest effective 
concentration of K252a was respectively 8 nM and 16 nM to significantly inhibit 50 
ng/ml and 10 ng/ml NGF-induced neurite outgrowth from PC12D cells (P < 0.05, 
Student’s t-test) (Fig. 4-7). Since K252a is a general protein kinase inhibitor, the 
effective inhibition to protein kinases is dependent on the concentration of K252a to the 
cell cultures. For example, it has been reported that 3 nM K252a could significantly 
inhibit the activity of protein kinase A receptor (TrkA) while PKA and PKC would be 
inhibited at concentrations of K252a higher than 25 nM. In order to specifically analyse 
the role of Trk receptor and also examine the involvement of protein kinases for the 
MC14-enhanced neurite outgrowth from PC12D cells, a wide concentration range of 
K252a was tested. As shown in Fig. 4-8, significant reduction of neurite outgrowth from 
PC12D cells was observed for the cultures pretreated with 8 nM K252a compared with 
the cultures treated with MC14 and NGF only (the inhibitor-untreated control). 
Approximately 40% of the number of neurite-bearing cells was reduced when the cells 
were pretreated with 16 nM K252a. Pretreatment of cells with 64 nM K252a completely 
blocked the combined effects of MC14 and NGF on PC12D cells as no neurite-bearing 
cells were observed under this concentration level of K252a. 
 
(2) Effect of mitogen-activated protein kinase (MAPK) kinase inhibitor on 
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MC14-enhanced neurite outgrowth from PC12D cells  
   PD98059, a well-known specific MAPK kinase (or MEK) inhibitor, has been 
reported to inhibit the MAP kinases activity in PC12 cells. In order to determine the 
optimal effective concentration of PD98059 for inhibiting the NGF-induced neurite 
outgrowth from PC12D cells, cells were preincubated at concentrations of PD98059 
ranging from 0 to 100 µM for 1h before MC14 and NGF were added. Neurite outgrowth 
of PC12D cells after pretreatment of cells with PD98059 in the presence of 10 ng/ml 
and 50 ng/ml NGF are shown in Fig. 4-9. Pretreatment of cells with PD98059 at 
0.1-100 µM did not significantly inhibit the neurite outgrowth of cells induced by 10 
ng/ml NGF. However, substantial inhibition of neurite outgrowth by PD98059 was 
observed for the cultures induced by 50 ng/ml NGF. Approximately 50% inhibition of 
neurite outgrowth was recorded by the pretreatment with PD98059 at 1-10 µM. Since 
these data were comparable to the effect of PD98059 on PC12 cells as reported 
elsewhere (Pang et al., 1995). Therefore, the inhibitory effects were determined at 3 µM 
or 10 µM PD98059.  
   Effect of PD98059 at 3 µM and 10 µM on MC14-enhanced neurite outgrowth from 
PC12D is shown in Figs. 4-10 and 4-11, respectively. Pretreatment of 3 µM PD98059 
substantially blocked the neurite outgrowth enhanced by 1.5 µg/ml and 3 µg/ml MC14 
(Fig. 4-10). At 10 µM PD98059, complete inhibition of the neurite outgrowth 
enhancement by 1.5 µg/ml MC14 was observed while 90% of neurite outgrowth 
induced by the combined effect of 3 µg/ml MC14 and 10 ng/ml NGF was blocked. 
Since no significant inhibition of neurite outgrowth induced by 10 ng/ml NGF could be 
observed within the test concentration of PD98059, the activation of MAP kinases may  
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Fig. 4-7. The neurite outgrowth inhibitory effect of K252a on NGF-induced 
PC12D cells. Cells were pretreated with K252a for 1 h before the addition of 50 
ng/ml or 10 ng/ml NGF and further incubated for 48 h. Neurite outgrowth is 
expressed as a percentage relative to the optimal response to NGF (50 ng/ml, 
100%). Each point represents the mean ± SD from two replicate experiments. 
Significant difference from the inhibitor-untreated control: *P < 0.05, **P < 
0.01 (Student’s t-test).   
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Fig. 4-8. Effect of K252a on neurite outgrowth promoting activity of MC14 on PC12D 
cells. Cells were pretreated with the indicated concentration of K252a for 1 hour 
before the addition of 10 ng/ml and 3 µg/ml MC14 and further incubated for 48 h. 
Closed bar represents the cells treated with 10 ng/ml NGF only. Open bar represents 
cells treated with MC14 and NGF only (inhibitor-untreated control). Neurite 
outgrowth is expressed as a percentage relative to the optimal response to NGF (50 
ng/ml, 100%). Each point represents the mean ± SD from two replicate experiments. 
Significant difference from the inhibitor-untreated control: *P < 0.05, **P < 0.01 
(Student’s t-test).   
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Fig. 4-9. The neurite outgrowth inhibitory effect of PD98059 on NGF-induced 
PC12D cells. Cells were pretreated with PD98059 for 1 h before the addition of 50 
ng/ml or 10 ng/ml NGF and further incubated for 48 h. Neurite outgrowth is 
expressed as a percentage relative to the optimal response to NGF (50 ng/ml, 
100%). Each point represents the mean ± SD from two replicate experiments. 
Significant difference from the inhibitor-untreated control: **P < 0.01 (Student’s 
t-test).   
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Fig. 4-10. Effect of PD98059 (3 µM) on neurite outgrowth promoting activity of 
MC14 on PC12D cells. Cells were pretreated with 3 µM PD98059 for 1 hour before 
the addition of 1.5 µg/ml or 3 µg/ml MC14, and 10 ng/ml NGF. Neurite outgrowth 
is expressed as a percentage relative to the optimal response to NGF (50 ng/ml, 
100%). Each point represents the mean ± SD from two replicate experiments. 
Significant difference from the inhibitor-untreated control: **P < 0.01 (Student’s 
t-test).   
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Fig. 4-11. Effect of PD98059 (10 µM) on neurite outgrowth promoting activity of 
MC14 in PC12D cells. Cells were pretreated with 10 µM PD98059 for 1 h before 
the addition of 1.5 µg/ml or 3 µg/ml MC14, and 10 ng/ml NGF. Neurite outgrowth 
is expressed as a percentage relative to the optimal response to NGF (50 ng/ml, 
100%). Each point represents the mean ± SD from two replicate experiments. 
Significant difference from the inhibitor-untreated control: **P < 0.01 (Student’s 
t-test).   
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not be necessary for the neurite outgrowth induced by low level of NGF (10 ng/ml). 
While substantial inhibition of neurite outgrowth from PC12D cells, which were treated 
with MC14 and 10 ng/ml NGF, by PD98059 suggested that the enhanced neurite 
outgrowth was due to the activation of MAP kinases-mediating signaling pathway, 
which appeared to be activated by MC14, rather than 10 ng/ml NGF.  
 
(3) Effect of Protein Kinase A (PKA) inhibitor on MC14-enhanced neurite outgrowth 
from PC12D cells 
   Next, the effect of a cAMP-dependent PKA inhibitor was tested on MC14-enhanced 
neurite outgrowth from PC12D cells. As shown in Fig. 4-12, the pretreament with 4 nM 
PKA inhibitor significantly inhibited (P < 0.05, Student’s t-test) the neurite outgrowth 
from PC12D cells induced by 50 ng/ml NGF while slight inhibition of the neurite 
outgrowth by 10 ng/ml NGF was observed at 100 nM of the PKA inhibitor. Therefore, 1, 
10 and 100 nM of the PKA inhibitor were employed and their effects on the activity of 
MC14 were evaluated. Pretreatment of cells with 1 nM PKA inhibitor caused a 34% 
reduction of neurite outgrowth from PC12D cells compared with the inhibitor-untreated 
cultures (cells treated with 10 ng/ml NGF and 3 µg/ml MC14 only) (Fig. 4-13). The 
neurite enhancement by MC14 was completely blocked by 10 nM PKA inhibitor, 
suggesting that the MC14-enhanced neurite outgrowth from PC12D cells is likely 
mediated, at least partially, by the activation of PKA. 
 
(4) Effect of Protein Kinase C (PKC) inhibitor on MC14-enhanced neurite outgrowth 
from PC12D cells 
   Pretreament of PC12D cells with the PKC inhibitor, chelerythrine chloride at  
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Fig. 4-12. The neurite outgrowth inhibitory effect of PKA inhibitor on 
NGF-induced PC12D cells. Cells were pretreated with PKA inhibitor for 1 h before 
the addition of 50 ng/ml or 10 ng/ml NGF and further incubated for 48 h. Neurite 
outgrowth is expressed as a percentage relative to the optimal response to NGF (50 
ng/ml, 100%). Each point represents the mean ± SD from two replicate 
experiments. Significant difference from the inhibitor-untreated control: **P < 0.01 
(Student’s t-test).   
 
 
Chapter IV  Neurite Outgrowth Promoting Activity 
 73 
Fig. 4-13. Effect of PKA inhibitor on neurite outgrowth promoting activity of 
MC14 in PC12D cells. Cells were pretreated with PKA inhibitor for 1 h before the 
addition of 3 µg/ml MC14 and 10 ng/ml NGF. Neurite outgrowth is expressed as a 
percentage relative to the optimal response to NGF (50 ng/ml, 100%). Each point 
represents the mean ± SD from two replicate experiments. Significant difference 
from the inhibitor-untreated control: *P < 0.05, **P < 0.01 (Student’s t-test).   
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concentrations ranging from 0 to 9600 nM did not produce significant difference of the 
number of neurite-bearing cells from those of the inhibitor-untreated controls, both 10 
ng/ml and 50 ng/ml NGF-induced cells (Fig. 4-14), indicating that the PKC inhibitor 
cannot effectively inhibit the neurite outgrowth induced by NGF on PC12D cells. To 
study the effect of this PKC inhibitor on MC14-enhanced neurite outgrowth, the 
reported effective concentration of chelerythrine chloride (IC50 = 660 nM) for inhibiting 
the PKC activity was taken as reference to determine its test concentration. 
   Compared with the neurite outgrowth of PC12D cells stimulated by MC14 and NGF, 
no significant neurite outgrowth inhibition was observed for the cultures pretreated with 
chelerythrine chloride at 600 nM (IC50 for PKC inhibition) or even 9600 nM (16-time of  
IC50) (Fig. 4-15). These data indicate that chelerythrine chloride did not inhibit the 
NGF-induced neurite outgrowth, as well as MC14-enhanced neurite outgrowth from 
PC12D cells.  
 
4-3. Discussion  
 
4-3-1. Neurite outgrowth promoting activity of MC14 on PC12D cells 
   PC12D cells have been considered as an ideal model system for studying the 
mechanism of NGF action as they response NGF by extending neurite and undergo 
neuronal differentiation (Katoh-Semba et al., 1987; Sano & Iwanaga, 1994). In addition, 
they can be used to evaluate the neurotrophic action of certain biologically active 
compounds, or the substances that could potentiate the effect of NGF, by determining 
their neurite outgrowth as a morphological parameter. The purified active substance 
(designated as MC14) isolated from the brown alga S. macrocarpum, significantly  
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Fig. 4-14. The neurite outgrowth inhibitory effect of chelerythrine chloride on 
NGF-induced PC12D cells. Cells were pretreated with chelerythrine chloride for 1
h before the addition of 50 ng/ml or 10 ng/ml NGF and further incubated for 48 h. 
Neurite outgrowth is expressed as a percentage relative to the optimal response to 
NGF (50 ng/ml, 100%). Each point represents the mean ± SD from two replicate 
experiments.    
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Fig. 4-15. Effect of chelerythrine chloride on neurite outgrowth promoting activity 
of MC14 in PC12D cells. Cells were pretreated with chelerythrine chloride for 1 h 
before the addition of 3 µg/ml MC14 and 10 ng/ml NGF. Neurite outgrowth is 
expressed as a percentage relative to the optimal response to NGF (50 ng/ml, 
100%). Each point represents the mean ± SD from two replicate experiments.  
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enhances neurite outgrowth from PC12D cells from a relative low NGF concentration to 
the saturated concentration of NGF, implying that it may be beneficial during the 
developmental stage of nervous system (Sagara et al., 1998). Moreover, as MC14 is a 
non-peptide molecule with a low molecular weight, it may readily access to the brain 
and modulate the action of NGF. Apart from neurogenesis, NGF is also essential to the 
development and maintenance of peripheral and central nervous systems. Numerous 
evidence from animal and clinical tests has already revealed that NGF possesses a 
potential for treating neurodegenerative diseases including Alzheimer’s disease (Fischer 
et al., 1987; Ebendal et al., 1991; Olson, 1993; Seiger et al., 1993; Brinton & Yamazaki, 
1998; Connor & Dragunow, 1998). However, the high molecular weight of NGF limits 
its therapeutic application because of its impermeability to the blood-brain barrier and 
susceptible to be metabolized by peptidase when administered peripherally (Olson, 
1993). The present study provided the first line of evidence showing that the MC14 is a 
potent neurite outgrowth enhancer on PC12D cells, implying that it may also have the 
potential to enhance the action of NGF in terms of supporting the neuronal cell survival 
and rescuing the neuronal cell death caused by age-related diseases. The study of 
neuroprotective effect of MC14 will be discussed in detail in chapter V. 
 
4-3-2. Chronic effect of MC14 on neurite outgrowth  
   The results of chronic effect of MC14 on PC12D cells clearly demonstrated that 
MC14 could significantly enhance the neurite outgrowth from PC12D cells at the early 
period of treatment and subsequently maintain and support the neurite outgrowth in 
long-term period of treatment. More importantly, MC14 promotes the construction of 
network-like neuritic connection between the neuronally differentiated PC12D cells, 
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suggesting that MC14 does not only promote the initial neurite extension from the cell 
body, but also facilitate the construction of neuritic network, implying that the 
pharmacological treatment of MC14 might promote NGF to form the functional 
synaptic connection among the neuronal cells during developmental stage, or functional 
synaptic reconstruction after axonal injury in the nervous system. Further study of the 
neurite regenerating effect of MC14 will be discussed in chapter VI. 
 
4-3-3. Mechanisms of the neurite outgrowth promoting activity of MC14 on PC12D 
cells  
   Although the signaling cascades mediating the NGF-induced neurite outgrowth on 
the PC12 cells have been extensively studied, little is known about those in the sub-cell 
line of PC12 cells, PC12D cells. In this study, the signaling cascades activated by NGF 
on PC12D cells was characterized, and the mechanisms of action of MC14 was 
elucidated by analysing the signal transduction pathways involved in the neurite 
outgrowth promoting action of MC14 on PC12D cells.  
   As intracellular signaling cascade is initiated by the interaction of ligand-receptor 
binding, the involvement of the NGF receptor TrkA in MC14-stimulated cells was 
studies first. The result indicates that activation of TrkA receptor is required for the 
NGF-induced neurite outgrowth from PC12D cells as significant inhibition of neurite 
outgrowth was observed when TrkA receptors had been inactivated by 8 nM of K252a 
(an inhibitory concentration for the TrkA activity). Hence, neurite outgrowth of PC12D 
cells is initiated by NGF-TrkA interaction, like the case in the PC12 cells. In addition, 
the results demonstrate that intracellular protein kinases have an essential role in 
regulating the neurite outgrowth from PC12D cells as a complete inhibition of neurite 
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outgrowth was observed by treating the cells with K252a at 64 nM, which is the 
inhibitory concentration for protein kinases. Due to the observation that K252a at a 
TrkA-inhibiting concentration (8 nM) could also slightly but significantly inhibit the 
action of MC14, it may enhance the neurite outgrowth from PC12D cells, at least 
partially, by promoting the activation of a greater number of NGF receptors so that 
NGF-receptor mediated intracellular signaling pathway is amplified. This may be 
probably achieved by facilitating the binding of NGF to TrkA receptor. Besides, the 
action of MC14 is mediated by the intracellular protein kinases as no neurite-bearing 
cells could be found when total protein kinases were inactivated by 64 nM K252a.   
   In order to identify the downstream signaling molecules involved in the 
NGF-receptor-mediated signaling cascade, MAP kinase is studied as it regulates many 
important neurotrophic actions of NGF such as neuronal differentiation. Results of 
PD98059 inhibition tests revealed that MAP kinases-mediating signaling pathway can 
only be activated by high concentration of NGF. Besides, this signaling pathway can be 
activated by MC14 even in low concentration of NGF. Since the treatment of PD98059 
at its MAPK effective inhibiting concentration completely blocks the MC14-enhanced 
neurite outgrowth, the MAP kinases-mediated signaling cascade should be the major 
pathway regulating the MC14 action on PC12D cells. Comparing to the result of Sano 
et al (1998) who showed that the activation of MAP kinases is not necessary for the 
neurite outgrowth from PC12D cells, our finding also demonstrated that PD98059 has 
no observable inhibitory effect on 10 ng/ml NGF-induced neurite outgrowth from 
PC12D cells. However, our data show that activation of MAP kinase is required for the 
morphological differentiation of PC12D cells induced by 50 ng/ml NGF. Furthermore, 
the NGF-induced neurite outgrowth in PC12D cells may involve more than one 
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pathway besides the NGF-TrkA-MAPK signaling cascade. One reason comes from the 
observation that neurite outgrowth can be induced by 10 ng/ml NGF under the 
inhibitory concentration of PD98059. Besides, inactivation of TrkA on 
MC14-stimulated PC12D cells only partially inhibited neurite outgrowth from PC12D 
cells. Therefore, MC14 may be able to separately activate MAPK kinase to complement 
the action of NGF. Nevertheless, it should be noted that MAP kinase is a key mediator 
to stimulate the MC14-enhanced neurite outgrowth from PC12D cells. Actually, 
numerous reports have demonstrated that MAP kinase-mediated signaling cascade is 
responsible for many important cellular processes induced by neurotrophic factors and 
other growth factors (Baeueries & Baltimore, 1988; Traverse et al., 1992; Pang et al., 
1995; Dudley et al., 1995; Waters et al., 1995; Joneson et al., 1996; Hansen et al., 2000). 
This may be explained by the fact that MAP kinase is the major cytoplasmic protein 
kinase that can translocate into the nucleus, at which it activates various transcription 
factors for gene expressions, leading to differentiation, development or proliferation in 
different cell lines (Erikson, 1991). Based on these evidence, it is not surprising to find 
that the activation of MAP kinases is essential for the MC14-promoted neurtie 
outgrowth from PC12D cells. An interesting finding in this study is that PKA is also 
involved in the action of MC14 in PC12D cells, further support the diversified signaling 
cascades regulating the combined actions of MC14 and NGF in PC12D cells. PKA is 
generally known to be responsible for inhibiting apoptosis and its activation results in 
cell survival (Shirakawa & Mizel, 1989). The present finding implies that PKA may 
also be responsible for neurite outgrowth or differentiation in PC12D cells. In consistent 
with the finding by Katoh-Semba et al (1987), who reported that cAMP or 
cAMP-enhancing agents could induce the neurite outgrowth from PC12D cells, MC14 
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may amplify the production of cAMP by activating adenylate cyclase, or directly 
activate PKA, leading to the enhancement of neurite outgrowth from PC12D cells.  
   As PKC activation has been shown to enhance the neurite outgrowth via Ras-MAP 
kinase pathway after the stimulation of neural cell adhesion molecular or fibroblast 
growth factor (Hundle et al., 1995; Huang et al., 1995; Burry, 1998; Kolkova et al., 
2000). However, the present results indicate that PKC is neither involved in the 
NGF-induced nor MC14-enhanced neurite outgrowth from PC12D cells. This result 
implies that NGF cannot bind to the receptor of PKC-mediated signaling pathway, and 
MC14 is not capable of activating the PKC or its up-stream kinases.  
   Taken together, the striking finding in this study is that at least two independent 
signaling pathways are activated for the MC14-stimulated neurite outgrowth from 
PC12D cells, the TrkA-MAP kinase signaling cascade and the cAMP-dependent PKA 
signaling pathway. These two signaling pathways may be activated by MC14 
individually to complement the action of NGF. Alternatively, MAP kinase is probably a 
downstream-effector of PKA-mediated signaling cascade because of the fact that MAP 
kinase is an important mediator protein kinase to integrate the complicated networking 
system and various extracellular stimuli in order to ‘fine- tune’ the network and, more 
importantly, to allow cross talk between the kinase pathways. 
   To summarize the results obtained from this part of study , the signaling pathways 
initiated by NGF in PC12D cells leading to neurite outgrowth is depicted in Fig. 4-16, 
and the proposed mechanisms of the action of MC14 in enhancing the neurite outgrowth 
from PC12D cells is shown in Fig. 4-17. The results of this study will provide an 
important insight with respect to the understanding of the signaling pathways involved 
in the neurite outgrowth of PC12D cells induced by NGF, and more importantly, for the 
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further use of PC12D cells as a model system to investigate the mechanisms of action of 
other NGF-promoting substances. In addition, the mechanism of action of MC14 to 
enhance the neurite outgrowth was suggested. These information would be equally 
important for the elucidation of biochemical change taken place in PC12D cells in 
response to NGF and MC14.  
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Fig. 4-16. Schematic representation of signaling pathways involved in 
NGF-induced neurite outgrowth from PC12D cells. See next page for caption.   
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Fig. 4-16 (cont’). Binding of NGF to TrkA receptor results in activation of a series 
of signaling proteins, including a group of GTP-binding proteins SHC, GRB, SOS 
and Ras. Subsequent, Ras protein phosphates Raf, resulting in enhanced 
mitogen-activated protein kinase kinase (MEK) phosphorylation and activation, 
which promotes dual threonine/tyrosine phosphorylation of mitogen-activated 
protein kinase (MAP-K), an event critical for stimulation of MAP-K activation. 
NGF may also activate adenylate cyclase by an unknown mechanism that, in turn, 
stimulate the conversion of ATP to cyclic 3’, 5’-adenosine monophosphate (cAMP), 
which activates cAMP-dependent protein kinase A (PKA). It is expected that PKA 
can phosphorylate several different kinase including Raf, leading to the activation 
of MAP-K via MEK. MAP-K then translocates into nuclus and phosphorylate 
several transcription factors that elicit gene expression for neurite outgrowth and 
differentiation in PC12D cells. The proposed pathways elicited by NGF in PC12D 
cells leading to neurite outgrowth is indicated by the thick solid arrows. The 
unknown pathway is indicated by broken arrow. The point of action of inhibitors is 
indicated in T-line.  
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Fig. 4-17. Schematic representation of signaling pathways involved in 
MC14-enhanced neurite outgrowth from PC12D cells. See next page for caption.  
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Fig. 4-17 (cont’). Schematic representation of signal transduction pathways 
activated by MC14 in the presence of NGF in PC12D cells. The potential acting 
points of MC14 on the signaling pathways in PC12D cells induced by 
NGF-dependent or –independent intracellular signaling pathways are indicated by 
the gray think arrow. At receptor level, MC14 may facilitate the binding of NGF to 
TrkA receptor on the PC12D cells. Other surface receptor such as growth factor 
receptor or G-protein couple receptor may be directly activated by the interaction 
with MC14 resulting in the activation of certain MAP-K signaling cascade. In 
addition, MC14 activates PKA or its up-stream protein kinase such as adenylate 
cyclase. MEK-mediated signaling pathway is likely to be mainly amplified by 
MC14 leading to the enhancement of neurite outgrowth from PC12D cells. The 
unknown pathway is indicated by broken arrow. NGF-mediated signaling 
pathways are shown in solid arrow.    
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Chapter V 
Acetylcholinesterase Promoting Activity of MC14  
 
 
   Acetylcholine (Ach) is a well-studied neurotransmitter in the nervous system that is 
released from the synaptic terminals of cholinergic neuron. Acetylcholine is synthesized 
by the enzyme choline acetyltransferase (ChAT) from the precursor choline and acetate. 
After finishing its job as a neurotransmitter, acetylcholine is inactivated by being split 
into choline and acetate by the enzyme acetylcholinesterase (AchE) as shown in the 
following equation (Matthews, 1998):  
 
 
 
   ChAT and AchE are the key enzymes for maintaining the normal function of 
acetylcholine as a neurotransmitter, and their expressions represent the functional 
differentiation of neurons (Das & Barone, 1999). One of the action of NGF during the 
early developmental stage is to induce the expression of these enzymes in cholinergic 
neurons (Barde, 1994).  
   On the other hand, it has been reported that NGF significantly increases the AchE 
                         ChAT 
Acetate + Choline                         Acetylcholine 
       AchE 
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activity in PC12 cells ((Rieger et al., 1980; Greene & Rukenstein, 1981). Because this 
enzyme is present in PC12 cells grown without NGF and, unlike choline 
acetyltransferase, has a specific activity that does not vary as a function of cell density, 
the assessment of AchE in PC12 cells has been widely used as a biochemical marker to 
evaluate the NGF-induced functional differentiation of PC12 cells (Rieger et al., 1980; 
Katoh-Semba et al., 1987; Pradines et al., 1995). Greene & Rukenstein has reported that 
the effect of NGF on regulating AchE activity and neurite outgrowth in PC12 cells may 
be regulated via parallel or branching pathways (Greene & Rukenstein, 1981).  
   Accordingly, it is necessary to examine more closely whether MC14 can promote 
NGF-induced AchE activity in PC12D cells, in order to provide a biochemical evidence 
for MC14 to promote a functional differentiation of PC12D cells. 
 
5-1. Materials and Methods 
 
5-1-1. Materials 
   Sodium chloride solution (0.15 mol/l, supplemented with chloroform), 
m-nitrophenol, acetylcholine chloride and acetic acid were purchased from Sigma. Total 
protein content of each sample was determined by Micro BCA Protein Assay Reagent 
Kit from Pierce.  
 
5-1-2. Cell culture 
 
   PC12D cells  were seeded on 6-well tissue culture plate (2 X 106 cells per well) 
coated with collagen in complete medium for 24 h. For the time-course study of 
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NGF-induced AchE activity in PC12D cells, medium was then changed to fresh 
complete medium containing various concentrations of NGF, the cultures were 
incubated at 37°C for 12, 24, 48, 72 and 96 h. For the study of dose-response activity of 
MC14, medium was changed to fresh complete medium containing NGF with or 
without MC14, the cultures were incubated at 37°C for 72 h. Cells were harvested and 
washed with ice-cold PBS twice to remove the serum (which may contain AchE). Cell 
pellets were collected by centrifugation at 1000 rpm for the determination of AchE 
activity. 
 
5-1-3. Preparation of cell lysate  
   Cells were resuspended in 200 µl ice-cold Tris-HCl (20 mM, pH 7.5) containing 
0.5% Triton X-100, 10 mM MgCl2 and 150 mM NaCl, and lysed by brief sonication on 
ice-bath. For protein concentration determination, 50 µl of the each cell lysate sample 
was reserved and stored in 4°C before protein assay. The rest of sample was assayed for 
AchE activity.   
 
5-1-4. Assay of acetylcholinesterase activity    
   AchE activity in each lysate sample was determined according to the instruction 
manual of Sigma AchE assay kit with minor modification. Briefly, cell lysate (20 µl 
each) was transferred into two 1.5 ml plastic tubes labelled ‘test’ and ‘blank’. Twenty µl 
of NaCl solution (0.15 M) was added into each tube. The ‘blank’ was incubated in 60°C 
water bath for 10 min. Samples in both ‘test’ and ‘blank’ were added with 300 µl water, 
200 µl m-nitrophenol solution (0.75 g/l in 0.02 M phosphate buffer, pH 7.8) and 
acetylcholine chloride solution (150 g/l) sequentially. After mixing, the solution was 
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incubated in 25°C water bath one by one with one min interval. After 30 min, the 
absorbance at 420 nm of the solution was measured by spectrophotometer (Jusco, 
V-550). The difference of absorbance (∆Abs) from ‘test’ and blank’ was calculated for 
each cell lysate sample as follow: 
 
  ∆Abs = Abs(BLANK) – Abs(TEST) 
  
5-1-5. Calibration 
  To the 300 µl pooled cell lysate, 300 µl NaCl solution (0.15 M) was added and 
incubated in 60°C water bath for 10 min. Standard of acetic acid solution were prepared 
by serial diution with the stock acetic acid solution (0.02 M) and the inactivated cell 
lysate as described in the instruction manual. The absorbance of each standard acetic 
acid solution was recorded at 420 nm. Calibration curve was plotted of the difference of 
absorbance between each standard acetic acid solution and water (blank), versus the 
corresponding AchE activity as stated in the instruction manual. The AchE activity of 
each lysate sample was determined from the calibration curve. The specific AchE 
activity was calculated based on the protein concentrations in the enzymatically assayed 
sample determined with the Micro BCA Protein Assay Reagent Kit (Pierce). One 
Rappaport unit was defined as the amount of cholinesterase which will liberate one 
micromole of acetic acid from acetylcholine in 30 min at 25°C at pH 7.8.  
 
5-1-6. Statistical analysis 
   Each datum point is the mean ± SD (n=3). Significant difference from the control 
was determined by the Student’s t-test. P < 0.05 was considered to be a significant 
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difference. 
       
 
5-2. Results 
 
5-2-1. Calibration curve 
   The AchE determination was based on the use of an indicator m-nitrophenol to 
measure the acetic acid produced by the enzymatic hydrolysis of acetylcholine 
(Rappaport et al., 1959). AchE catalysed the hydrolysis of cholinesterase of various 
short chain organic acids, including acetylcholine, which is that substrate used in the 
assay. 
By conducting the reaction in the presence of the acid-base indicator (m-nitrophenol), 
the acetic acid produced lowers the pH, causing a loss of color. This color change is 
proportional to the AchE activity presented in the cell lysate sample. The blank is 
prepared by inactivating at 60°C for 10 min to compensate for background absorbance 
contributed by the sample. Absorbances of both ‘blank’ and ‘test’ were read at 420 nm 
and the absorbance difference was used to estimate the acetylcholinesterase level. The 
calibration curve used in the present experiment is shown in Fig 5-1. The pattern and 
scale of the calibration curve was very close to the reference proved by the instruction 
manual. Hence, it was used for determining the AchE activity of the cell lysate.  
 
              AchE, pH 7.8 
Acetylcholine + H2O                            Acetic acid + Choline 
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Fig. 5-1. Calibration curve for the determination of AchE activity in the lysate 
sample. Change of absorbance represents the difference of absorbance (420 nm) 
between sample and water (blank). The corresponding AchE activity is 
pre-determined by the AchE assay kit. One Rappaport unit is the amount of 
cholinesterase which will liberate 1 µmole of acetic acid from acetylcholine in 
30 min at 25°C at pH 7.8 under conditions stated in the Methods and Materials. 
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5-2-2. Time profile of NGF-induced AchE activity in PC12D cells 
   The time profiles of the AchE activity in PC12D cells induced by 0, 10 and 50 ng/ml 
NGF are shown in Fig. 5-2. When the cells were treated in complete medium without 
NGF treatment, the cellular specific AchE activity remained at 0.2-0.28 rappaport 
unit/µg protein, indicating that the specific AchE activity in PC12D cells did not change 
with time throughout the experimental period. The specific AchE activity in PC12D 
cells increased steadily from the initial 0.28 rappaport unit/µg protein at 12 h to 0.44 
rappaport unit/µg protein at 96 h, suggesting that AchE activity was slightly induced by 
the treatment of cells with 10 ng/ml NGF. However, the specific AchE activity in 
PC12D cells was substantially elevated after treating the cells in 50 ng/ml NGF for 72 h, 
at which a 2.7-fold enhancement was detected. At 96 h, the specific AchE activity 
dropped to 0.6 rappaport unit/µg protein. This may be explained by the reduction of 
cells’ health condition due to the deficiency of nutrient and the accumulation of 
metabolic wastes in the medium. For further experiments, an optimal incubation time of 
72 h was employed for determining the AchE promoting effect of MC14. 
 
5-2-3. AchE promoting activity of MC14 on PC12D cells 
   To assess the promoting effect of MC14 on the NGF-induced specific AchE activity, 
PC12D cells were treated with NGF in the presence or absence of MC14 for 72 h. Table 
5-1 shows that the significant enhancements of the specific AchE activity in PC12D 
cells were detected after the cells were treated with 3 µg/ml MC14 in 2 ng/ml NGF (P < 
0.05, Student’s t-test), 10 ng/ml NGF (P < 0.01, Student’s t-test) and 50 ng/ml NGF (P 
< 0.01, Student’s t-test). Treatment of cells with 3 µg/ml MC14 together with 2, 10 and 
50 ng/ml NGF resulted in an 1.3-fold, 1.2-fold and 1.5-fold increase in the specific  
 
 
Chapter V  AchE Promoting Activity 
 94
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
12 24 48 72 96
0 ng/ml NGF
10 ng/ml NGF 
50 ng/ml NGF 
Sp
ec
ifi
c A
ch
E 
ac
tiv
ity
  
(R
ap
pa
po
rt 
un
it/
 µ
g/
 p
ro
te
in
) 
Treatment time (h) 
Fig. 5-2. Time-course AchE activity in PC12D cells induced by NGF. PC12D 
cells were treated with the indicated concentration of NGF for the indicated 
period. Specific AchE activity of the cell lysates was determined based on the 
protein concentration in the enzymatically assayed sample. Each datum point 
represents the mean ± SD (n=3).    
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Table 5-1. Acetylcholinesterase promoting activity of MC14  
 
 
 NGF 
(ng/ml) 
             AchE                            P-value 
     (Rappaport unit/µg protein)               (Student’s t-test) 
    
  NGF only MC14 (3 µg/ml)  
    
  0 0.692 ± 0.049 0.753 ± 0.110 0.428    (P > 0.05) 
  2 0.769 ± 0.060 0.994 ± 0.121* 0.043    (P < 0.05) 
 10 0.871 ± 0.065 1.077 ± 0.061** 0.007    (P < 0.01) 
 50 0.910 ± 0.100 1.322 ± 0.099** 0.007    (P < 0.01) 
 PC12D cells were incubated for 72 h in complete medium with the indicated 
concentrations of NGF in the presence or absence of MC14 (3 µg/ml). Each 
datum point represents mean ± SD (n=3). Significant difference from NGF-only 
control: *P < 0.05, **P < 0.01 (Student’s t-test) where P < 0.05 was considered to 
be a significant difference. 
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AchE activity in PC12D cells, respectively. However, no significant change of the 
specific AchE activity in PC12D cells was observed when the cells were treated with 3 
µg/ml MC14 only compared with the untreated control, suggesting the MC14 did not 
induce AchE activity in PC12D cells.    
 
5-3. Discussion 
 
Acetylcholine acts as an excitatory neurotransmitter for the cholinergic neurons in the 
central nervous system (CNS). Nuclei containing the cell bodies of cholinergic neurons 
are scattered throughout the brain, and cholinergic axons innervate most region of the 
CNS. Prominent sources of cholinergic inputs to the cortex and the hippocampus are 
nuclei in the basal forebrain, especially the septal nuclei and the nucleus basealis of 
meynert. Cholinergic neurons in these nuclei have widespread and diffuse projections, 
innervating the cortex, hippocampus and brain stem (Nicholls et al.,1992). Considerable 
evidence from both animal and human studies suggests that cholinergic systems are 
important for learning, memory, and cognition (Fibiger, 1991). Therefore, acetylcholine 
has an important role for these neuronal functions. On the other hand, for a functional 
synaptic transmission of nerve impulse, acetylcholine has to be degraded into choline 
and acetate by AchE, and about half of the choline molecule degraded from 
acetylcholine will be transported back to the cholinergic axon terminals for maintaining 
sufficient substrate for acetylcholine synthesis. Drugs that interfere with transmitter 
degradation or uptake can have profound effects on signaling, indicating that the rapid 
termination of transmitter action by AchE is crucial to synaptic function (Nicholls et al., 
1992).  
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Present result indicates that MC14 can significantly promote the NGF-induced AchE 
activity in PC12D cells, demonstrating that MC14 can enhance the functional 
differentiation of PC12D cells. Besides, it provides additional biochemical evidence for 
the activity of MC14 to promote functional neurodifferentiation. Interestingly, several 
agents, namely EGF, dexamethasone and Bt2cAMP, have been reported to modulate the 
phenotypic properties (e.g. neurite outgrowth) of PC12 cells neither affected their 
specific AchE activity nor significantly altered the response of AchE to NGF treatment 
(Edgar & Thoenen, 1978). The present finding clearly indicates that MC14 can promote 
both the NGF-induced morphological and enzymatical differentiation. However, MC14 
does not mimic these actions of NGF.  
The present result implies that MC14 may be beneficial to the normal development of 
the cholinergic nervous system associated with learning, memory and recognition.   
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Chapter VI  
Neuronal Survival Supporting Activity of MC14 
 
 
   In chapters IV and V, the actions of MC14 on promoting neurite outgrowth and 
acetylcholinesterase activity in PC12D cells have been demonstrated. Both of these 
morphological and biochemical assessments support the MC14’s capability of 
promoting differentiation on PC12D cells. These findings also provided evidence for the 
NGF-potentiating activity of MC14. Since NGF can induce diverse cellular effects, 
which are regulated through separate and distinct intracellular signaling pathways 
(Kimura et al, 1994; Yao & Cooper, 1995; Belliveau et al., 1997), it is necessary to 
further assess whether MC14 also promote NGF-induced survival support for exploring 
the potential of MC14 to treat neurodegenerative diseases such as Alzheimer’s disease, 
which causes progressive neuronal cell death and loss of neurons (Whitehouse et al., 
1982). Moreover, a number of reports have shown that some neuroactive agents such as 
forskolin and cAMP analogs do not exhibit both neuronal differentiating and  
neuroprotecive activities (Rukenstein et al., 1991; Ashcroft et al., 1999). These findings 
suggests that cellular responses such as neurite outgrowth and survival can be 
differentially regulated by different agents, making it necessary to further investigate 
whether MC14 also promotes survival supporting activity.  
   PC12 cell line has been extensively used as a modeling system to study the 
mechanisms of neuronal cell death because the neuronally differentiated PC12 cells 
depend NGF for survival in serum-free medium. Deprivation of NGF will cause the 
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neuronal PC12 cell death via apoptosis, an intracellular controlled process to cause cell 
death (Batistatou et al., 1991; Mesner et al., 1995). This characteristic has made PC12 
cell line a very useful model system for the study of mechanisms of apoptosis as well as 
the neuroprotective effect of NGF on neuronal cells.  
   In this study, the survival supporting action of NGF on neuronal PC12D cells in 
serum-free medium was confirmed and the activity of MC14 to promote 
neuroprotection in the presence and absence of NGF were investigated. Cells viability 
was determined by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] assay, which has been widely used as a sensitive and accurate method to 
measure cell viability (Denizot & Lang, 1986; Gerlier & Thomassel, 1986; Hansen et al., 
1989; Vistica et al., 1991). The assay is designed for the spectrophotometric 
quantification of cell viability based on cleavage of the yellow tetrazolium salt MTT to 
purple formazan crystals by metabolic active cells. This cellular reduction involves the 
pyridine nucleotide cofactors NADH and NADPH (Berridge & Tan, 1993). After the 
formazan salt crystals solubilized in the solubilizing solution and incubating overnight 
in humidified atmosphere, the resulting colored solution is quantified using a scanning 
multiwell spectrophotometric reader. The absorbance is proportional to the number of 
viable cells.  
   In addition to evaluate the survival supporting activity of NGF and promoting effect 
of MC14, their mechanisms of actions were investigated in order to get a thorough 
understanding of the signal transduction pathways regulating their actions. The second 
part of this chapter will focus on an in vitro study of neuroprotective effect of MC14 on 
PC12D cells against oxidative stress induced by hydrogen peroxide. This result would 
provide strong supportive pharmacological evidence for the potential application of 
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MC14 as a therapeutic agent to treat neurodegenerative diseases.  
 
6-1. Survival supporting effect of MC14 on serum free-induced neuronal PC12D 
cell death 
 
   PC12 cell line has been extensively used as a modeling system to study the 
mechanisms of neuronal cells death because the neuronally differentiated PC12 cells 
depend NGF for survival in serum-free medium (Mesner et al., 1992). In order words, 
the deprivation of NGF will cause an intracellular controlled process for cell death. This 
characteristic has made PC12 cells a very useful cellular system for the study of the 
mechanisms of apoptosis (programmed cell death) as well as the neuroprotective action 
of NGF-promoting neuroactive substances. In this study, the survival supporting action 
of NGF on neuronal PC12D cells under serum-free condition for evaluating their 
potential application as a modeling system to study NGF-induced responses. 
Furthermore, the activity of MC14 to promote neuroprotection in the presence and 
absence of NGF were investigated. Finally, the mechanisms of action of MC14 was 
described to get a better understanding of its effect.   
 
6-1-1. Methods and Materials 
 
(1) Cell culture and preparation of neuronal PC12D cells 
   PC12D cells were maintained in complete medium as described in chapter 4. 
Neuronal PC12D cells were prepared as follow: PC12D cells (5x106 cells) were seeded 
on 10-cm tissue culture dish in complete medium for 24 h. For the ease of cell 
 
 
Chapter VI  Neuronal Survival Supporting Activity 
 101
detachment, the tissue culture dish was not coated with poly-L lysine. After 24 h 
incubation, medium was changed to a fresh medium containing DMEM supplemented 
with 5% FBS and 50 ng/ml NGF to induce differentiation. After 48 h, neuronal PC12D 
cells were harvested by trituration and washed in serum-free DMEM by three cycles of 
centrifugation-resuspension (Batitatou & Greene, 1991). 
 
(2) Time-course study of serum-free induced neuronal PC12D cell death   
   The neuronal PC12D cells were plated on 96-well plate coated with poly-L-lysine at 
5x103 cells per well in serum-free DMEM. Cell viability was determined by MTT assay 
after an incubation period of 2, 4, 12, 24, 48 and 60 h. 
  
(3) Study of NGF-induced survival supporting effect on neuronal PC12D cells  
   Neuronal PC12D cells were plated on poly-L-lysine coated culture plate as 
described above. For studying the dose-dependent survival supporting effect of MC14 
on the neuronal PC12D cells under serum-free condition, NGF at a concentration range 
of 0-50 ng/ml was added to the cultures and incubated for 24 h. The absorbance value   
of cultures treated with 100 ng/ml NFG was assigned as positive control (optimal 
concentration for supporting cell survival in serum-free medium). The viability of other 
cell cultures was expressed as a percentage of positive control (100 ng/ml NGF, 100%) 
from the same experiment.   
 
(4) Study of survival promoting and supporting activities of MC14 in the presence or 
absence of NGF 
   After neuronal PC12D cells were plated on 96-well plate as described above, NGF 
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and MC14 were added to the cell cultures. Concurrently, corresponding cell cultures 
were treated with NGF only for comparing the promoting effect of MC14. To assess the 
survival supporting effect of MC14, neuronal PC12D cells were treated with or without 
MC14. Cell viability was determined by MTT assay after incubated in serum free 
medium for 24 h.  
 
(5) Effect of various inhibitors on MC14-stimulated neuroprotection on neuronal 
PC12D cells 
   After the neuronal PC12D cells were plated on 96-well plate as described above, 
aliquot of each inhibitor was added to cell cultures and incubated for 1 h before the 
additions of MC14. After a further 24 h incubation, the cell viability was determined by 
MTT assay. The following stock concentrations of inhibitors dissolved in the indicated 
solvent were used in the experiment: PD98059 (20 mM, DMSO); K252a (200 µM, 
MeOH); PKA inhibitor (5 mg/ml, DMEM) and chelerythrine chloride (0.5 mg/ml, 
DMEM). Each inhibitor was further diluted with serum-free DMEM to a suitable 
working concentration and aliquot of each inhibitor was added to the test well in less 
than 1% v/v of the medium, which has no effect to the cells. The inhibitors also have no 
effect on the cells incubated in serum free medium.   
 
(6) MTT assay  
   Cell survival was evaluated by the tetrazolium salt MTT 
(3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide, Sigma) (Hansen et al., 
1989). MTT was added to the cultures at a final concentration of 0.5 mg/ml to each well. 
The plate was incubated for 4 h in a water-saturated atmosphere of 5% CO2 at 37°C 
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before the addition of 100 µl solubilization solution (10% SDS in 0.01 M HCl). The 
plate was allowed to stand overnight in a water-saturated atmosphere at 37°C. After 
conforming the complete solubilization of the purple formazen crystals by microscopic 
observation, the spectrophotometrical absorbance was measured by a microtiter plate 
reader (BIO-RAD, Model 450). The absorbance at 570 nm and 655 nm were used as the 
main and reference wavelengths, respectively.   
 
(7) Phase-contrast microscopy 
The morphology of cells under various treatments in serum-free medium was 
recorded using a phase-contrast microscope with 200-400X magnification. Photo-slides 
were taken using a compatible camera (Oympus SC-35). Image was scanned from the 
slide and transformed into computer file using Polaroid Polarscan 25/LE system. 
 
(8) Statistical analysis 
   Each datum point represents the mean ± S.D. (n=4-6). Significant difference from 
the control was determined by the Student’s t-test. P < 0.05 was considered to be a 
significant difference.    
 
6-1-2. Results 
 
(1) Neuronal PC12D cell death induced in serum-free medium  
   As determined by MTT assay, cell viability significantly decreased after the 
neuronal PC12D cells were incubated in NGF-deprived serum-free medium for 6 h and 
more than  50% reduction  was  detected  after  24 h (Fig. 6-1).  At the end of the  
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Fig. 6-1. Time-course neuronal PC12D cell death in serum-free medium. Neuronal 
PC12D cells were incubated in NGF-deprivated serum-free medium at the 
indicated time. Cell survival was determined by MTT assay, and expressed as a 
percentage relative to positive control (100 ng/ml NGF, 100%). Each point 
represents the mean ± SD (n=4) from two replicated experiments.   
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experimental period (60 h), cell viability was lower than 10% of positive control. Hence, 
an incubation time of 24 h was used as to examine the survival supporting activity of 
NGF and survival promoting effect of MC14 in the following experiments. With respect 
to the morphological change, increasing number of shrunk cells were observed after 6 h 
and almost all cell shrunk after 60 h of incubation in serum free medium (Fig. 6-2B). 
 
(2) Survival supporting effect of NGF  
   NGF supported the survival of neuronal PC12D cells in serum-free medium in a 
concentration dependent manner (Fig. 6-3). At 100 ng/ml NGF, almost no shrunk cell 
was observed and some of the cells even extended long neurite (Fig. 6-2C), suggesting 
that NGF could effectively protect neuronal PC12D cells from serum-free-induced 
degeneration. Hence, the culture treated with 100 ng/ml NGF was assigned to be the 
positive control for the determination of cell viability.     
 
(3) Survival promoting effect of MC14  
   The survival promoting effect of MC14 was first examined at 0.75 µg/ml MC14 in 
the presence of 0-100 ng/ml NGF. As shown in Fig. 6-4, slight but significant survival 
promoting effect of 0.75 µg/ml MC14 was detected in the presence of 0.02-50 ng/ml 
NGF. In an attempt to evaluate the optimal promoting effect, a high dose of MC14 
together with NGF were added to the cultures. Treatment with 1.5 µg/ml MC14 further 
enhanced the percentage of viable cells by 25-40% over those treated with NGF only 
(Fig. 6-5). Both MC14 treatments exhibited NGF concentration-dependent survival 
promoting effect. In addition, the combined effect of MC14 and 50 ng/ml or 100 ng/ml 
NGF increased the cell viability to an extend higher than that of positive control, while  
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Fig. 6-2. Morphologies of neuronal PC12D cells after various treatment for 24 h. 
(A) Neuronal PC12D cells right before incubated in NGF-deprived serum free 
medium. Neuronal PC12D cells incubated in serum free medium in the (B) absence 
or presence of (C) 100 ng/ml NGF. (D) Neuronal PC12D cells treated with 1.5 µg/ml 
MC14 only. Neuronal PC12D cells treated with 0.4 ng/ml NGF in the absence (E) or 
presence (F) of 1.5 µg/ml MC14. Scale bar: 20 µM. 
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Fig. 6-3. Survival supporting effect of NGF on neuronal PC12D cells. Neuronal 
PC12D cells were incubated in the indicated concentrations of NGF in 
serum-free medium for 24 h. Cell survival was determined by MTT assay, and 
expressed as a percentage relative to the positive control (100 ng/ml NGF, 
100%). Each point represents the mean ± SD (n=4) . 
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Fig. 6-4. Survival promoting effect of MC14 on neuronal PC12D cells. Neuronal 
PC12D cells were incubated in 0.75 µg/ml MC14 and the indicated 
concentrations of NGF in serum free medium for 24 h. Cell survival was 
determined by MTT assay, and expressed as a percentage relative to the 
positive control (100 ng/ml NGF, 100%). Each point represents the mean ± SD 
(n=4). Significant difference from MC14-untreated control: *P < 0.05, **P < 
0.01 (Student’s t-test).   
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Fig. 6-5. Survival promoting effect of MC14 on neuronal PC12D cells. Neuronal 
PC12D cells were incubated in 1.5 µg/ml MC14 and the indicated 
concentrations of NGF in serum free medium for 24 h. Cell survival was 
determined by MTT assay, and expressed as a percentage relative to the 
positive control (100 ng/ml NGF, 100%). Each point represents the mean ± SD 
(n=4). Significant difference from MC14-untreated control: **P < 0.01 
(Student’s t-test).   
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the combined effect of MC14 and 2 ng/ml NGF was comparable to positive control 
(Fig-6-5), demonstrating that the treatment of MC14 (1.5 µg/ml) can prevent 
serum-free-induced neuronal cell death even at a relatively low concentration of NGF (2 
ng/ml). Besides, more than 40% of cells can be rescued from serum-free-induced cell 
death in an extremely low level of NGF (0.08-0.4 ng/ml). Another striking observation 
is that MC14 (0.75 and 1.5 µg/ml) could substantially support cell survival even in the 
absence of NGF (Figs. 6-2D, 6-4, 6-5), suggesting that MC14 possess significant 
neuroprotective effect, which was concentration-dependent (Fig. 6-6). Therefore, the 
mechanisms involved in survival supporting effect of MC14 and NGF under serum free 
medium were further investigated as described in the following section.  
 
(4) Effect of various signaling molecule inhibitors on survival support activity of NGF 
in serum-free medium 
   Mounting evidence have shown that NGF-induced cellular responses are associated 
with the Ras-dependent stimulation of the mitogen-activated protein kinases and others 
have demonstrated that phosphatidylinositol 3-kinase may be important in survival of 
neuronal cells (Yao & Cooper, 1995; Suzukawa et al., 2000). To study the participation 
of these two signaling pathways in the NGF-induced survival support on neuronal 
PC12D cells under serum free condition, a specific MAPK kinase inhibitor PD98059, 
and a PKC inhibitor chelerythrine chloride were tested.  
   Pretreatment of cells with PD98059 did not reduce the percentage of cell survival 
induced by 0.08-10 ng/ml NGF (Fig. 6-7). Unexpectedly, the pretreatment of PD98059 
significantly enhanced the survival suppoting effect induced by 10 ng/ml NGF.  
   With respect to the PKC inhibition, no significant inhibitory effect was detected by  
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Fig. 6-6. Survival supporting effect of MC14 on neuronal PC12D cells. 
Neuronal PC12D cells were incubated in the indicated concentrations of MC14 
in serum free medium for 24 h. Cell survival was determined by MTT assay, 
and expressed as a percentage relative to the positive control (100 ng/ml NGF, 
100%). Each point represents the mean ± SD (n=4). Significant difference from 
MC14-untreated control: *P < 0.05 (Student’s t-test).   
0
10
20
30
40
50
60
70
80
90
0 0.375 0.75 1.5 3
MC14 concentration (µg/ml) 
C
el
l v
ia
bi
lit
y 
(%
 o
f p
os
iti
ve
 c
on
tr
ol
) 
 
*
**
 
 
Chapter VI  Neuronal Survival Supporting Activity 
 112 
0
20
40
60
80
100
120
0 0.08 0.4 2 10
Only NGF treatment
Pretreated with PD98059 inhibitor
NGF concentration (ng/ml) 
C
el
l v
ia
bi
lit
y 
(%
 o
f p
os
iti
ve
 c
on
tr
ol
) 
 
Fig. 6-7. Effect of PD98059 on survival supporting effect of NGF on neuronal 
PC12D cells. Neuronal PC12D cells were pretreated with or without 3 µM 
PD98059 for 1 h before adding the indicated concentrations of NGF in serum 
free medium. After 24 h, cell viability was determined by MTT assay, and 
expressed as a percentage relative to the positive control (100 ng/ml NGF, 
100%). Each point represents the mean ± SD (n=4). Significant difference from 
inhibitor-untreated control: **P < 0.01 (Student’s t-test).   
** 
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the pretreatment of cells with chelerythrine chloride in the presence of 0-10 ng/ml NGF 
(Fig. 6-8), suggesting that the NGF-rescuing effect on neuronal PC12D under 
serum-free condition may be independent of PKC-mediated pathway. 
   To confirm the effect of PD98059 and chelerythrine chloride, a dose higher than 
their effective concentration was examined on the neuronal PC12D cells treated with 10 
ng/ml NGF. Result shows that chelerythrine chloride (600 nM and 6000 nM) did not 
significantly reduced the percentage of viable cell compared with inhibitor untreated 
control (Fig. 6-9). Again, significant enhancements of viable cell (more than 30%) were 
detected after the cells were pretreated with 3 and 10 µM PD98059 (Fig. 6-10). This 
indicates that the inhibition of MAP kinases activation may probably contribute to, 
rather than inhibit, the rescue effect of NGF on neuronal PC12D cells under serum free 
condition.  
   In order to further investigate the other potential signaling pathways that may 
mediate NGF-induced survival supporting activity on neuronal PC12D cells, PKA 
inhibitor and K252a were tested. Results indicated that no significant inhibitory effect 
of PKA inhibitor could be detected at 2, 10 and 50 nM (Fig. 6-11). However, a 
substantial reduction of cell viability was resulted after the treatment of 200 nM K252a 
(an effective inhibitory concentration for general protein kinases). Besides, a weak 
inhibition was observed at the treatment of 50 nM K252a while no significant change 
was detected in the cultures pretreated with 5 nM K252a (TrkA receptor inhibitory 
concentration) (Fig. 6-12). These results demonstrate that the neuronal survival 
supporting activity of NGF may not require the activation of PKA-mediated pathway 
and the activation of TrkA receptor while the activation of other intracellular kinases is 
essential for the NGF-mediated action.  
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Fig. 6-8. Effect of chelerythrine chloride on survival supporting effect of NGF 
on neuronal PC12D cells. Neuronal PC12D cells were pretreated with or 
without 600 nM chelerythrine chloride for 1 h before adding the indicated 
concentrations of NGF in serum free medium. After 24 h, cell viability was 
determined by MTT assay, and expressed as a percentage relative to the 
positive control (100 ng/ml NGF, 100%). Each point represents the mean ± SD 
(n=4).  
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Fig. 6-9. Effect of chelerythrine chloride on survival supporting effect of NGF 
on neuronal PC12D cells. Neuronal PC12D cells were pretreated with or 
without the indicated concentrations of chelerythrine chloride for 1 h before 
adding the 10 ng/ml NGF in serum free medium. After 24 h, cell viability was 
determined by MTT assay, and expressed as a percentage relative to the 
positive control (100 ng/ml NGF, 100%). Each point represents the mean ± SD 
(n=4).  
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Fig. 6-10. Effect of PD98059 on survival supporting effect of NGF on neuronal 
PC12D cells. Neuronal PC12D cells were pretreated with or without the 
indicated concentrations of PD98059 for 1 h before adding the 10 ng/ml NGF in 
serum free medium. After 24 h, cell viability was determined by MTT assay, 
and expressed as a percentage relative to the positive control (100 ng/ml NGF, 
100%). Each point represents the mean ± SD (n=4).  
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Fig. 6-11. Effect of PKA inhibitor on survival supporting effect of NGF on 
neuronal PC12D cells. Neuronal PC12D cells were pretreated with or without 
the indicated concentrations of PKA inhibitor for 1 h before adding the 10 
ng/ml NGF in serum free medium. After 24 h, cell viability was determined by 
MTT assay, and expressed as a percentage relative to the positive control (100 
ng/ml NGF, 100%). Each point represents the mean ± SD (n=4).  
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Fig. 6-12. Effect of K252a on survival supporting effect of NGF on neuronal 
PC12D cells. Neuronal PC12D cells were pretreated with or without the 
indicated concentrations of K252a for 1 h before adding the 10 ng/ml NGF in 
serum free medium. After 24 h, cell viability was determined by MTT assay, 
and expressed as a percentage relative to the positive control (100 ng/ml NGF, 
100%). Each point represents the mean ± SD (n=4). Significant difference from 
inhibitor-untreated control: *P < 0.05 **P < 0.01 (Student’s t-test).  
** 
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(5) Effect of signaling molecule inhibitors on survival supporting activity of MC 14 
   Next, the effect of various inhibitors on survival supporting effect of MC14 in the 
absence of NGF was studied. Pretreatment of neuronal PC12D cells with the test 
concentrations of K252a, chelerythrine chloride, PD98059 or PKA inhibitor showed no 
significant inhibition to MC14-induced cell survival effect on neuronal PC12D cells 
(Fig. 6-13), demonstrating that the activation of TrkA receptor, PKA, MAPK kinase or 
PKC were not required for the survival supporting effect of MC14.  
 
6-1-3. Discussion 
 
(1) Neuronal PC12D cell death induced by NGF-deprived serum-free medium  
   Neuronally differentiated PC12 cells have been considered to be the useful cell 
model for studying neuronal cell death because they exhibit the typical aspects, 
including the requirement of protein synthesis for the ‘programmed’ cell death, 
aggregation of chromatin, DNA fragmentation and conservation of mitochondria, by 
NGF withdrawal from serum free medium (Martin et al., 1988; Mesner et al., 1992). 
The present study describes the typical neuronal cell death of the neuronally 
differentiated PC12D cells, a subline of PC12 cells, can also be induced by 
NGF-withdrawal in serum-free medium. The aspect of time course of neuronal PC12D 
cell death resembles to that of sympathetic neurons and neuronal PC12 cells as reported 
previously (Mesner et al., 1992; Mesner et al., 1995). In addition, it has been reported 
that addition of anti-NGF antiserum caused the sympathetic neuron death between 24- 
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Fig. 6-13. Effect of various signaling molecular inhibitors on survival 
supporting effect of MC14. Neuronal PC12D cells were pretreated with or 
without the indicated concentrations of inhibitors for 1 h before adding 1.5 
µg/ml MC14 in serum free medium. After 24 h, cell viability was determined by 
MTT assay, and expressed as a percentage relative to the positive control (100 
ng/ml NGF, 100%). Each point represents the mean ± SD (n=4).  
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48 h by disruption of nuclear membrane, dilation of the rough endoplasmic reticulum 
and release of cytosolic enzyme (Martin et al., 1988). In consistent with these results, 
the present finding reveals that the metabolic activity of neuronal PC12D cells, as 
determined by MTT assay, significantly decreased within 24 h and almost completely 
inhibited after 48 h when the cells were incubated in NGF-deprived serum-free medium, 
suggesting that neuronal PC12D cells are also an ideal model system for the study of 
neuronal cell death by NGF-withdrawal under serum free condition.  
 
(2) Survival supporting activity of NGF and MC14 on neuronal PC12D cells 
   NGF plays a vital role in regulating the normally occurring neuronal death during 
neurogenesis. NGF is secreted from the target cells and prevents the neuronal cell death 
at the time when these cells begin to be innervated (Barde, 1994). After the neuronal 
cells are fully differentiated, the maintenance of neuronal survival depends on the 
existence of NGF. If NGF is insufficient or deprived, neuronal cells will commit 
‘suicide’ by eliciting a programmed cell death pathway (Semkova & Krieglstein, 1999). 
Death of the neuronal PC12 cells, like sympathetic neurons, can be prevented by NGF 
(10-100 ng/ml). Although the exact mechanism of NGF’s survival-supporting effect 
remains to be determined, it has been known that certain gene expressions and cellular 
responses are induced by NGF to support cell survival (Bournat et al., 2000; Maggirwar 
et al., 2000). In this study, NGF is found to be capable of preventing the neuronal 
PC12D cell death in serum free medium, suggesting that they are responsive to NGF in 
terms of its survival supporting effect. More importantly, the neuronal PC12D cells can 
be used as a neuronal model system for the identification and verification of the 
biologically active substance that can support cell survival or promote NGF-induced 
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survival activity.  
   Results of the neuronal PC12D cell viability under the treatment of MC14 and NGF 
clearly indicate that MC14 can enhance NGF-induced cell survival activity. Treatment 
of cells with MC14 and a relatively low concentration of NGF (2 ng/ml) can prevent 
cells death as those treated with the optimal effective concentration of NGF (50 ng/ml). 
This result implies that age- or diseases-related neurodegeneration, which is induced by 
the deficiency of NGF in the brain region, might be alleviated or prevented by the 
treatment of MC14. In addition to effectively promoting NGF-induced cell survival, 
MC14 alone can significantly enhance the viability of neuronal PC12D cells in 
NGF-deprived serum free medium, demonstrating that it might trigger the similar 
signaling pathway employed by NGF for the survival support.  
 
(3) Mechanisms of NGF-induced survival supporting effect on neuronal PC12D cells 
   The present study shows that the NGF-induced survival of neuronal PC12D cells is 
not affected by inhibiting the activity of TrkA receptor, suggesting that NGF support the 
survival of neuronal PC12D cells via the activation of signaling cascade other than that 
initiated by NGF-TrkA interaction. This result is in consistent with a study by 
Taglialatela et al.(1996), who showed that inhibition of TrkA phosphorylation does not 
abolish NGF rescue of serum-deprived PC12 cells from apoptosis. They used antisense 
oligonucleotide treatment to inhibit TrkA expression, and found that NGF can still 
rescue serum-deprived PC12 cells. Thus, NGF may rescue the TrkA-deficient PC12 
cells by binding on the other growth factor receptor such as p75 receptor (Taglialatela et 
al., 1996). Therefore, it is speculated that NGF may bind to other surface receptor of the 
neuronal PC12D cells to elicit the TrkA-independent signaling pathway for the rescue 
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of cells under serum-free medium. However, it has also been reported that the activation 
of TrkA receptor is essential for the NGF-mediated survival in sympathetic neuron. 
(Belliveau et al., 1997) while the increase in the expression of TrkA receptor enhances 
the percentage of apoptotic neurons from chick embryo (Ahlemeyer et al., 2000). These 
conflicting results may be explained by the different type of neurons in the experiments. 
The present study showed that NGF-induced cell survival is mediated via the 
intracellular kinase activity as substantial cell death was observed under the treatment of 
200 nM K252a, at which the intracellular kinases are inhibited nonspecifically.  
   Concerning the effects of chelerythrine chloride on NGF-induced rescue on the 
neuronal PC12D cells, it shows no inhibitory effect on NGF-induced survival support, 
demonstrating that PKC- mediating signaling pathways may not involve in this action 
of NGF. Interestingly, it has been reported that phosphatidyl-inositol-3 (IP3) kinase is 
required in the prevention of apoptosis by NGF (Yao & Cooper, 1995). As protein 
kinase C is a downstream effector protein kinase in the IP3-signaling cascade, NGF may 
activate IP3, which subsequently activates the other immediate effector protein kinase 
as a divergent pathway. Thus, NGF supports survival of neuronal PC12D cells even the 
activity of PKC is blocked. Alternatively, neuronal PC12D cells might not express 
enough IP3 level in serum-free medium and so the IP3-dependent signaling cascade is 
not activated by NGF at all.  
   On the other hand, PKA is apparently independent of NGF-induced survival 
supporting effect on neuronal PC12D cells as no inhibitory effect is observed for the 
PKA inhibitor even at its 10-time PKA inhibiting concentration (50 nM). This result 
clearly demonstrates that PKA is not required for NGF rescue of neuronal PC12D cells. 
This is consistent with that reported by Rukenstein et al., they used a variant PC12 cells 
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with defective PKA activity to show that NGF, cAMP, insuline and FGF could still 
promot long-term survival of this variant PC12 cells in serum free medium. This result 
strongly suggests that the activation of PKA is not required for the survival actions of 
these growth factor.  
   Although the Ras-MAP kinase pathway has been considered to be actively involved 
in neuronal differentiation of PC12 cells induced by NGF (Traverse et al., 1992; Pang et 
al., 1995; Hashimoto et al., 2000), its role during the NGF-induced survival support is 
less described. The present study using the specific MAPK kinase inhibitor PD98059 
indicates that the inhibition of MAP kinases activity does not block the survival 
supporting effect of NGF, but rather enhances the cell viability in serum free medium 
compared with the effect of inhibitor-untreated control (Figs 6-7,6-10). In other words, 
the inactivation of MAP kinases promotes the survival supporting action of NGF in 
neuronal PC12D cells in serum free condition. This implies that MAP kinase-mediated 
pathways might involve in cell death signal, instead of survival supporting signal in 
neuronal PC12D cells incubated in serum free medium. It has been demonstrated that 
another MAP kinase inhibitor olomoucine is able to prevent apoptosis of central and 
peripheral neurons by inhibiting JNK (c-Jun N-terminal kinases) and its activation leads 
to neuronal apoptosis (Maas et al., 1998). Despite the mechanism of inhibitory action of 
olomoucine and PD98059 on MAP kinase may be different, MAP kinase inhibited by 
PD98059 in the neuronal PC12D cells may involve in NGF-deprived induced apoptotic 
cell death.   
  
(4) Mechanisms of survival supporting activity of MC14 on neuronal PC12D cells 
   To investigate the signal transduction pathways mediating the survival supporting 
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effect of MC14, the inhibitory effects on several typical signaling pathways were 
examined. Pharmacological inhibition of TrkA, PKC, PKA or MAP kinase results in no 
significant inhibition of MC14-enhanced survival support on neuronal PC12D cells 
under serum-free and NGF-deprived conditions. This result demonstrates that MC14 
rescues neuronal PC12D cells via a novel signaling pathway independent of PKC, PKA 
and MAP kinase. In addition, MC14 does not directly bind on and activate the 
NGF-specific tyrosine receptor kinase A. Recently, accumulative evidence have shown 
that the activation of transcription factor NF-κB (nuclear factor-κB) in neuronally 
differentiated PC12 cells and sympathetic neurons can prevent NGF-deprived cell death 
and other apoptotic cell death (Maggirwar et al., 1998; Foehr et al., 2000; Maggirwar et 
al., 2000). In addition, a number of recent reports have indicated that PI3 kinase 
(phosphatidylinositol 3-kinase) and a major substrate of PI3 kinase activity, Akt/PKB, 
regulates the survival of several cell types (Franke et al., 1997; Crowder & Freeman, 
1998). Additionally, constitutive activation of PI3 kinase or Akt/PKB contributes to 
NGF-independent survival functions in sympathetic neurons (Crowder & Freeman, 
1998). It is speculated that MC14 might support the survival of neuronal PC12D by 
activating the PI3-Akt/PKB pathway, subsequently activating the NF-κB to protect cells 
in NGF-deprived serum free medium. Taken together, the present result demonstrates 
that MC14 exhibits a NGF-independent survival function to rescue the NGF-deprived 
neuronal PC12D cell. Additionally, MC14 can also complement the survival supporting 
effect of NGF to rescue neuronal PC12D cells in serum free medium.  
 
(5) Neurite outgrowth promoting effect and survival supporting effect of MC14 are 
regulated via different mechanisms in PC12D cells 
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Comparing the findings described in this chapter and chapter 4, the mechanisms of 
actions of MC14 for neuronal differentiation and survival support are regulated by 
distinct signaling pathways in PC12D cells. Exposure of naïve PC12D cells to NGF 
induces differentiation and neurite outgrowth from PC12D cells. The neurite-outgrowth 
promoting mechanisms of MC14 involve the facilitation of NGF binding to its receptor 
TrkA, and the activations of PKA and MAPK kinase. In addition, the promoting effect 
of MC14 is mediated by at least two separate signaling pathways, namely TrkA-MAPK 
pathway and PKA-MAPK pathway. They probably complement each other to promote 
the action of NGF for neurite outgrowth and neurodifferentiation of PC12D cells. 
Regarding the survival supporting effect of MC14, TrkA receptor is apparently not 
involved in the action of MC14. This may be explained by the incapability of MC14 to 
directly bind on the receptor TrkA. In contrast to neurite outgrowth promoting activity 
of MC14, the PKA-mediated cascade is also not required for MC14 to rescue neuronal 
PC12D cells in NGF-deprived serum free medium. An interesting finding in these 
studies is that although MAP kinase-mediated pathway has a key role in controlling 
neuronal differentiation of PC12D cells, this pathway seems to have reverse action on 
survival support as the blockage of the MAP kinase-pathway by PD98059 results in 
enhancing the NGF-induced survival support effect on neuronal. On the other hand, 
several different properties of MC14 on PC12D cells can also be found in the present 
studies. The most striking finding is that MC14 alone can support survival of neuronal 
PC12D cells in NGF-deprived serum free medium, but MC14 fails to induce neurite 
outgrowth from PC12D cells in the absence of NGF.  
   Three important implications from these findings can be derived. First, the 
treatment of MC14 may not only potentiate the action of NGF for neuronal 
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differentiation during the developmental stage of mammals, but also rescue the 
apoptotic cell death caused by NGF-unrelated (e.g. Parkinson’s disease) or NGF-related 
(e.g. Alzheimer’s disease) neurodegenerative disorders, as well as naturally occurring 
neurodegeneration in the CNS. Second, MC14 activates distinct intracellular signaling 
pathways to bring about different cellular responses such as neurodifferentiation and 
maintenance of survival. The critical factors determining these divergent actions of 
MC14 include the developmental state of PC12D cells (i.e. naïve PC12D cells vs 
neuronally differentiated PC12D) and the culture environment (i.e. serum containing vs 
serum-free medium). Third, the bioactive substance showing survival supporting 
activity is not necessarily capable of inducing neurodiferentiation. Apart from MC14, 
several substances have been reported to have neuron-rescuing activity but fail to 
induce neurite outgrowth (Rukenstein et al., 1991; Belliveau et al., 1997; Ashcroft et al., 
1999; Singer et al., 1999). Hence, it should be cautious when screening the samples for 
neuroprotective substances using the neurite outgrowth inducting bioassay on PC12D 
cells.     
In conclusion, the present study provide direct evidence to show that MC14 can 
support the neuronal survival, and promote the rescuing effect of NGF under serum-free 
medium. This demonstrates that MC14 may be a promising therapeutic agent to treat 
neurodegenerative disorders such as Alzheimer’s diseases.    
   
6-2. Survival supporting effect of NGF and MC14 against oxidative stress on 
PC12D cells 
 
   Oxidative stress has been implicated in the pathophysiology of many 
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neurodegenerative diseases including Parkinson’s disease (PD) and Alzheimer’s disease 
(AD) (Schulz et al., 2000; Gilgun-Sherki et al., 2001). Oxidative stress can cause 
cellular damage and subsequent cell death mainly by apoptosis as the reactive oxygen 
species oxidize vital cellular components such as lipids, protein and DNA (Gorman, 
1996; Simonia & Coyle, 1996). In fact, the brain is exposed throughout life to excitatory 
amino acids whose metabolism produces reactive oxygen species, thereby promoting 
excitotoxicity (Gilgun-Sherki et al., 2001). Beta-amyloid over-production represents 
another form of oxidative stress. Pappolla et al (1998) provided evidence for the 
hypothesis that beta-amyloid, the product of abnormal processing of the amyloid protein 
precursor (APP) in AD, is neurotoxic and that such toxicity is mediated by free radicals 
in vitro and in transgenic mice model of AD. These findings suggest that the oxidative 
stress resulted from the over-production of beta-amyloid is likely to be one of the 
pathologies leading to Alzheimer’s disease.  
   The most common cellular free radicals are hydroxyl radical (OH•), superoxide 
radical (O2-•), and nitric oxide (NO•) (Jenner and Olnaw, 1996; Simonia and Coyle, 
1996). Other molecules, such as hydrogen peroxide (H2O2) and peroxynitrate (ONOO), 
are not free radicals, but can lead to their generation through ferrous iron-mediated 
chemical reactions. Free radicals and related molecules are often classified together as 
reactive oxygen species (ROS) to signify their ability to promote oxidative changes 
within the cell (Simonia and Coyle, 1996). The follow chemicals reactions demonstrate 
the processes of free radical formation inside the cell (Gilgun-Sherki et al., 2001). 
 
Mixed function oxidase 
Product + H2O2 Substrate + O2 
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H2O2 + Fe2+       OH- + •OH + Fe3+   
 
Therefore, the treatment of cells with hydrogen peroxide can mimic the intracellular 
oxidative stress (Jackson et al., 1990; Xiao et al., 2000). In the present study, hydrogen 
peroxide-induced cell death of PC12D was used as an in vitro study to investigate the 
neuroprotective effect of MC14 against H2O2-insult. The result would provide important 
pharmacological evidence for the potential of MC14 as a therapeutic agent for the 
treatment of neurodegenerative diseases such as AD and PD.  
 
6-2-1. Methods and Materials 
 
(1) Bioassay of H2O2-induced cell death and neuroprotective activity of NGF and 
MC14 
   PC12D cells were maintained as described in section 6.2.1. For bioassay, cells were 
seeded on poly-L-lysine coated 96-well plate at a density of 5x104 cells per well in 
complete medium. Experiments were carried out after 24 h incubation at 37°C in a 
humidified atmosphere containing 5% CO2. Hydrogen peroxide (H2O2) was freshly 
prepared from 30% stock solution prior to each experiment to produce oxidative stress. 
The cells were preincubated with NGF and/or MC14 for 2 h before the addition of H2O2. 
Cell viability was determined by MTT assay after incubating the cells in H2O2 for 6 h. 
 
(2) Extraction and electrophoretic analysis of DNA 
   Soluble DNA in PC12D cells was extracted by the method of Hockenbery et al. 
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(1990) with minor modifications. In brief, PC12D cells (5x106 cells) were seeded on 
10-cm culture dish in complete medium. After 24 h, aliquot of freshly diluted solution 
of H2O2 was added to the dish to make a final concentration of 400 µM. Control cells 
were treated in complete medium only. After incubation for 12 h, cells were harvested 
by trituation and washed twice with ice-cold PBS. Cell pellets were collected by 
centrifugation at 1000 rpm for 10 min. Then, cells were lysed with 300 µl lysis buffer 
(0.5% Triton X-100, 5 mM Tris buffer at pH 7.4 and 20 mM EDTA) for 30 min at 4 °C. 
The supernatants were collected after centrifugation at 27,000 g for 15 min. Soluble 
DNA in the supernatant fraction of the cell lysate was extracted sequentially with an 
equal volume of phenol, phenol-chloroform and chloroform. RNase was added to the 
samples to a final concentration of 20 µg/ml, and the solutions were incubated at 37°C 
for 60 min. The samples were further extracted twice with phenol-chloroform. 
Subsequently, DNA was precipitated with 1/10 sample volume of 3 M sodium acetate 
(pH 5.2) and two volumes of ethanol at -80°C overnight. DNA pellets were collected by 
centrifugation at 13,000 rpm for 30 min and washed with 70% ethanol. DNA pellets 
were dried and redissolved in 20 µl sterilized water. DNA concentration was determined 
by UV absorbance at 260 nm. Three µg of DNA per sample were subjected to 
electrophoresis on a 3.5% polyacrylamide gel. The markers DNA λHind III and 100 bp 
DNA were used to determine the size of DNA. 
  
6-2-2. Results 
 
(1) Induction of cell death by H2O2  
The H2O2-induced PC12D cell death was determined by MTT assay and checked by 
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microscopic observation. In the experiments, cell culture incubated in complete medium 
without H2O2 treatment was used as a control and assigned as 100% cell viability. As 
shown in Fig. 6-14, H2O2-induced cell death exhibited a concentration dependent 
manner. Cell viability was slightly but significantly decreased after PC12D cultures 
were exposed to 200 µM H2O2 whereas a substantial reduction of viable cells (48%) 
was detected when the cells were exposed to 400 µM H2O2.  At 800 µM H2O2, the cell 
viability further dropped to 23% compared with that of untreated control. Under 
microscopic observation, the number of shrunk cells increased with H2O2 concentration 
(Photo not shown) and it confirmed the data obtained from viability determination by 
MTT assay. Moreover, the dead cells were shrunk into a dense dark particle with  
intact plasma membrane (observed by microscopy, photo not shown), indicating that 
H2O2 induced the typical apoptotic cell death in PC12D cells (Mesner et al., 1992). To 
confirm whether H2O2 induced PC12D cell death via apoptosis, soluble DNA of PC12D 
cell was isolated after H2O2-treatment and then analysed by polyacrylamide gel 
electrophoresis. As shown in Fig. 6-15 (lank 4), the soluble DNA fraction contained 
ladder-like pattern of DNA fragments with molecular weight of approximately a 
multiples of 180 base pairs, which is equivalent to the length of nucleosome subunit 
after DNA cleavage by nuclease, after the cells were treated with 400 µM H2O2 for 24 h. 
Whereas no fragmented DNA ladder was observed in the untreated control cells (Fig. 
6-15, lank 3), suggesting that H2O2 induced apoptotic death in PC12D cells. 
 
(2) Protective activity of NGF against H2O2-induced apoptosis 
   Protective effect of NGF against H2O2-induced apoptosis in PC12D cells was shown 
in Fig. 6-16. A concentration-dependent neuroprotective effect of NGF was observed in  
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Fig. 6-14. Hydrogen peroxide-induced PC12D cell death. PC12D cells were 
treated with the indicated concentration of H2O2 for 6 h. Cell viability was 
determined by MTT assay, and expressed as a percentage relative to the 
untreated control (complete medium, 100%). Each point represents the mean ± 
SD (n=4).  
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Fig. 6-15. Polyacrylamide gel eletrophoretic analysis of soluble DNA of PC12D cells 
after H2O2-insult. PC12D cells were incubated with or without 400 µM H2O2 for 24 
h. Soluble DNA was extracted and electrophoresed on 3.5% polyacrylamide gel. 
Lane 1: DNA λHind III markers. Lane 2: 100 bp DNA ladder markers. Lane 3: 
Untreated cells in complete medium. Lane 4: Cells treated in 400 µM H2O2 for 24 
h. Arrows indicate DNA fragments in PC12D cells induced by H2O2 insult.   
1   2   3   4 
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Fig. 6-16. NGF-induced neuroprotective effect against H2O2-insult on PC12D 
cells. PC12D cells were pretreated with the indicated concentration of NGF for 
2 h and subsequently treated with the indicated concentration of H2O2 for 6 h. 
Cell viability was determined by MTT assay, and expressed as a percentage 
relative to the untreated control (complete medium, 100%). Each point 
represents mean value (n=3).  
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the cultures exposed to 50-400 µM H2O2, suggesting that NGF can induce protective 
mechanisms against the H2O2-insult on PC12D cells.   
 
(3) Survival promoting effect of MC14 against H2O2-induced apoptosis 
   When the cells were preincubated with 3 µg/ml MC14 and NGF (0.4-50 ng/ml) for 
2 h, H2O2-induced cell injury was significantly attenuated compared with those treated 
with NGF alone. Results of MTT assay show that 27-47% of cell viability were 
enhanced by MC14, suggesting that MC14 could significantly promote NGF-induced 
survival activity against the oxidative insult on PC12D cell. In addition, it should be 
noted that the preincubation of MC14, even in the absence of NGF, could enhance cell 
viability by 2.7-fold compared with the MC14-untreated control (Fig. 6-17). This result 
clearly demonstrates that MC14 can significantly promote cell survival in the presence 
of NGF, and protects PC12D cells against H2O2-induced apoptosis.     
 
6-2-3. Discussion 
 
   There are substantial evidence showing that many neurodegenerative diseases such 
as AD and PD are brought about by the induction of highly intracellular regulated 
program (also known as apoptosis) that leads to neuronal death (Cotman 1998; Gilgun-sherki 
et al., 2001). Loss of trophic support, DNA damage, excitotoxic and beta-amyloid 
insults are believed to be the main cause of such death. Since markers of DNA damage 
and apoptosis have been shown to be present in the AD brain even at the early stage of 
the disease, if left the apoptotic damage unrepaired, the brain will become more 
vulnerable to further pathology (Xiao et al., 2000). An in vitro study has shown that  
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Fig. 6-17. Neuroprotective promoting effect of MC14 against H2O2-insult on 
PC12D cells. PC12D cells were pretreated with 3 µg/ml MC14 and the indicated 
concentration of NGF for 2 h before the addition of 400 µM H2O2. After 6 h 
incubation, cell viability was determined by MTT assay, and expressed as a 
percentage relative to the untreated control (complete medium, 100%). Each 
point represents mean value ± SD (n=4). Significant difference from the 
corresponding NGF-only control: **P < 0.01 (Student’s t-test). 
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treatments that decrease the oxidative stress protect neurons following beta-amyloid 
insult (Behl et al., 1999). This result indicates that oxidative stress is the key mediator in 
apoptotic paradigms. Therefore, therapeutics addressing to this fundamental mechanism 
might not only slow down the degenerative process, but also restore or promote the 
neuronal function. As the major component of reactive oxygen species, H2O2 has been 
extensively used as an inducer of oxidative stress in PC12 cells (Jackson et al., 1990; 
Satoh et al., 1996; Lee et al., 2000). The present study confirmed that H2O2 also causes 
a marked decrease in survival of PC12D cells. In addition, electrophoretic analysis of 
DNA demonstrates that H2O2 triggers DNA fragmentation in PC12D cells, indicating 
that there is an apoptotic component in H2O2-induced cell injury as DNA fragmentation 
has been regarded as an indication of apoptosis (Kaufmann et al., 2000). This cytotoxic 
effect of H2O2 is consistent with those reported by others. Satoh et al. (1996) reported 
that H2O2 significantly decreases the number of viable PC12 cells after 24 h. Besides, 
H2O2 causes membrane blebbing, nuclear condensation and DNA fragmentation, 
suggesting that the death PC12 cells via apoptosis (Satoh et al., 1996). The present 
result demonstrates that PC12D is also a useful model system to investigate apoptotic 
cell death induced by oxidative stressed.  
   When PC12D cells were preincubated with NGF, H2O2-induced cell death was 
significantly attenuated, suggesting that NGF protects PC12D cells against oxidative 
insult by H2O2. NGF-induced neuroprotection against free radical-insult in both dorsal 
root ganglion and PC12 cells has been well documented (Jackson et al., 1990; Goins et 
al., 1999; Guo & Mattson, 2000). The neuroprotective effect of NGF is based on the 
hypothesis that NGF induce the free radical-detoxifying mechanisms such as catalase 
activity, as catalase has been shown to be able to converse hydrogen peroxide to 
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molecular oxygen and water in vitro (Jackson et al., 1990).  
   Pretreatment of PC12D cells with MC14 significantly enhanced the NGF-induced 
protection. According to the hypothesis of the neuroprotective effect of NGF described 
above, MC14 may promote survival against H2O2-insult by amplifying the 
NGF-induced free radical detoxifying mechanisms. Since MC14 alone also exhibits 
protective effect against the cytotoxic injury induced by H2O2, it may be able to directly 
activate the catalase, or other detoxifying mechanisms. Besides, the possibility of MC14 
to directly scavenge the free radicals, like the action of some antioxidants such as 
vitamin C (Path, 1990), should not be ruled out.    
   Using the H2O2-induced PC12D cell model, the present study demonstrates that 
MC14 can effectively increase the number of viable cells under the oxidative stress, and 
protect cells against H2O2-induced apoptosis. In addition, MC14 also significantly 
promotes the neuroprotective effect of NGF against H2O2 insult. This finding and the 
neuronal survival supporting effect described in section 6.3 strongly suggest that MC14 
is a promising candidate as a therapeutic agent to treat Alzheimer’s disease and other 
neurodegenerative diseases.  
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Chapter VII 
Neurite-Regenerating Activity of MC14 
 
 
   In adult animals, most of neurons are postmitotic. The loss of neurons due to injury 
or diseases such as Alzheimer’s disease (AD) cannot be replaced. However, nerve cells 
can regenerate severed neuritic processes to re-establish synaptic connection (Nicholls 
et al., 1992). NGF is one of the most important neurotrophic factors responsible for 
stimulating the regeneration of neurites from the injured neurons so as to reinnervate the 
damaging synaptic connections. Synapses are sites where activity in neuronal circuits 
are modulated. Synaptic signaling is believed to play important roles in regulating 
neuronal survival and structural plasticity during development (Oppenheim, 1991; 
Lewin & Barde, 1996), and aberrant synaptic signaling is implicated in some 
pathological neurodegenerative conditions (Mattson et al., 1998). It has been suggested 
that the neurodegenerating process is likely to begin at the loss of synaptic connectivity 
in various disorders including AD (Terry et al., 1991; Dekosky et al., 1996). 
Accordingly, the regeneration of neuritic processes is a pivotal initial step for a 
functional recovery following neurodegeneration.  
   In chapter VI, the activity of MC14 to support and promote NGF-induced neuronal 
survival has been demonstrated. Further investigation of the activity of MC14 to 
regenerate neurite from the degenerating neuronal cells is important for understanding 
its applicability and effectiveness on recovering the degenerating nervous system caused 
by neurodegenerative diseases or injuries.   
   The objective of this study is to develop a neurite-degenerating model system by 
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culturing the neuronal PC12D cells in NGF-deficient condition, and use this 
experimental paradigm to study whether the treatment of MC14 under NGF-deficient 
condition would alleviate neurite degeneration, and promote neurite regeneration. In 
addition, the mechanically neurite-sheared neuronal PC12D cell model was used to 
further examine the neurite-regeneration promoting effect of MC14 on neurite-severed 
neurons. The study would provide a comprehensive understanding and important insight 
on the therapeutic application of MC14 for the treatment of neurodegeneration caused 
by diseases or injuries in the nervous system.  
 
7-1. Materials and Methods 
 
7-1-1. Cell culture and preparation of neuronal PC12D cells   
   PC12D cells were maintained at 37˚ C in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% heat-inactivated horse serum (HS), 5% fetal bovine 
serum (FBS), 100 U/ml penicillin, 200 µg/ml streptomycin and 25 µg/ml ampicillin 
under a water-saturated atmosphere of 5% CO2. The neuronal PC12D cells were 
prepared by seeding the naïve PC12D cells on collagen-coated 24-well culture plate 
with a cell density of 1x105 per well. After 24 h incubation, the medium was changed to 
fresh medium containing 50 ng/ml NGF and further incubated for 48 h to obtain the 
neuronal PC12D cells.  
 
7-1-2. Neurite degeneration of neuronal PC12D cells, and the effect of MC14 on 
attenuating neurite degeneration under NGF-deficient condition 
   After the neuronal PC12D cells were rinsed for 2 times with fresh DMEM, the 
medium was replaced with DMEM supplemented with 1% HS in NGF-deficient 
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concentrations ranging from 0.4-10 ng/ml, and the cells were further incubated in 72 h. 
In addition, 50 ng/ml NGF and NGF-untreated cultures were used as positive and 
untreated controls, respectively. Neurite degeneration of the neuronal PC12D cells was 
determined by monitoring the proportion of intact neurite-bearing cells after 24, 48 and 
72 h exposure to NGF-deficient condition using a phase-contrast microscope with 200X 
magnification. Processes with length longer than 2 diameters of cell body were counted 
as neurites while the cells bearing the degenerated or disintegrated neurites shorter than 
two diameters of their cell bodies were not counted as neurite-bearing cells. For each 
datum point, the mean value was calculated from 4 random-field observations of 2 
independent experiments and a minimum of 100 cells per field were counted.  
   To determine the attenuating effect of MC14 under NGF-deficient condition, 
neuronal PC12D cells were treated with 1.5 µg/ml MC14 at the time of exposing to 
deficient NGF concentrations (0.4-10 ng/ml) in DMEM supplemented with 1% HS. To 
determine the effect of MC14-pretreatment against neurodegeneration under 
NGF-deficient condition, naïve PC12D cells were treated with or without 6.25 µg/ml 
MC14 in the presence of 50 ng/ml NGF for 6 days (with medium renewal twice for 
every 72 h) to prepare MC14-pretreated and MC14-unpretreated neuronal PC12D cells, 
respectively. These two groups of cells were than washed with fresh medium, and then 
incubated in the deficient concentrations of NGF in the absence of MC14 for further 4 
days.  
7-1-3. Neurite-regeneration promoting activity of MC14  
   Two model systems were used to investigate the neurite-regeneration promoting 
effect of MC14. For the first model system, neurite-degenerating PC12D cells were 
induced by NGF-deficient treatment. Briefly, neuronal PC12D cells were rinsed with 
fresh DMEM for 2 times and then incubated in 0.4 ng/ml NGF in DMEM supplemented 
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with 1% HS for 48 h. Thereafter, cells were treated with a second-dose of MC14 
(0.2-0.8 µg/ml) and NGF (2 ng/ml) for 48 h. To determine the effect of NGF, another 
group of cultures were treated with a second-dose of NGF (2-50 ng/ml) only. Cells with 
regenerated neurites longer than two diameters of their cell bodies were counted as 
neurite-regenerated cells.  
   Regarding the second approach for examining the neurite-regenerating activity of 
MC14, the mechanically neurite-sheared cells were used. Neurites of the neuronal 
PC12D cells were prepared as described above, neurites of the neuronal PC12D cells 
were sheared from the cell bodies by trituation as described by Twiss & Shooter (1995). 
In brief, medium was aspirated, and the cell processes were sheared by trituation with 
medium using a 5-ml glass pipette. Cells were centrifuged at 1000 rpm, and washed for 
3 times with fresh medium by repeated centrifugation-resuspension. The neurite-sheared 
cells were then plated at 5x103 cells per well on a 96-well culture plate in complete 
medium containing 0-50 ng/ml NGF in the presence or absence of 3 µg/ml MC14. After 
48 h incubation, the proportion of cells with regenerated neurites was determined. Cells 
with regenerated neuritic processess 2-time longer than their cell bodies were counted 
as neurite-regenerated cells.         
 
7-1-4. Observation of cells and phase-contrast photography 
   The neurite-regenerated cells were observed using an Olympus phase-contrast 
microscope with 200-400X magnification. Photo-slides were taken using an Olympus 
SC-35 type camera. Images were scanned and transformed into computer file using 
Polaroid Polascan 35/LE system. Contrast of the image was adjusted if necessary.  
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7-1-5. Statistical analysis 
   Each datum point is the mean ± SD of four random-field observations from two 
independent experiments. Significant difference was determined by the Student’s t-test.  
P<0.05 was considered to have significant difference. 
     
7-2. Results 
  
7-2-1. Neurite degeneration in NGF-deficient medium 
   Neuronal PC12D cells have been demonstrated to be able to survival in the presence 
of 50 ng/ml NGF in serum-free medium (Chapter VI). In this study, an experimental 
paradigm was used to induce neurite degeneration without significant cell death by 
treating the neuronal PC12D cells in deficient NGF concentration in low 
serum-supplemented (1% HS) medium. As shown in Fig. 7-1, significant reduction of 
long neurite-bearing cells was observed after the neuronal PC12D cells were exposed to 
NGF-deficient medium from 0.4-10 ng/ml for 24 h compared with positive control. 
Approximately 40% reduction of neurite-bearing cells was recorded after the cells were 
exposed to 10 ng/ml NGF for 72 h. Under microscopic observation, neuronal PC12D 
cells extended long neurites in 50 ng/ml NGF (Fig. 7-2a,b). After treated with 
NGF-deficient medium (0.4-10 ng/ml) for 72h, however, the disrupted and degenerated  
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Fig. 7-1. Neurite degeneration of neuronal PC12D cells in NGF-deficient 
medium supplemented with 1% horse serum. Neuronal PC12D cells were 
incubated in the indicated concentrations of NGF for 72 h. Neurite-bearing 
cells were counted at 0, 24, 48 and 72. Neurite-bearing cells are expressed as a 
percentage relative to positive control (50 ng/ml, 100%). Data are given as 
mean (n=4) ± SD from 2 independent experiments.     
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Fig. 7-2. Neurite degeneration of neuronal PC12D cells incubated in 
NGF-deficient medium. PC12D cells were differentiated into neuronal PC12D 
cells after treated with 50 ng/ml for 48 h (a), and then exposed to 50 ng/ml 
NGF  (b), 10 ng/ml NGF (c), 2 ng/ml NGF (d), 0.4 ng/ml NGF (e) or 0 ng/ml 
NGF (f) for 72 h. Scale bar: 50 µm. 
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neurites were observed (Fig. 7-2c-f). It should be noted that many neurite fragments 
were observed in the medium, indicated that the observed reduction of neurite-bearing 
cells was attributed by the neurite degeneration, rather than neurite retraction.  
 
7-2-2. Effect of MC14 on attenuating neurite-degeneration induced by NGF-deficient 
treatment 
   After PC12D cells were neuronally differentiated, they were subjected to 
NGF-deficient medium (0.4-10 ng/ml) supplemented with or without MC14. The 
proportion of neurite-bearing cells was monitored at 0, 24, 48 and 72 h. In the medium 
supplemented with 1.5 µg/ml MC14 at 10 ng/ml NGF, the decreasing rate of the 
neurite-bearing cell number was significantly lowered compared with that of 
MC14-untreated control (Fig. 7-3a). Comparing the cells treated with 50 ng/ml (positive 
control), there was only 25% reduction of neurite-bearing cells for the cells treated with  
MC14 after 72 h, whereas more than 70% reduction was recorded for those cells treated 
with NGF only. Significant differences of the neurit-bearing cell number in the 
MC14-treated and untreated cultures were also recorded in 2 and 0.4 ng/ml NGF (Fig. 
7-3b,c). These results indicated that the presence of MC14 could attenuate neurite 
degeneration under NGF-deficient condition. The phase-contrast photographs clearly 
show that greater number of MC14-treated cells maintained their long neurites in 
NGF-deficient conditions compared with the corresponding MC14-untreated controls 
(Fig. 7-4).     
 
7-2-3. Protective effect of MC14 pretreatment of cells from neurite-degeneration 
under NGF-deficient condition  
   To corroborate the neurite-protective effect of MC14 before the induction of neurite 
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Fig. 7-3. Effect of MC14 on attenuating neurite degeneration of neuronal 
PC12D cells under NGF-deficient condition. Neuronal PC12D cells were 
treated with the indicated concentrations of NGF with 1.5 µg/ml MC14 for the 
indicated time. Neurite-bearing cells are expressed as a percentage relative to 
positive control (50 ng/ml NGF, 100%). Data are given as mean (n=4) ± SD 
from 2 independent experiments. Significant difference from MC14-untreated 
control: **P < 0.01 (Student’s t-test).    
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a b
c d
e f 
Fig. 7-4. Effect of MC14 on attenuating neurite degeneration under 
NGF-deficient condition. Neuronal PC12D cells were incubated in the absence (a, 
c, e) or presence (b,d,f) of 1.5 µg/ml MC14 at 10 ng/ml (a, b), 2 ng/ml (c, d) or 0.4 
ng/ml NGF (e, f) for 72 h. Scale bar: 50 µm. 
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degeneration, naïve PC12D cells were treated with MC14 during their differentiation 
period before subjecting to NGF deficiency. After MC14-pretreatment, the cell medium 
was changed to fresh medium containing the deficient concentration of NGF only, then 
the cells were further incubated for 4 days. Comparing with the control group without 
MC14 pretreatment, the extent of neurite-degeneration was significantly reduced for the 
MC14-preteated cells in the deficient concentration of 0.4-10 ng/ml NGF (Fig. 7-5), 
suggesting that MC14 pretreatment of naïve PC12D cells appeared to increase the 
resistance of cells against neurite degeneration under NGF-deficient condition.  
 
7-2-4. Neurite regenerating effect of MC14 
   Two modeling systems were used to examine the neurite regenerating capability of 
MC14 on neurite-degenerated cells. For the first modeling system, neurite-degenerated 
cells were induced by incubating the neuronal PC12D cells in 0.4 ng/ml NGF for 48 h. 
Subsequently, a second dose of NGF (2, 10, 50 ng/ml), or MC14 (0.2, 0.4, 0.8 µg/ml) 
plus 2 ng/ml NGF was added to the neurite-degenerated cultures. After 48 h, 
neurite-bearing cells were counted again. As shown in Fig. 7-6, a dose-dependent 
enhancement of neurite-bearing cells was recorded in the cultures treated with MC14 
compared with those treated with 2 ng/ml NGF only. It should be noted that the 
combined effect of 0.8 µg/ml MC14 and 2 ng/ml NGF was higher than that of the 
second dose of 50 ng/ml NGF. The morphological changes of cells before and after the 
second dose treatments are shown in Fig. 7-7. After the neuronal PC12D cells were 
treated with 0.4 ng/ml NGF, most of the neurites were degenerated, leaving a few 
neurite-bearing cells (Fig. 7-7a). After the second-dose treatment with 2 ng/ml NGF, no 
significant neurite regeneration was observed (7-8b). However, the number of 
neurite-bearing cells was markedly 
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Fig. 7-5. Neuroprotection of MC14-pretreatment of PC12D cells against 
neurite-degeneration. Naïve PC12D cells were treated with (MC14-pretreated 
PC12D group) or without (MC14-unpretreated group) 6.25 µg/ml MC14 in the 
presence of 50 ng/ml NGF for 6 days (initial cultures). Media of both groups of cells 
were changed with fresh media containing the indicated concentrations of NGF 
only. Proportion of neurite-bearing cells were counts after 4 days of incubation. 
Neurite-bearing cells are expressed as a percentage relative to positive control (50 
ng/ml NGF, 100%). Data are given as mean ± SD (n=4). Significant difference 
between MC14-pretreated and unpretreated cells are analysed by Student’s t-test 
with ** p < 0.01.   
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Fig. 7-6. Neurite-regeneration activity of MC14 and NGF. Neurite degenerated 
cells (ND) were induced by exposing the neuronal PC12D cells (initial cultures, 
IC) in 0.4 ng/ml NGF for 48 h. Cells were then treated with the second dose of the 
indicated concentrations of NGF, or MC14 plus 2 ng/ml NGF for further 48 h. 
Neurite-bearing cells are expressed as a percentage relative to that of initial 
cultures before NGF-deficiency. Data are given as mean (n=4) ± SD. Significant 
difference from MC14-untreated control (#): ** p < 0.01 (Student’s t- test).  
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Fig. 7-7. Neurite-regenerating effect of MC14 and NGF. Neurite-degenerated cells 
were exposed to 0.4 ng/ml NGF for 24 h (a), and then treated with a second dose of 
2 ng/ml NGF (b), 0.8 µg/ml MC14 plus 2 ng/ml NGF (c) or 50 ng/ml NGF (d) for 
further 48 h. Scale bar: 50 µm.  
a b 
c d 
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Fig. 7-8. Neurite-regeneration promoting effect of MC14 on neurite-sheared 
PC12D cells. Neurites of the neuronal PC12D cells were sheared by trituation and 
the resulting neurite-sheared cells were treated with or without 3 µg/ml MC14 in 
the presence of the indicated concentrations of NGF for 48 h. Data are given as 
mean (n=4) ± SD. Significant difference from the NGF-only control: *P < 0.05 
and **P < 0.01 (Student’s t-test).  
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increased after the cells were treated with the second doses of 2 ng/ml NGF and 0.8 
µg/ml MC14 (Fig 7-7c), while the number of neurite-bearing cells was higher than that 
of the second dose of 50 ng/ml NGF (Fig. 7-7d).   
   To get a further insight into the neurite regenerating effect of MC14 on 
neurite-severed neurons, the neuronal PC12D cells were sheared and subsequently 
treated with or without MC14 in the presence of NGF ranging from 0.016-50 ng/ml for 
48 h. Measurement of neurite-regenerated cells showed that the treatment of 3 µg/ml 
MC14 in the presence of 0.4-50 ng/ml NGF resulted in significant enhancements of 
neurite-regenerated cells compared with the respective MC14-untreated control (Fig. 
7-8). Besides, the MC14-enhanced neurite regeneration showed a dose-depended 
manner of NGF. The maximum enhancement of neurite regeneration by 4-fold was 
recorded after the neurite-sheared cells were treated with 3 µg/ml MC14 in the presence 
of 10 ng/ml NGF. The morphologies of neurite-sheared cells and neurite-regenerated 
cells after various treatments of MC14 and NGF are shown in Fig. 7-9. It should be 
noted that MC14 stimulated the cells to extend more branching and longer neurites 
compared with the corresponding NGF-only controls.  
   Taken together, these data clearly demonstrate that MC14 can effectively promote 
neurite regeneration from the mechanically sheared cells as well as the neurite 
degenerating cells induced by NGF deficient treatment.     
 
7-3. Discussion 
 
   Substantial studies have shown that NGF-responsive neurons such as sympathetic 
neurons, cholinergic neurons and PC12 cells undergo neurite degeneration, followed by  
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Fig. 7-9. Neurite regeneration promoting activity of MC14 on neurite-sheared PC12D 
cells. Morphology of the neuronal PC12D cells after sheared by trituation (a). The 
neurite-sheared cells treated with neither MC14 nor NGF (b), 0.4 ng/ml NGF only (c), 3 
µg/ml MC14 and 0.4 ng/ml NGF (d), 2 ng/ml NGF only (e), 3 µg/ml MC14 and 2 ng/ml 
NGF (f), 10 ng/ml NGF only (g), 3 µg/ml MC14 and 10 ng/ml NGF (h), 25 ng/ml NGF 
only (i), 3 µg/ml MC14 and 25 ng/ml NGF (j) for 48 h. Scale bar: 50 µm. 
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cell death after NGF deprivation (Batistatou & Greene, 1991; Mesner et al., 1995; Araki 
& Wurtman, 1998; McGinty et al., 2000). It has also been reported that the removal of 
NGF from the medium of neuronally differentiated PC12 cells leads to a sequential 
events, including reduction in metabolic activity, increase in the expression of amyloid 
precursor protein, neurite degeneration, DNA fragmentation and finally apoptotic cell 
death (Batistatou & Greene, 1991; Araki & Wurtman, 1998). It has been described in 
chapter VI that complete removal of NGF in serum-free medium will cause neuronal 
PC12D cell death within 24 h. In the present experimental paradigm, neuronal PC12D 
cells were incubated in NGF-deficient medium supplemented with 1 % horse serum. 
Under these conditions, the neuronal PC12D cells do not completely degenerate or 
commit apoptotic cell death, but exhibited neurite disruption within the experimental 
period of 72 h. This phenomenon resembled that of neuronal cells cultured in 
NGF-deficient medium as reported by others (Batistatou & Greene, 1991; Araki & 
Wurtman, 1998). Thus, this model system was used to study the neurite-regenerating 
activity of MC14.  
   Under this experimental paradigm, substantial proportion of cells exhibited neurite 
disruption after exposed to the NGF-deficient concentration (0.4-10 ng/ml) from 24-72 
h. Although the molecular mechanisms involved in the observed neurite degeneration of 
the neuronal PC12D cells by NGF-deficient treatment is remained to be clarified, a 
recent report has described that NGF deprivation would be followed by the formation of 
the persistent actin-depolymerizing factor and cofilin-actin rods that span the diameter 
of neurites, disrupt the microtubules and cause degeneration of the distal neurite without 
killing the cultured hippocampal neuron (Minamide et al., 2000). The neurite 
degeneration in the neuronal PC12D cells induced by NGF-deficient treatment might  
 
 
 
Chapter VII  Neurite Regenerating Activity 
 157 
result from the similar mechanisms as the biochemical events of neuronal PC12D cells 
are resemble those of neuronal cells (Greene & Tischler, 1976; Katoh-Semba et al., 
1987).   
   Treatment of neuronal PC12D cells with MC14 in NGF deficient medium 
significantly reduces the rate of neurite degeneration, implying that MC14 may 
effectively attenuate neurite degeneration caused by the deficiency of neurotrophic 
support in the nervous system. Apart from alleviating neurite degeneration, the 
pretreatment of naïve PC12D with MC14 during their differentiation period appears to 
increase the resistance of cells against neurite degeneration under NGF-deficient 
condition as  significant lower rate of neurite degeneration was observed in the 
MC14-pretreated cells after the subsequent incubation in NGF-deficient medium. These 
results imply that the pretreatment of MC14 may have protective effect against neurite 
degeneration, and that MC14 might have neuroprotective effect if treated before the 
onset of neurodegenerative disease. Although the signaling pathway involved in the 
observed protective effect of MC14 on PC12D cells remains to be elucidated, it is 
speculated that the pretreatment of naïve PC12D cells with MC14 during their 
differentiation period might stabilize the microfilaments in the neurites so as to increase 
their resistance against degeneration in NGF deficient medium.  
   It has been demonstrated by others that the treatment of neurite-degenerated 
neuronal cells with NGF or certain growth factors can induce their neurite regeneration 
(Green et al., 1983; Davies et al., 1997; Schicho et al., 1999). Consistently, neuronal 
PC12D cells response to the second dose of NGF to regenerate neurite. More strikingly, 
the combined effects of MC14 and a relative low concentration of NGF (2 ng/ml) 
markedly enhance the neurite regeneration compared with the effect of NGF alone.  
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   On the other hand, it has been demonstrated that the resupplement of NGF to 
neurite-severed cells can rescue neuronal sympathetic neurons and PC12 cells from 
apoptosis or neurite degeneration (Cai et al., 1999). To investigate whether MC14 could 
promote neurite regeneration after neuronal injury, the mechanically neurite-sheared 
neuronal PC12D cells, used as a neurite-severed neuronal model, were treated with 
MC14 in the presence of various NGF concentrations. The result clearly demonstrates 
that MC14 can significantly promote NGF-induced neurite regeneration from the 
neurite-severed cells. Additionally, this finding provides a supporting evidence for the 
activity of MC14 to effectively enhance neurite-regeneration from injured neurons.  
   Collectively, the neurite-regeneration promoting activity of MC14 suggests that it 
might enhance axonal regeneration, which is an important initial step for the subsequent 
reinnervation with the neurons after neuronal injury. On the molecular basis, a previous 
report showed that NGF stimulates the synthesis of structural neural proteins such as 
growth-associated protein and Tα1 α-tubulin in neuron cell body (Mohiuddin et al., 
1995). Recent studies have also demonstrated that the enhancement of vesicle fusion 
and insertion of newly synthesized membrane at distal neurite portion and at the growth 
cone allow expansion of neurite elongation (Phenninger & Friedman, 1993; Horner & 
Gage, 2000). During the regeneration of neurite from the severed-neuron, NGF plays a 
crucial role in guiding the neurite to reinnervate and reconnect the synapse (Horner & 
Gage, 2000). Based on these findings, it is plausible that MC14 might facilitate the 
regeneration process by enhancing the rate of microtubules assembling and 
reconstruction, leading to the observed neurite regeneration from PC12D cells. 
Alternatively, MC14 might mediate the signaling pathway of NGF which regulates the 
level of intracellular messengers such as cyclic AMP to enhance the phosphorylation  
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state of cytoskeleton-associated proteins to regenerate the neurites from the severed 
cells.  
   An in vivo study has suggested that the insufficient supply of NGF may lead to 
neurite degeneration and disruption of synaptic connection of cholinergic neurons to 
hippocampus, resulted in retardation of memory and cognitive functions (Fischer et al., 
1987). It has also been demonstrated that NGF infusion to aged monkey basal forebrain 
has can effectively reinnervate the neurons to hippocampus, which plays a key role in 
memory and cognitive function (Kordower et al., 1994). Therefore, MC14 might be a 
promising agent to promote NGF-induced repair of neuronal network to improve 
memory and cognitive functions for neurodegenerative diseases or injury. Besides, the 
present study provides a more direct evidence to show that MC14 may attenuate 
neurodegeneration. Furthermore, MC14 exhibits neuroprotective effect, implying that it 
may help to delay the onset or slow down the progression of neurodegenerative diseases 
such as AD. 
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Chapter VIII  
Structure-Activity Relationship of MC14 and Its Analogues  
 
 
 
   The development of therapeutic drugs for the treatment of neurodegenerative disorders 
such as Alzheimer’s disease (AD) has become an urgent issue, due to the lack of effective 
therapeutic drugs and to the expected rise in the number of AD patients in the near future. 
In chapter II, the structural elucidation by NMR spectroscopic analysis of MC14 has been 
described in detail, and the chemical structure of MC14 was elucidated (Fig. 2-6). MC14 
is  composed of a carotenoid-like moiety and a quinone moiety (Fig. 8-1). Although 
MC14 has a promising NGF-potentiating activity, its relatively complex structure renders 
its chemical synthesis not commercially feasible. The present study aimed to identify the 
part of the MC14’s structure that is essential to the molecule’s NGF-potentiating effect. 
To accomplish this, the activity of 1,4-benzoquinone (the fundamental quinone) and eight 
carotenoid analogues were examined. In addition, the structure-activity relationship of 
quinones was investigated in order to study the effect of their structural modification on 
NGF-mediated neurite outgrowth-enhancing activity. The results may provide 
information important to the development of a comparatively simple synthetic chemical 
as a therapeutic agent with high efficacy in treating neurodegenerative disease. 
Furthermore, the results may provide valuable information for delineating the 
mechanisms by which these biologically active substances act on NGF-mediated neurite 
outgrowth from PC12D cells.  
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Fig. 8-1. (A) Chemical structure of MC14. MC14 is composed of a quinone 
moiety and a carotenoid-like moiety. (B) Chemical structure of 
1,4-benzoquinone.  
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8-1. Materials and Methods  
 
8-1-1. Materials 
   All quinone compounds were purchased from Adrich Chemical Co., while β-carotene 
and other carotenoids were kindly given by Dr. Tanaka, Faculty of Fisheries, Kagoshima 
University, Japan. All reagents and drugs were of analytical grade. 
 
8-1-2. Cell culture and bioassay of neurite outgrowth-promoting activity  
 
   PC12D  were maintained as described in chapter IV. When bioassay was conducted, the 
cells were seeded on a 96-well culture plate with a cell density of 5 x 103 cells per well. 
After 24 h incubation, the medium was changed to fresh medium containing appropriate 
test concentrations of various samples and 10 ng/ml NGF. In addition, the cells treated 
with 50 ng/ml NGF alone and 10 ng/ml NGF alone were designated as positive control 
and negative control, respectively. After 48 h incubation, the neurite outgrowth from 
PC12D cells was monitored using a phase-contrast microscope with 200X magnification. 
Processes with lengths longer than 2 diameters of the respective cell body were counted 
as neurites. For each datum point, the mean value was calculated from four random field 
observations, and a minimum of 100 cells per field were counted. The neurite outgrowth 
promoting activity was calculated as the proportion of neurite-bearing cells to the total 
number of cells in the same field.    
 
8-1-3. Statistical analysis 
   Each datum point is the mean ± S.D. of four random field observations from two 
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replicate experiments. Significant differences from the negative control (10 ng/ml NGF) 
were determined by the Student’s t-test. P < 0.05 was considered to be a significant 
difference. 
 
8-2. Results 
 
   As described in chapter II, the chemical structure of MC14 was elucidated to be 
sargaquinoic acid, which consisted of a quinone structure and a carotenoid side chain. To 
delineate the structurally essential moiety of MC14 molecule for its NGF-potentiating 
activity, 1,4-benzoquinone and carotenoids were used to represent the quinone and 
carotenoid moieties of the MC14 molecule, and their neurite outgrowth promoting 
activity were determined. 
 
8-2-1. Neurite outgrowth promoting activity of carotenoids and 1,4-benzoquinone  
   Each carotenoid consisted of an alkyl-chain with at least 20 carbons to mimic the 
alkyl-chain of the MC14 molecule (Table 8-1). The bioassay results showed that none of 
the carotenoid compounds enhanced the proportion of neurite-bearing cells compared to 
the negative control, suggesting that the carotenoid moiety alone did not stimulate 
NGF-mediated neurite outgrowth from PC12D cells (Fig. 8-2). In contrast, 
1,4-benzoquinone showed a significant enhancing effect on neurite outgrowth from 
PC12D cells. The proportion of neurite-bearing cells increased from 7% to 23% in the 
presence of 6.25  
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Table 8-1. Chemical structures of carotenoids tested in this study. 
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Fig. 8-2. Neurite outgrowth-promoting activity of (a) beta-carotene, 
echinenone, rubixanthin and (b) canthaxanthin, capsanthin, zeaxanthin. 
PC12D cells were treated with the indicated concentrations of tested 
chemicals in the presence of 10 ng/ml NGF for 48 h. Cells treated with 50 
ng/ml NGF (- - - - - - -) and 10 ng/ml  NGF (____  - ____  -) were used as positive 
control and negative control, respectively. Arrows indicate cytotoxicity.  
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µg/ml 1,4-benzoquinone, which is equivalent to a 260 % increase compared to the effect 
induced by the negative control (Fig. 8-3). The maximum effective concentration of 
1,4-benzoquinone was the same as that of MC14, indicating similar levels of potency in 
enhancing neurite outgrowth from PC12D cells. Taken together, these results clearly 
demonstrated that the quinone moiety of the MC14 molecule might be the essential 
structure for NGF-potentiating activity.   
   The morphological appearance of cells activated by 1,4-benzoquinone is shown in Fig. 
8-4e. Both the neurite length and the cell shape were similar to those of the cells 
stimulated by MC14. In respect of a cytotoxic effect on PC12D cells, both MC14 and 
1,4-benzoquinone exhibited similar levels of cytotoxicity at the lowest toxic 
concentration of 12.5 µg/ml, at which the cells underwent apoptosis-like cell shrinkage. 
Comparing the maximum neurite outgrowth-enhancing activity, we found that 
1,4-benzoquinone enhanced neurite outgrowth by 260% of the negative control while 
MC14 enhanced that by 500% of the negative control, indicating that 1,4-benzoquinone 
was less effective than MC14 in terms of NGF-potentiating activity. This may be due to 
the structural difference between the quinone moiety of MC14 and 1,4-benzoquinone.  
 
8-2-2. Neurite outgrowth promoting activity of naturally occurring quinone 
compounds 
   In order to investigate the effects of substitute groups of 1,4-benzoquinone on neurite 
outgrowth-enhancing activity, 12 naturally occurring quinones with various substitute 
groups were selected, and bioassays were performed under the same conditions. The 
chemical structures of the quinones tested in the study were shown in Table 8-2. Among 
them, alizarin, lapachol and lawsone exhibited significant neurite outgrowth-enhancing  
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Fig. 8-3. Neurite outgrowth-promoting activity of 1,4-benzoquinone. 
PC12D cells were treated with the indicated concentrations of 
1,4-benzoquinone in the presence of 10 ng/ml NGF for 48 h. Cells 
treated with 50 ng/ml NGF (- - - - - - -) and 10 ng/ml  NGF (____  - ____  -) 
were used as positive control and negative control, respectively. Arrows 
indicate cytotoxicity. Significant difference from the negative control: 
*P < 0.05, P < 0.01 (Student’s t-test).  
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Fig. 8-4. Phase-contrast photomicrographs of PC12D after various treatments for 48 h. 
(a) MC14-untreated control culture (0 ng mL-1 NGF). (b) PC12D cells treated with 10 
ng mL-1 NGF (negative control). (c) PC12D cells treated with 50 ng mL-1 NGF (positive 
control). PC12D cells treated with (d) 6.25 µg mL-1 MC14, (e) 6.25 µg mL-1
1,4-benzoquinone, (f) 100 µg mL-1 lawsone, (g) 12.5 µg mL-1 alizarin or (h) 100 µg mL-1
lapachol in the medium containing 10 ng mL-1 NGF for 48 h. Bar = 25 µm. 
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Table 8-2. Chemical structures of quinones tested in this study. 
Quinone compounds Chemical formula Chemical structure 
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effects on PC12D cells (Table 8-3). The maximum activities of lapachol, alizarin and 
lawsone were 265%, 325% and 329%, respectively, of the negative control. The highest 
effective concentrations for alizarin, lapachol and lawsone were 12.5 µg/ml, 50 µg/ml 
and 100 µg/ml, respectively, indicating that alizarin is the most potent of these three 
neurite outgrowth enhancers. The photomicrographs of PC12D cells treated with these 
active quinones are shown in Fig. 8-4f-h. In an attempt to investigate the neurotrophic 
action of the quinones alone, an identical concentration range of the quinones was 
examined in the absence of NGF. It was revealed that none of the quinones induced 
neurite outgrowth from PC12D cells (data not shown), implying that these quinones, like 
MC14, could significantly enhance the NGF-mediated neurite outgrowth from PC12D 
cells but do not mimic the effect of NGF. 
 
 
8-3. Discussion 
                
   Naturally occurring quinones consist of a large variety of compounds, including 
numerous pigments, vitamin K and electron carriers such as plastiquinone and 
ubiquinone (Smith et al., 1997). These compounds are known to have antihemorrhagic 
effect on blood clotting, antitumour activity and electron transport function within the 
membranes of chloroplasts and mitochondria (Stryer, 1996). This study demonstrates that 
three naturally occurring quinones can enhance NGF-mediated neurite outgrowth. In the 
literature, there are few reports on the chemicals capable of potentiating NGF action. 
Pamela et al. (1995) reported that a synthetic compound, AIT-082, which is a purine 
derivative, exhibited neurite outgrowth-enhancing activity on PC12h cells. A fungal  
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Table 8-3. Neurite outgrowth-promoting activity of various quinone compounds on PC12D cells. PC12D cells were treated with the indicated concentrations of quinones in the presence of 10 ng mL-1 
NGF for 48 h. Neurite outgrowth-promoting activity was calculated as described in Materials and methods. Cells treated with 50 ng mL-1 and 10 ng mL-1 were served as positive control (PC) and 
negative control (NC), respectively. Standard deviation for each mean value (n = 4) is indicated in parenthesis. CT = cytotoxicity.   
 
Quinone compounds Neurite outgrowth-promoting activity 
 NGF concentration (ng mL-1) 
 50  10 
 Quinone concentration (µg mL-1) 
 0 0 3.13 6.25 12.5 25 50 100 200 
 (PC) (NC)        
          
Alizarin 0.278 0.077 0.090 0.164* 0.250** CT CT CT CT 
 (0.029) (0.015) (0.024) (0.033) (0.015)     
          
1,4-anthraquinone 0.278 0.077 0.039 0.037 0.059 0.046 0.121 CT CT 
 (0.029) (0.015) (0.010) (0.009) (0.028) (0.021) (0.046)   
          
Anthrarufin 0.278 0.077 0.059 0.061 0.046 0.058 0.043 0.038 CT 
 (0.029) (0.015) (0.006) (0.017) (0.015) (0.009) (0.016) (0.008)  
          
Carminic acid 0.278 0.077 0.056 0.070 0.098 0.064 0.097 CT CT 
 (0.029) (0.015) (0.023) (0.022) (0.045) (0.015) (0.016)   
          
1,8-dihydroxyanthraquinone 0.278 0.077 0.062 0.084 0.053 0.069 0.103 0.122 CT 
 (0.029) (0.015) (0.003) (0.013) (0.015) (0.056) (0.026) (0.017)  
          
2,3-dimethylanthraquinone 0.278 0.077 0.097 0.117 0.082 0.110 0.082 0.114 CT 
 (0.029) (0.015) (0.003) (0.046) (0.053) (0.001) (0.006) (0.042)  
          
Emodin 0.278 0.077 0.051 0.049 CT CT CT CT CT 
 (0.029) (0.015) (0.020) (0.041)      
          
2-ethylanthraquinone 0.278 0.077 0.097 0.059 0.107 0.107 0.101 CT CT 
 (0.029) (0.015) (0.032) (0.023) (0.053) (0.024) (0.050)   
          
Lapachol 0.278 0.077 0.079 0.081 0.081 0.096 0.204** 0.133* CT 
 (0.029) (0.015) (0.029) (0.025) (0.014) (0.047) (0.045) (0.035)  
          
Lawsone 0.278 0.077 0.127 0.141* 0.150** 0.156** 0.229* 0.253** CT 
 (0.029) (0.015) (0.035) (0.038) (0.024) (0.028) (0.083) (0.036)  
          
Lawsone dimer 0.278 0.077 0.064 0.045 0.047 0.115 CT CT CT 
 (0.029) (0.015) (0.011) (0.012) (0.004) (0.039)    
          
Xanthone 0.278 0.077 0.034 0.039 0.062 0.037 CT CT CT 
 (0.029) (0.015) (0.007) (0.008) (0.023) (0.018)    
          
Value significantly different from negative control is bold: * p < 0.05, ** p < 0.01 
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metabolite, NG-061, a derivative of phenylacetic acid hydrazide, and some unknown 
soluble factors from rat basophilic leukemia cells were also reported to have neurite 
outgrowth-stimulating effects on PC12 cells (Suzuki et al., 1998; Ito et al., 1999). In 
addition, a neuropeptide somatostatin and nardosinone from a Chinese medicinal plant 
were demonstrated to significantly enhance neurite outgrowth from PC12D cells 
(Ferriero et al., 1994; Li et al., 1999). Most of these natural and synthetic compounds are 
comparatively complex and not amenable to commercial exploitation. Previous chapters 
have demonstrated that MC14 is promising therapeutic agent for the treatment of 
neurodegenerative disorders by virtue of its strong NGF-potentiating activity. However, 
its chemical structure is also comparatively complex. The analysis of structural moiety of 
MC14 molecule responsible for the observed NGF-potentiating activity will help 
identifying a chemical with a relatively simple structure suitable for industrial chemical 
synthesis, and provide information for the structure modification of NGF-potentiating 
chemicals. The neurite outgrowth enhancing activity of carotenoids and 
1,4-benzoquinone clearly demonstrated that only the quinone moiety of the MC14 
molecule is structurally essential for NGF-potentiating activity. 
   The stronger activity of MC14 than that of 1,4-benzoquinone may be contributed to the 
presence of substitute groups of quinone moiety of the MC14 molecule. To test this 
hypothesis, the NGF-potentiating activity of 12 naturally occurring quinones with various 
substitute groups were examined. The results show that the substitutions of hydroxyl 
groups on the quinone molecule is likely to enhance the NGF-potentiating activity. By 
comparing the activities of alizarin and anthraquinone, the presence of 2 hydroxyl groups 
on alizarin seems to be essential for its activity. The arrangement of these 2 hydroxyl 
groups on anthraquinone molecule also significantly influences the activity as neither 
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anthrarufin nor 1,8-dihydroxyanthraquinone shows activity, indicating that only the 
substitutions of two hydroxyl groups at the 1’ and 2’-positions of anthraquinone structure 
exhibits the neurite outgrowth-promoting activity. 
   On the other hand, the presence of a hydroxyl group at the 1’-position of lawsone and 
lapachol is also expected to be crucial to their activity, since it is the unique structure for 
both compounds. In addition, the loss of activity of lawsone dimer may be attributed to 
the steric effect of its bulky structure, suggesting that molecular configuration is also one 
of the effects determining the neurite outgrowth-enhancing activity of quinone. Taken 
together, the positions of the hydroxyl groups on the quinone molecule may play a key 
role in NGF-potentiating activity, and they might be the binding sites of the quinone to 
NGF molecule or to NGF receptor. 
   In comparing the neurite outgrowth-enhancing effect of MC14 and the active quinones, 
it was speculated that MC14 might first interact and bind to the NGF molecule by its 
quinone moiety to form a NGF-MC14 complex. The alkyl-chain of MC14 then facilitates 
the attachment of this complex to the hydrophobic plasma membrane of PC12D cell. 
Alternatively, the MC14 might bind to NGF molecule and in turn enhance the binding of 
NGF to its TrkA receptor, which subsequently up-regulates the NGF-mediated signal 
cascades that promote transcription events, leading finally to neurite outgrowth. In 
addition, MC14 might prolong the interaction time of NGF and its receptor by the binding 
of the MC14 side-chain on the plasma membrane.   
   The present study may serve toward the development of a chemical with a simple 
structure and a potent NGF-enhancing effect for the pharmacological treatment of 
neurodegenerative diseases. 
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Chapter IX 
Novel Effect of Vitamin K1 (Phylloquinone) and Vitamin K2 
(Menaquinone) on Promoting Nerve Growth Factor-Mediated 
Neurite Outgrowth from PC12D Cells 
 
   During a comparative analysis of the structural analogues of MC14, it was found 
that vitamin K1 and K2 are structurally similar to MC14 (Fig. 9-1). Since the K vitamins 
have been showed to have age-dependent survival-promoting activity on cultured CNS 
neurons (Nakajima et al., 1993), study of the effect of K vitamins on NGF-potentiating 
activity will be important for further understanding their neuronal activities. In this 
study, the bioassays of the NGF-mediated neurite outgrowth promoting activity on 
PC12D cells were performed. In addition, several specific inhibitors were used to 
investigate the signaling pathways involved in the K vitamins-enhanced neurite 
outgrowth on PC12D cells. 
 
9-1. Materials and Methods 
 
9-1-1. Materials 
 Vitamin K1 and K2 were purchased from Sigma. All other materials used were 
described in chapter IV. 
 
9-1-2. Cells culture and neurite outgrowth promoting assay  
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Fig. 9-1. Chemical structure of MC14, vitamin K1 and 
vitamin K2. The common moiety shared by these 
compounds is indicated by bold line.  
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PC12D cells were cultured as described in chapter IV. When bioassay was conducted, 
cells were harvested and plated at a density of 5 X 103 per well on a collagen-coated 
96-well plate in complete medium. After 24 h, NGF (0-50 ng/ml) and 100 µg/ml 
vitamin K compounds (the highest concentration without observable cytotoxic effect on 
PC12D cells) were added to the cells. After 48 h, the proportion of neurite-bearing cells 
was determined using a phase-contrast microscope with 200X magnification. For each 
datum point, the mean value was calculated from six random field observations of two 
replicate experiments, and a minimum of 100 cells per field were counted.  
 
9-1-3. Effect of various inhibitor on activity of K vitamins 
 For studying various inhibitors’ effects, cells were preincubated for 1 h in the 
presence or absence of the inhibitors before the addition of NGF and vitamin K 
compounds. After incubation for 48 h, the proportion of neurite-bearing cells was 
determined. 
 
9-2. Results 
 
 Treatment of PC12D cells with K vitamins in the presence of 2.5-50 ng/ml NGF 
significantly increased the proportion of neurite-bearing cells over those treated with 
NGF alone, and the concentration-response curve of NGF was shifted to the left by 100 
µg/ml vitamin K1 and K2 (Fig. 9-2). In addition, the K vitamins significantly enhanced 
the proportion of cells with neurite at the optimally-effective concentration of NGF (50 
ng/ml). However, vitamin K compounds alone could not induce neurite outgrowth from 
PC12D cells. On the other hand, the K vitamins enhanced neurite outgrowth from  
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Fig. 9-2. Dose-response curve of the neurite outgrowth from PC12D cells for 
NGF, NGF plus 100 µg/ml vitamin K1 and NGF plus 100 µg/ml vitamin K2. 
Each point represents the mean ± SD (n=6) from two replicate experiments. 
Significant difference from the NGF-only control: *P < 0.05; **P < 0.01 
(Student’s t-test).  
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Fig. 9-3. Dose-response curve of the neurite outgrowth enhancing effect of 
vitamin K1 and K2 on PC12D cells in the presence of 10 ng/ml NGF. Each 
point represents the mean ± SD (n=6) from two replicate experiments. The 
horizontal solid line represents the mean value for the cultures treated with 
10 ng/ml NGF alone; the dotted lines represent the SD (n=6) of this value. 
Significant difference from the NGF-only control: **P < 0.01 (Student’s 
t-test).  
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PC12D cells in the presence of 10 ng/ml NGF in concentration-dependent manner (Fig. 
9-3). To investigate the mechanisms of K vitamins, the effect of specific inhibitors for 
MAPK kinase, PKA and PKC on K vitamins-stimulated neurite outgrowth from PC12D 
cells was tested. As shown in Fig. 9-4, the PKA inhibitor at 5 nM substantially blocked 
the K vitamins-enhanced neurite outgrowth from PC12D cells. Pretreatment of cells 
with 10 µM PD98059, a specific MAPK kinase inhibitor, almost completely inhibited 
the enhancing effect of vitamin K compounds. In contrast, no significant inhibition of 
neurite outgrowth was observed for those cells treated with chelerythrine chloride.     
 
9-3. Discussion 
 
 Naturally occurring vitamin K compounds consist of vitamin K1 (phylloquinone) 
and vitamin K2 (menaquinone). Although their physiological roles (e.g. blood 
coagulation, bone metabolisms and osteoporosis) have been well documented (Suttie, 
1991), their roles in the central nervous system (CNS) remain to be clarified. The 
present study describes that vitamin K1 and K2 show significant NGF-mediated neurite 
outgrowth promoting activity. Concerning the study of their mechanisms of actions, the 
effect of K vitamins is substantially blocked by the pretreatment of cells with a specific 
PKA inhibitor, suggesting that vitamin K1 and K2 enhance NGF-induced neurite 
outgrowth probably by activating protein kinase A or adenylate cyclase in the PKA-dependent 
signaling pathway. In addition, PD98059 completely blocks the K vitamins-enhanced 
neurite outgrowth, demonstrating that K vitamins may also amplify an up-stream step of 
MAPK kinase. Sano et al (1998) reported that the activation of MAP kinases is not 
required for the NGF-induced extension of neurite from PC12D cells  
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Fig. 9-4. Neurite outgrowth of PC12D cells in response to 10 ng/ml NGF, 10 
ng/ml NGF plus 50 µg/ml K vitamins in the absence or presence of 5 nM PKA 
inhibitor, 10 µM PD98059 or 0.66 µM chelerythrine chloride. The neurite 
outgrowth is expressed as a percentage relative to the optimal response to NGF 
(50 ng/ml, 100%). Each point represents the mean ± SD (n=6) from two 
replicate experiments. Significant difference from the inhibitor-untreated 
control: **P < 0.01 (Student’s t-test).  
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(Sano et al., 1998). Thus, K vitamins  might  activate MAP kinases  as a separate  
signaling  pathway, complementing the action of NGF in PC12D cells. However, it has 
been demonstrated that cyclic AMP induces neuronal differentiation via the activation 
of MAPK kinase in PC12 cells (Hansen et al., 2000). K vitamins might activate the 
cAMP-dependent PKA, subsequently activating MAPK kinase in PC12D cells. 
Although PKC’s involvement in NGF-induced differentiation of PC12 cells has been 
suggested (Coleman & Wooten, 1994; Dupont et al., 2000), our data show that the PKC 
inhibitor chelerythrine chloride does not significantly block the effect of K vitamins, 
indicating that the action of K vitamins may be independent of PKC-mediated 
mechanism.  
The present results suggest that K vitamins enhance neurite outgrowth from PC12D 
cells by the activation of PKA, subsequently amplifying the signal transduction via 
MAP kinases, while PKC is apparently not involved in the action of K vitamins.  
It has been proposed that the sufficient daily uptake of vitamin K, especially for the 
elderly, may contribute to the prevention of risk of hip and spinal fractures (Suttie, 
1991). As vitamin K is a relatively small molecule, they may rapidly enter the CNS after 
oral administration and might act in the CNS to enhance the effect of NGF on 
cholinergic basal forebrain neurons that are important in memory functions. The present 
study implies that the dietary intake of vitamin K or vitamin K-rich foods may also be 
beneficial to the protection of nervous system, and prevent or delay the onset of 
age-related pathogensis of neurodegenerative diseases such as Alzheimer’s disease. 
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Chapter X 
MC22, the Second NGF-Potentiating Substance Isolated from 
Sargassum macrocarpum 
 
 
   During a modified process for the extraction of MC14, another active fraction was 
identified from S. macrocarpum. Since this active substance was found to be more 
hydrophilic than MC14, a new chromatographic separation procedure was used for its 
purification. Finally, this active substance was successfully purified and designated as 
MC22. The chemical structure of MC22 was elucidated by NMR analyses. Its biological 
activities, including neurite outgrowth promoting effect and neuronal survival 
supporting effect, as well as the mechanisms will be described in this chapter. 
 
10-1. Materials and Methods 
 
10-1-1. Isolation and purification of MC22 
   The algal sample (500 g wet weight) of the brown alga Sargassum macrocarpum 
was washed 3 times with artificial sea water (ASW, Jamarine Laboratory), and once 
with phosphate-buffered saline (PBS). The sample was then cut into small pieces and 
homogenized in 2L PBS with a domestic mixer. The residue after centrifugation at 
5000g was extracted with 2L methanol (MeOH) for 1 h by a mechanical homogenizer 
(Polytron, Kinematica) and the MeOH-extract was obtained after suction filtration 
through a #1 filter paper (Advantec). The filtrate of MeOH-extract was concentrated by 
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vacuum-evaporation to minimal volume, and then partitioned with 1L 
hexane-water-methanol (3:2:1) mixture. The fraction of aqueous methanol layer was 
further partitioned with chloroform-methanol-water (3:1:2). The chloroform fraction 
was subjected to the silica gel column chromatography (silica gel 60, Merck) (column 
size, ∅ 3.2 x 50 cm) eluting with chloroform-methanol (15:1). The flow rate was 
adjusted to 5 ml/min and a volume of approximately 5 ml per fraction was collected in 
glass tubes. The active fraction was determined by the bioassay of neurite outgrowth 
promoting activity as described in chapter II. Then, the pooled active fractions were 
subjected to a size exclusion chromatography (Toyopearl HW-40F, TOSOH) (column 
size, ∅ 3.2 x 50 cm1.7 x 50 cm) with 100% MeOH as eluting solvent. Active fractions 
were pooled, redissolved in hexane-ethyl acetate (6:4), and subjected to thin layer 
chromatography (TLC) (Silica gel 60, Merck) developing with hexane-ethyl acetate 
(6:4). The active fraction was collected at Rf value of 0.19-0.22, and finally purified by 
reverse phase high performance liquid chromatography (HPLC) using Shodex RS-pak 
DE-413 column (∅ 20 x 250 mm, Showa Denko) eluting with acetonitrile-water (9:1) at 
a flow rate of 3.5 ml/min and detecting at 212 nm by a UV detector (UV-970, Jasco). 
 
10-1-2. Mass spectrometry 
   The molecular weight of MC22 was determined by a high resolution electron impact 
mass spectrometry (EI-MS, JMS-DX303, JEOL). 
 
10-1-3. 1H- and 13C-nuclear magnetic resonance (NMR) spectrometries 
   The chemical structure of MC22 was elucidated using 1H - and 13C-nuclear magnetic 
resonance spectra by Toray Research Center. The 1H - and 13C-NMR spectra of MC22 
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were recorded in CD3OD by a GSX400 NMR spectrometer and a UNITY INOVA600 
NMR spectrometer (Varian), respectively.  
 
10-1-4. Neurite outgrowth promoting activity 
   The neurite outgrowth promoting activity of MC22 in various concentrations of 
NGF and the dose-dependent activity of MC22 were examined as described in section 
4-2-3 and 4-2-4, respectively. 
 
10-1-5. Neuronal survival promoting activity 
   The effect of MC22 on promoting survival of the neuronal PC12D cells was studied 
as described in section 6-1-1-(4) and 6-2-1-(1). The method used to investigate the 
mechanism of action of MC22 is described in section 6-1-1-5. 
 
10-2. Results 
 
10-2-1. Purification of MC22 
   The active fractions collected from various chromatographic columns during the 
purification of MC22 were traced by TLC (silica gel 60) with an Rf value of 0.35 
(chloroform-methanol 15:1), and confirmed by bioassay of neurite outgrowth promoting 
activity. The active fractions on TLC plate was identified by their appearance of 
fluorescent blue color under UV illumination at 366 nm. Since MC22 was found to be 
more hydrophilic than MC14, it was purified by TLC developed with hexane-ethyl 
acetate (6:4) followed by a reverse phase chromatography with acetonitrile-water (9:1) 
as the eluting agent. The retention time of MC22, eluted with acetonitrile-water (9:1) 
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with a flow rate of 3.5 ml/min, was about 25 min. Finally, approximately 1.2 mg of 
MC22 was purified from 500 g wet weight of the alga. The absorption peaks of MC22 
in methanol was observed at 220 nm (main) and 334 nm. MC22 showed pale yellow oil 
after freeze-dried and it was stored in methanol at 4°C for further bioassays.  
 
10-2-2. Structural elucidation of MC22 
   Result of EI mass spectroscopic analysis revealed the molecular weight of MC22 to 
be 424. Based on various NMR spectra, MC22 was determined to be composed of five 
-CH3 groups, six –CH2- groups, one >C< group, seven =CH- groups, seven =C< groups, 
one –OH group, and one -COOH- group. Therefore, the molecular formula of MC22 
was elucidated to be C27H36O4. For the purpose of describing the structure of MC22 
from the NMR spectra, peaks appeared in the 1H-NMR spectrum were assigned with 
small letter a-q while peaks in 13C-NMR spectrum were assigned with capital letters 
A-Z and Z’. The chemical shifts, proton number and multiplicity in both spectra are 
listed in Table 10-1. The results from HSQC spectrum (Fig. 10-1), together with the 
1H-NMR spectrum (Fig. 10-2) and 13C-NMR spectrum (Fig. 10-3) indicated that CH3 
groups appeared at position (a,F), (b,B), (c,C), (e,E) and (h,A); CH2 groups at (d,K), 
(f,J), (g,D), (g,G), (i,I) and (j,H); CH groups at (k,Q), (l,R), (m,T), (n,X) (o,P), (p,M) 
and (q,N). The splits of p and q (2.4 Hz) were resulted from the spin coupling between 
the protons at the meta-position of benzene structure. Results from the DQF-COSY 
spectrum (Fig. 10-4) revealed the partial structure of MC22 as shown in Fig. 10-5. The 
determination of c,e and the trans-configuration of structure in Fig. 10-5B were 
confirmed by NOESY  
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Table 10-1. Chemical shifts of 1H- and 13C-NMR spectra of MC22 
 
1H Shift (ppm) P.N.#  M (J)* 13C Shift (ppm) M* 
 a 1.359 3 s A 15.5 -CH3 
 b 1.562 3 s B 15.8 -CH3 
 c 1.578 3 s C 17.7 -CH3 
 d 1.653 2 d,d (6.1,4.6) D 22.6 -CH2- 
 e 1.672 3 s E 25.7 -CH3 
 f 2.049 2 t (7.5) F 26.0 -CH3 
 g 2.110 4 m G 27.8 -CH2- 
 h 2.130 3 s H 28.2 -CH2- 
 i 2.250 2 t (7.5) I 34.7 -CH2- 
 j 2.551 2 q (7.5) J 39.1 -CH2- 
 k 5.084 1 t (7.10 K 40.7 -CH2- 
 l 5.126 1 t (7.0) L 77.8 >C< 
 m 5.569 1 d (9.8) M 110.3 =CH- 
 n 5.926 1 br.t N 117.1 =CH- 
 o 6.244 1 d (9.8) O 121.4 =C< 
 p 6.319 1 d (2.4) P 122.9 =CH- 
 q 6.742 1 d (2.4) Q 123.5 =CH- 
    R 124.8 =CH- 
    S 126.4 =C< 
    T 130.7 =CH- 
    U 130.9 =C< 
    V 132.2 =C< 
    W 134.4 =C< 
    X 144.3 =CH- 
    Y 144.9 =C< 
    Z 148.6 =C<  
    Z’ 171.5 >COO- 
       
HO 
CH3 
O 
CH3 
CH3 CH3 COOH 
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q,N 
Z 
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m,T b,B Z’ 
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Y L 
d,K 
g,D 
l,R f,J n,X i,I k,Q e,E 
W U V 
c,C 
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CH3
*Multiplicity: s-singlet, d-doublet, t-triplet, m-multiplet, br.-broad 
#P.N. = proton number 
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Fig. 10-1. HSQC spectrum of MC22.  
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Fig. 10-2. 1H-NMR stectrum of MC22  
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Fig. 10-3. 13C-NMR stectrum of MC22  
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Fig. 10-4. DQF-COSY spectrum of MC22  
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Fig. 10-5. Partial structures of MC22 determined by DQF-COSY, NOESY and 
HMBC.  
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Fig. 10-6. NOESY spectrum of MC22. 
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Fig. 10-7. Partial structures of MC22 determined by DQF-COSY, NOESY and 
HMBC.  
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Fig. 10-8. HMBC spectrum of MC22.  
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Fig. 10-9. Chemical structure of MC22 
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spectrum (fig. 10-6). The partial structures of carbon chain of MC22 shown in Fig. 
10-7A was determined by the long-range couplings of the protons in CH3 observed from 
the HMBC spectrum (Fig. 10-8). Accordingly, the conjugations of (d,D) and (d,R) to 
K-D-R, as well as (d,T) to L-T-P were confirmed. The conjugation of n-j-f was 
determined by DQF-COSY. Besides, The coupling of Z’-U-I-G-Q was determined by 
the related peaks of (i,U), (i,Q), (I,Z’). These data led to the identification of the partial 
structure of MC22 as shown in Fig. 10-7B. Based on the related peaks of m, o, p and q 
appeared in the HMBC spectrum, the partial structure of MC22 containing an 
1,2-benzopyran structure was determined (Fig 10-7C). Together with the data obtained 
from NOESY spectrum, and the assignment of protons and carbons, the chemical 
structure of MC22 was elucidated and is shown in Fig. 10-9.          
 
10-2-3. Neurite outgrowth promoting activity of MC22 
   The effect of MC22 on promoting neurite outgrowth from PC12D cells was 
examined from 0-100 ng/ml NGF. Treatment of PC12D cells with MC22 (12.5 µg/ml) 
significantly enhanced the proportion of neurite-bearing cells at 2.5-25 ng/ml NGF 
compared with the MC22-untreated control (Fig. 10-10). However, no significant 
neurite outgrowth was observed by the MC22-treatment alone. As shown in Fig. 10-11, 
the neurite outgrowth promoting activity of MC22 was dose-dependent. The maximum 
effect was observed when the cells were treated with 25 µg/ml MC22. Concentration of 
MC22 higher than 25 µg/ml resulted in cytotoxicity as cell shrinkage was observed.  
  
10-2-4. Survival supporting activity of MC22 
   In order to evaluate the ability of MC22 to promote NGF-induced survival  
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Fig. 10-10. Neurite outgrowth promoting activity of MC22 in the indicated 
concentrations of NGF. PC12D cells were treated with or without 12.5 µg/ml MC22 
in NGF for 48 h. Each point represents the mean ± SD (n=4) from two replicate 
experiments. Neurite outgrowth is expressed as a percentage relative to the positive 
control (100 ng/ml NGF, 100%). Significant difference from the NGF-only control: 
* P < 0.05; ** P < 0.01 (Student’s t-test) 
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Fig. 10-11. Concentration-response curve of the neurite outgrowth enhancing 
effect of MC22 on PC12D cells in the presence of 10 ng/ml NGF. The horizontal 
solid line represents the mean value for cultures treated with 10 ng/ml NGF 
alone, the dotted lines represent the SD of this value. Neurite outgrowth is 
expressed as a percentage relative to the positive control (100 ng/ml NGF, 100%). 
Each point represents the mean ± SD (n=4) from two replicate experiments. 
Significant difference from the NGF-only control: * P < 0.05; ** P < 0.01 
(Student’s t-test). 
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Fig. 10-12. Survival promoting effect of MC22 on neuronal PC12D cells. Neuronal 
PC12D cells were incubated in 4 µg/ml MC22 and the indicated concentrations of 
NGF in serum free medium for 24 h. Cell survival was determined by MTT assay, 
and expressed as a percentage relative to the positive control (50 ng/ml NGF, 
100%). Each point represents the mean ± SD (n=4). Significant difference from 
MC14-untreated control: * P < 0.05; **P < 0.01 (Student’s t-test).   
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Fig. 10-13. Effect of chelerythrine chloride on survival promoting effect of NGF 
and MC22 on neuronal PC12D cells. Neuronal PC12D cells were pretreated with or 
without 0.66 µM chelerythrine chloride for 1 h before adding the indicated 
concentrations of NGF in serum free medium. After 24 h, cell viability was 
determined by MTT assay, and expressed as a percentage relative to the positive 
control (50 ng/ml NGF, 100%). Each point represents the mean ± SD (n=4). 
Significant difference from inhibitor-untreated control: **P < 0.01 (Student’s t-test).  
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supporting effect, neuronal PC12D cells were treated with MC22 in the presence of 
various concentrations of NGF in serum-free medium. Cell viability was determined 
after 24 h incubation. Results showed that the treatment of MC22 significantly 
enhanced the number of viable cells at a concentration of NGF ranged from 0.08 to 50 
ng/ml in serum-free medium (Fig. 10-12). Unexpectedly, MC22 alone exhibited 
appreciable rescuing effect on neuronal PC12D cells. Approximately 20% enhancement 
of viable cells was detected for cultures treated with 4 µg/ml MC22 compared with 
untreated control in serum-free medium.  
   To investigate the intracellular signaling pathway regulating the neuronal survival 
supporting effect of MC22, a PKC inhibitor, chelerythrine chloride was used to pretreat 
the cells before the addition of MC22 and/or NGF. Results indicated that chelerythrine 
chloride did not significantly block the survival supporting effect of either NGF or 
MC22 alone (Fig. 10-13). However, the inhibitor substantially block the combined 
effect of NGF and MC22, as approximately 10% and 40% reductions of viable cells 
were detected when the cells were treated with MC22, together with 2 ng/ml or 10 
ng/ml NGF, respectively. This result suggested that PKC could be activated by the 
presence of both MC22 and NGF, while PKC activity was not affected by the individual 
treatment of MC22 or NGF in PC12D cells. 
   Regarding the neuroprotective effect of MC22 against H2O2-induced apoptosis on 
PC12D cells, the treatment of cells with 12.5 µg/ml MC22 in the presence of 0.4 and 2 
ng/ml NGF significantly enhanced the number of viable cells incubated in 400 µM 
H2O2 compared with the NGF-only control (Fig. 10-14).       
    
10-3. Discussion 
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Fig. 10-14. Neuroprotective promoting effect of MC22 against H2O2-insult on PC12D 
cells. PC12D cells were pretreated with 12.5 µg/ml MC22 and the indicated 
concentrations of NGF for 2 h before the addition of 200 µM H2O2. After 6 h 
incubation, cell viability was determined by MTT assay, and expressed as a percentage 
relative to the untreated control (complete medium, 100%). Each point represents 
mean value ± SD (n=4). Significant difference from the corresponding NGF-only 
control: ** P < 0.01 (Student’s t-test).     
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10-3-1. Purification and chemical structure determination 
   It is not unusual for the existence of more than one active metabolite in an organism. 
In fact, it is easy to overlook some of the other active fractions during the laboratory 
scale separation process of crude extract of an organism as these substances may be 
either ignored or undetectable in the bioassay (Cannell, 1998). During the isolation 
process of MC14 from S. macrocarpum with a modified extraction procedure, a fraction 
from the HPLC eluent was collected at a retention time of 22 min. This fraction was 
also found to have neurite outgrowth promoting activity on PC12D cells. As the 
retention time profile of this substance was different from that of MC14, confirming that 
it was the second active substance from the brown alga, S. macrocarpum. The HPLC 
elution profile revealed that this substance was more hydrophilic than MC14. Therefore, 
TLC and reverse phase HPLC were used to isolate this substance and finally it was 
successfully purified, and designated as MC22. By the NMR analyses, MC22 was 
elucidated to be sargachromenol with a molecular formula of C27H36O4, indicating that 
MC22 is a non-peptide and low molecular weight NGF-potentiating compound. To 
evaluate its neural activity, the neurite outgrowth promoting activity and survival 
supporting activity of MC22 were examined. 
 
10-3-2. Neural activity 
   In order to evaluate the neural activity of MC22, two typical NGF-mediated effects, 
neurite outgrowth promoting activity and neuronal survival promoting activity, were 
conducted. For the former, MC22 exhibits marked NGF-induced neurite outgrowth 
promoting activity on PC12D cells. Significant neurite outgrowth enhancement is also 
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observed at relative low concentration of NGF (2.5-10 ng/ml NGF). Besides, MC22 
enhances neurite outgrowth in a dose-dependent manner, which is similar to that of 
MC14. However, MC22 alone does not induce neurite outgrowth on PC12D cells in the 
absence of NGF.  
   In order to examine the neuronal survival promoting activity of MC22, the neuronal 
PC12D cells were treated with NGF in the presence and absence of MC22 in serum-free 
medium. Result of cell viability measurement demonstrates that MC22 significantly 
increases the number of viable cells compared with the NGF-only control, suggesting 
that MC22 can effectively enhance the rescuing effect of NGF under serum-free 
condition. Surprisingly, MC22 can support the survival of neuronal PC12D cells in the 
absence of NGF in serum-free medium. It has been reported that several compounds can 
rescue PC12 cells from serum-free cell death but show no neurite outgrowth enhancing 
effect (Rukenstein et al., 1991). MC22 shows similar feature to those compounds. 
Besides, the present studies (chapters IV and VI), together with other reports in the 
literature, show the regulation of neuronal survival and neuronal differentiation may 
involve distinct signaling pathways (Rukenstein et al., 1991; Wooten et al., 1998; 
Hughes et al., 2001). To investigate the signaling pathway involved in MC22-enhanced 
neuronal survival activity, a protein kinase C inhibitor, chelerythrine chloride was 
examined. Results demonstrate that the survival supporting effect of either MC22 or 
NGF alone on neuronal PC12D cells is not blocked by PKC-inhibition, suggesting that 
MC22 and NGF promote survival on neuronal PC12D cells via PKC-independent 
pathway. Interestingly, the PKC inhibitor substantially blocks the combined effect of 
MC22 and NGF on neuronal survival action in serum-free medium, implying that PKC 
can be activated in the presence of both NGF and MC22, leading to survival support 
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action on neuronal PC12D cells. Although the exact mechanism of their additive action 
remains to be elucidated, it is postulated that the interaction of MC22 and NGF 
stimulates and activates the PKC-mediated pathway. In contrast, the combined effect of 
MC22 and NGF on neurite outgrowth from PC12D cells does not require the activation 
of PKC (data not shown). Taken together, these results confirm that MC22 regulates 
NGF-induced cellular responses via separate signaling cascades.  
   Concerning the neuroprotective effect against H2O2-induced apoptotic cell death, 
MC22 significantly enhances NGF-induced neuroprotective activity against oxidative 
stress at a relatively low concentration of NGF, although no significant effect can be 
observed at high concentration of NGF. 
   The present results show that MC22, the second active substance isolated from S. 
macrocarpum, is a low molecular weight and non-peptide compound that can 
significantly promote neuronal survival on PC12D cells, implying that MC22, like 
MC14, has therapeutic value for the treatment of neurodegenerative diseases.     
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General Conclusion 
 
   This doctoral research work can be concluded into four major findings from the 
following studies: (1) the successful purification and chemical elucidation of two novel 
neural active substances, MC14 and MC22, from the marine brown alga Sargassum 
macrocarpum; (2) the delineation of the strcuture-activity relationship of MC14; (3) the 
comprehensive investigation of the neural activities of MC14 and MC22 for the 
evaluation of their potential to be a therapeutic agent to treat neurodegenerative 
diseases; (4) the elucidation of signaling pathways regulating the effects of MC14 and 
MC22.  
   Previous screening works of the marine algae collected from Japan coastline had 
identified a brown alga, S. macrocarpum contains a neural active substance (designated 
as MC14), which showed potent neurite outgrowth promoting activity. In this doctoral 
study, MC14 has been purified and its chemical structure was successfully elucidated to 
be sargaquinoic acid, with a molecular weight of 424. Moreover, during a modified 
isolation process of MC14, another neural active substance was identified and 
successfully purified using various chromatographies. The chemical structure of this 
substance was finally elucidated as sargachromenol, and designated to be MC22.  
   The structure-activity relationship study demonstrates that the quinone moiety of 
MC14 structure plays a crucial role in its neuritogenic activity, and the structural 
modification of substitute group on the quinone moiety may enhance the activity of 
MC14 as the bonding of a hydroxyl group at the 1’-position of the benzoquinone moiety, 
or two hydroxy groups at the 1’ and 2’-positions of anthraquinone shows the enhancing 
neurite outgrowth promoting activity.  
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   With respect to the biological activities, MC14 and MC22 markedly enhance 
NGF-induced neurite outgrowth from PC12D cells in a dose-dependent manner, clearly 
demonstrating that they possesses the neuronal differentiation promoting activity. In 
addition, the chronic effect of MC14 is shown to promote the network-like formation of 
neuritic processes, further supporting that MC14 may be beneficial to the development 
of the nervous system. Apart from the morphological differentiation, the treatment of 
MC14 significantly increases acetylcholinesterase activity, an important enzyme for 
maintaining the neurotransmitter function in neuronal cells, in the PC12D cells, 
suggesting that MC14 can also promote functional differentiation.  
   In addition to neural differentiation, NGF has an important role to support the 
survival of many neuronal populations of the central and pheripheral nervous systems, 
and the deficit of NGF in the nervous system has been linked to the pathology of many 
neurodegenerative diseases. One of the most encouraging findings in this study is that 
MC14 and MC22 can significantly protect neuronal PC12D cells against serum-free 
induced cell death. The important implication of this finding is that MC14 and MC22 
may rescue neuron cells or slow down the rate of degenerative neuronal loss caused by 
Alzheimer’s disease or other neuodegenerative disorders. In addition to promote 
NGF-induced survival support, strikingly, MC14 and MC22 also exhibit neuronal 
survival supporting effect even in the absence of NGF. This finding, together with the 
neuroprotective effect of MC14 and MC22 on PC12D cells against oxidative 
stress-induced cellular damage, further implies that MC14 and MC22 may be effective 
in alleviating neuronal cell death caused by other neurotrophic factor-independent 
neurodegenerative diseases, such as Parkinson’s diseases or Huntington’s disease. On 
the other hand, neuroregeneration study provides supporting evidence for the capability 
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of MC14 to regenerate damaging neurites, implying that MC14 may help repairing the 
degenerating neuronal cells by promoting the reconnection of synaptic system. 
   Concerning the mechanisms of MC14 to potentiate NGF-induced neurite outgrowth 
from PC12D cells, several intracellular signaling cascades were shown to involve in the 
regulation of the observed effect of MC14. First, the activation of TrkA receptor is 
required for the NGF-induced neurite outgrowth from PC12D cells. MC14 may 
facilitate the binding of NGF into its receptor TrkA and in turn promote the activation of 
TrkA to amplify the signaling pathway. Besides, the activation of mitogen-activated 
protein kinase (MAPK) is essential for MC14-enhanced neurite outgrowth. Therefore, 
the TrkA-MAPK-mediating pathway is identified to be a central signal transduction 
cascade for regulating neurite outgrowth of PC12D cells in response to the stimulation 
of MC14 and NGF. Furthermore, PKA appears to be activated by MC14 during the 
neurite outgrowth response of PC12D cells. As the activation of PKA is independent of 
the TrkA-mediated cascade, these findings demonstrate that at least two distinct 
signaling pathways are activated in PC12D cells in response to MC14 stimulation 
during the NGF-induced neurite outgrowth. These two pathways may be activated by 
MC14 individually to complement the action of NGF. In addition, it is also inferred that 
MAP kinase might be a common downstream effector sheared by both PKA-mediated 
and TrkA-mediated signaling pathways to modulate the cellular response of PC12D 
cells to MC14 and NGF. These findings would contribute to the pharmacological 
manipulation of intracellular signaling pathway to potentiate the action of NGF.  
   Although the mechanism of MC14 to support survival of neuronal PC12D cells in 
NGF-deprived serum-free medium still remains to be elucidated, pharmacological 
inhibition study has revealed that the activation of PKA and MAP kinases are apparently 
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not required for the neuronal survival supporting activity of MC14, while the activation 
of other intracellular protein kinase is involved in the neuroprotective effect of MC14. 
This result demonstrates that MC14 employs separate signaling pathways to regulate 
neurite outgrowth and support survival in PC12D cells.         
   Since the delivery problem of neurotrophic factors into the brain is the largest 
obstacle for their development as effective therapy for neurodegenerative disorders. The 
neural active substances isolated from S. macrocarpum, MC14 and MC22, are samll 
molecules with molecular weight < 500 Da, and they are lipid-soluble, implying that 
these active compounds can cross the blood-brain barrier, and they may have promising 
pharmacological potential as an alternative strategy for the neurotrophic therapy. 
Furthermore, rescue of degenerating neurons as well as stimulation of neurogenesis are 
theoretically very attractive strategies for the treatment of many neurodegenerative 
diseases. At present, the available drugs for AD is limited to cholinesterase inhibitor, it 
would be very important to evaluate drugs with different mechanisms of action for their 
potential therapeutic application to this multifactorial disease. The findings in this study 
demonstrate that MC14 and MC22 can potentiate the action of NGF, including 
neurodifferentiation activity, neuroprotective activity against oxidative stress, and most 
importantly, the survival supporting activity and neurite-regenerating activities. These 
evidence strongly support the pharmacological application of MC14 and MC22 for the 
treatment of neurodegenerative disorders such as Alzheimer’ disease.   
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